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The field of human social genomics examines the role of gene expression as a biological 
mediator in the relationship between the social environment and health. As many studies in this 
field have been small, lacked replication, and a consensus on best methodological approach, a 
larger epidemiologic investigation of such associations was warranted. The overarching goal of 
this dissertation is to contribute to the human social genomics literature by investigating the 
association between a range of social environmental factors (i.e. adult and childhood 
socioeconomic status (SES), loneliness, major or lifetime discrimination, perceived stress, 
chronic burden, and social support) and monocyte gene expression using the Multi-Ethnic Study 
of Atherosclerosis (MESA) and three different methodological approaches (i.e. an omnibus test 
for the entire gene expression set using Global Analysis of Covariance, testing each pair of social 
environmental factors and gene expression using multiple linear regression, and a machine 
learning method that performs variable selection with a correlated set of predictors called elastic 
net). 
Aim 1 provides evidence that some genes are “socially sensitive” (i.e. demonstrate 
differential expression across social environmental exposures). Of the 1,854 gene transcripts 
previously identified as part of the ‘conserved transcriptional response to adversity’ only a small 
percent - between 0 to 11% - were associated with one of the seven aforementioned exposures. 
In Aim 2, a focus specifically on expression of inflammation and immune response gene 
pathways based on Gene Ontology classifications found significant associations between 
loneliness (p=0.003), chronic burden (p=0.002), and major or lifetime discrimination (p=0.045) 
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in global analyses with expression of the small subset of 20 gene transcripts related to the 
chronic inflammation pathway. In Aim 3, the extent to which social environmental factors 
explain the relationship between race/ethnicity and gene expression was examined. Of the 1407 
unique gene transcripts examined, there were Black/White differences in 32%, Black/Hispanic 
differences in 19%, and Hispanic/White differences in 24%. Accounting for a racially/ethnically 
pattered social environmental factor (i.e. discrimination, adult SES) in the association between 
race/ethnicity and gene expression changed the effect estimate by >10% for less than 5% of the 
inflammation and immune response genes investigated.  
In investigating the associations between social environmental factors and monocyte gene 
expression, this dissertation provides an important contribution in the field of human social 
genomics by examining the reproducibility of associations, the utility of different methodological 






CHAPTER I: Introduction 
Goal 
 
The overarching goal of this dissertation is to investigate the association between the social 
environment and gene expression in peripheral blood cells (i.e. monocytes).  The contribution of 
social determinants (e.g. socioeconomic status, psychosocial stress, neighborhood environment, 
socially constructed racial categories) to health has been well established1–4. However, the 
mechanisms through which social exposures “get under the skin” to affect biological functioning 
are just starting to be elucidated. Gene expression is a likely biological mediator in the 
association between the social environment and health, yet more research is needed to interrogate 
this relationship.  
As proper immune system functioning plays a role in risk for both acute and chronic 
diseases, we focus attention on expression of genes in this biological process with a particular 
focus on those involved in the inflammatory response. Epidemiologic evidence suggests that 
chronic inflammation varies by social environmental factors including race/ethnicity. 
Contemporaneously, studies also show that exposure to adverse social environments is 
associated with gene expression. A main objective of this dissertation is to bridge these 
literatures by conducting an epidemiological study investigating the association between social 






Social environmental exposures such as socioeconomic status, psychosocial stress, and 
socially constructed racial/ethnic categorizations have been consistently found to associate with 
risk of chronic disease 2,4,5. The burden of disease is exacerbated by the pronounced disparities 
that exist in the U.S. across social environment measures. For example, it has been estimated that 
100,000 additional Black people die each year that would not die without the existence of racial 
health disparities, costing approximately 34 billion dollars in direct medical excess cost 6,7. In 
order to develop the most efficient treatment and prevention approaches to address the burden of 
chronic diseases, it is imperative that research uncovers the ways in which the social 
environment mechanistically affects biological functioning.  
The intended contribution of this dissertation is to examine altered gene expression as a 
biological mediator that in part explains how the social environment (including race/ethnicity) 
affects disease risk.  This work contributes to the emerging body of human social genomics 
literature that identifies genes whose expression is affected by social environmental exposures. 
This inherently interdisciplinary area is explored in this dissertation from multiple intersecting 
angles including social determinants of health, genetics, and the utility of three different 
methodological approaches in an effort to move this field forward.  
Background 
 
Social Environment and Disease Risk 
Substantial research in the epidemiological literature has found associations between the 
social environment and disease risk2,4,5. Among the most consistent social environmental factors 
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found to associate with disease risk are socioeconomic status, psychosocial stress, and socially 
constructed race/ethnicity.  Socioeconomic status (SES) is an important social environment 
exposure that is considered a fundamental cause of disease for four reasons: 1) it influences 
multiple disease outcomes 2) it affects disease outcomes through multiple risk factors 3) it 
involves access to resources that can used to avoid or minimize consequences of disease once it 
occurs and 4) it is reproduced over time through the replacement of intervening mechanisms 2. 
SES is associated with health through a variety of environmental, behavioral, and physiological 
pathways 2,8.  Factors such as access to health care, opportunities for physical activity, and access 
to healthy foods represent some of the mechanisms through which SES affect health 9–11. Despite 
use of varying measures of socioeconomic status (e.g. income, education, subjective social 
status) in the literature, SES has consistently been found to inversely associate with risk of many 
disease outcomes including heart disease, cancer, stroke, and diabetes 12–15.  
 Interestingly, socioeconomic status in childhood has been found to be associated with 
adult health status even after controlling for adult SES16.  Reviews by Galobardes and colleagues 
representing 40 studies found that childhood SES is inversely associated with risk of mortality 
from cardiovascular disease, respiratory disease, diabetes, cancers of the lung, liver, and 
stomach, diseases of the digestive system, and overall mortality 16,17. Like SES, psychosocial 
stress is an important social environmental exposure that has been shown to predict disease risk. 
Psychosocial stressors include factors such as perceived stress, discrimination, and chronic 
burden. The extant literature suggests that psychosocial stress exposure is associated with 
numerous disease outcomes including stroke, transient ischemic attack, atherosclerosis, and 
hypertension 1,18,19. Further, a meta-analysis of 10 prospective cohort studies (n=68,222) found 
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evidence of a dose response relationship between psychosocial distress with risk of mortality 
even after adjustment of behavioral and socioeconomic factors 20. 
The persistent racial/ethnic disparities in health can be partially explained by exposure to 
racially/ethnically patterned social environments21–23.   In the United States, Blacks and 
Hispanics tend to have lower socioeconomic statuses, as measured by income, education, and job 
status compared to non-White Hispanics 4,24. Recent work suggests that socioeconomic and 
demographic variables together may explain up to 80% of Black-White racial disparity in life 
expectancy for males and 70% for females 24. Further, Blacks and Hispanics consistently report 
higher levels of psychosocial stress in terms of frequency, longevity, and reactivity 25,26.   
Interestingly, it has also been found that U.S. born Hispanics have similar stress levels as Blacks 
while foreign born Hispanics had levels similar to Whites suggesting that minority status 
contributes to stress levels26.  
 
Chronic Inflammation 
To fully understand how social environmental factors affect disease risk, it is important to 
investigate the relationship between the social environment and biological risk factors. In this 
dissertation, we focus specifically on chronic inflammation, a risk factor for several chronic 
diseases that has been suggested as a mechanism through which the social environment (e.g. SES 
and psychosocial stress) associates with chronic disease risk27–29.  Chronic inflammation is 
characterized by prolonged and persistent inflammation lasting weeks to years due to an inability 
to overcome the effects of an injuring agent or a hyperresponsiveness of the immune response 30. 
In chronic inflammation, mononuclear cells in peripheral blood infiltrate tissues and produce 
proteinases and fibroblasts.  While these processes are beneficial in the short term to rid the body 
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of injuring agents, in the long term, these processes lead to destruction of the body’s healthy 
tissue.   
The consequences of a chronic inflammatory profile extend across a number of high 
burden diseases. For example, chronic inflammation has been linked to cardiovascular disease, 
diabetes, and some types of cancer 31–35.  A study by Zacho and colleagues found that people 
with high levels of the inflammatory biomarker C-reactive protein (CRP) had 1.6 times the risk 
of ischemic heart disease and 1.3 times the risk of cerebrovascular disease compared to those 
with low levels 31. Levels of the inflammatory biomarkers interleukin-6 (IL-6), CRP, and tumor 
necrosis factor-alpha (TNF-a) were shown to be higher in colorectal cancer patients compared to 
normal controls 35. Among cancer patients, levels of these biomarkers were found to be 
associated with tumor size35. Physiologically, chronic inflammation is believed to play a role in 
both atherosclerotic plaque formation and rupture which are characteristic of cardiovascular 
disease 30. In diabetes, inflammation is thought to lead to insulin resistance and beta cell 
dysfunction via oxidative stress and endoplasmic reticulum stress mechanisms 36,37.  
Inflammatory signaling also plays a role in processes associated with cancer development 
including cell proliferation, resistance to apoptosis, and genomic instability 34.  
Based on its association with disease, investigations of the factors that affect chronic 
inflammation is warranted. The current literature suggests that chronic inflammation may be 
influenced by both environmental (social environment) and biological (e.g. gene expression) 
factors. A study using the Midlife in the United States (MIDUS) study found that socioeconomic 
status, as measured by income and education, was inversely associated with C-reactive protein 
(CRP), interleukin-6 (IL-6), and fibrinogen levels 29. This finding has held across additional 
measures of SES in other studies such as job status, which has been found to associate with CRP, 
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IL-6, sICAM1 and ET-1 31–34. These findings have also been consistent across geographic 
contexts. In an international review across 9 countries (US, UK, Finland, Greece, Germany, 
Canada, Italy,  Turkey, and New Zealand) spanning 20 studies, SES was found to be inversely 
associated with CRP in 19/20 studies 41.  Similarly, socioeconomic status in childhood has also 
been found to associate with adult inflammatory profile. A study in the Atherosclerosis Risk in 
Communities (ARIC) found that childhood SES, as measured by social class and parental 
education, was inversely associated with levels of the inflammatory markers fibrinogen, von 
Willebrand factor, CRP, and WBCs in adulthood 42.  A 2011 study by Carroll and colleagues 
found childhood SES at 1-2 years of life to be  associated with IL-6 levels in adulthood, even 
after controlling for adult SES 43. Further, it has been suggested that childhood SES can predict 
CRP levels of offspring pointing towards intergenerational effects of childhood SES on 
inflammation and disease risk 44. 
Associations between psychosocial measures and inflammation have been previously 
investigated as well. Loneliness, the perception of the quality of one’s personal relationships is a 
strong risk factor for both acute and chronic diseases45–47. Lonely individuals report higher levels 
of stress, even after accounting for objective measures of social isolation48. Impaired immune 
system functioning is one the physiological consequences of loneliness 28,46,48.  Research has 
shown that loneliness is associated with delayed wound healing and altered cytokine likes (e.g. 
interleukin-1B, tumor necrosis factor) 28. 
Studies of the association between discrimination and protein level markers of 
inflammation have yielded mixed findings. For example, a study by Lewis and colleagues found 
a positive association between everyday discrimination and CRP using data from the Minority 
Aging Research Study of older African-Americans, yet a study by Kershaw and colleagues found 
7 
 
no relationship using the Multi-Ethnic Study of Atherosclerosis49,50. The complex relationship 
between discrimination and inflammation may be modified by factors such as race/ethnicity, sex, 
and body mass index50,51.  
Stress, whether experienced acutely or chronically has been associated with levels of 
inflammatory biomarkers. A meta-analysis consisting of 30 studies that assessed the relationship 
between acute psychological stress found that stress exposure consistently led to altered levels of 
inflammatory biomarkers including CRP, IL-16, TNF-alpha, and IL-1β 52 whereas chronic stress 
exposure such as job stress, childhood adversity, and caregiver stress, have been shown to have 
significant associations with levels of inflammatory biomarkers as well 53.  
Social support has been found to positively influence health in part due to its ability to 
buffer the effects of exposure to social and psychosocial stressors54. Epidemiologic evidence 
suggests that social support is associated with natural killer cell activity, an important leukocyte 
that is responsible for neutralizing tumor and virus infected cells55.   The relationship between 
social support and inflammation has been inconsistent with some studies showing an inverse 
relationship and others showing no relationship which may be in part due to lack of 
consideration of potential effect modifiers (e.g. race/ethnicity) in the literature56.  
Racial/ethnic differences in inflammation exist where minority groups, Blacks and 
Hispanics in particular, have adverse inflammatory profiles compared to non-Hispanic Whites. 
For example, Blacks had higher levels of CRP compared to non-Hispanic Whites in sex stratified 
analyses in a sample from the Dallas Heart Study 57. A study using NHANES assessing the 
association between acculturation and inflammation among Hispanics found that more 
acculturated Hispanics had higher levels of CRP compared to less acculturated Hispanics, 
suggesting that minority status may have an effect on inflammation 58. The association between 
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minority status and inflammation in U.S. samples is supported by a trans-country review of 15 
studies where the minority group had a worse inflammatory profile compared to the majority 
group in all countries 41. This review included studies from the United States, United Kingdom, 
and Canada. As expected, in the U.S. studies, Blacks and Hispanics tended to have higher levels 
of the inflammatory biomarker CRP compared to non-Hispanic Whites.  Similarly, studies in the 
U.K. found that South Asians, the minority group, had higher levels compared to European 
Whites. South Asians and Aboriginals had higher CRP levels than Europeans and Chinese 
individuals in the Canadian study.  This review suggests that membership in a racial/ethnic 
minority group is associated with adverse inflammatory profiles and highlights the effect of 
socially constructed race/ethnicity on inflammation. 
While most work investigating the association between the social environment and 
inflammation has been conducted with protein markers, some studies have interrogated this 
relationship at the gene level.  Investigators in the emerging field of human social genomics have 
begun to identify genes whose expression is sensitive to social environment stimuli59,60. It has 
been proposed that genes involved in certain biological processes, including inflammation, are 
differentially expressed based on exposure to adverse social environments, a phenomenon that 
has been coined “conserved transcriptional response to adversity.” For example, genome wide 
analyses investigating the relationship between loneliness and socioeconomic status with gene 
expression implicated 144 and 387 genes respectively, and there was an enrichment of 
proinflammatory genes among the differentially expressed 48,61.  Other studies have found a 
range of social environmental factors to associate with inflammatory gene expression including 
caregiver stress 62, well-being 63, positive vs. negative affect 64, and grief 65. Such studies have 
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helped to shed additional light on gene expression as a biological mechanism whereby social 
environmental factors affect biological functioning and thereby overall health61,66.  
Although genome wide studies have found evidence for racial/ethnic differences in gene 
expression, previous human social genomics studies have had limited capacity to investigate 
social environmental exposures as contributors to race/ethnicity differences in gene expression 
due to the use of homogenous samples. Using samples from HapMap, Storey et. al and Zhang et 
al. found gene expression differences between Whites and Yoruba Nigerians in 17% and 34% of 
genes respectively67,68.  Storey found that among differentially expressed genes, there was an 
enrichment of inflammation associated genes67.  However, the extent to which the social 
environmental factors can explain racial/ethnic differences in gene expression remains largely 
uninvestigated. 
In this dissertation, we extend our current understanding of human social genomics by 
investigating associations between the social environment and gene expression, with a particular 
focus on inflammation and immune response genes. This work helps to elucidate the 
mechanisms through which well-established associations between the social environment and 
health act such that more precise prevention and treatment approaches can be developed.  
Research Aims 
 
Aim 1:  Conduct a large, epidemiologic study assessing the association between a range of social 
environmental factors (i.e. childhood SES, adult SES, perceived stress, social support, perceived 
discrimination, loneliness, and chronic burden) with expression of the set of genes previously 




Hypothesis 1: We hypothesize that the social environmental factors will be significantly 
associated with the conserved transcriptional response to adversity genes in the MESA sample.  
 
Aim 2:  To examine the association between a range of social environmental factors (i.e. 
childhood SES, adult SES, perceived stress, social support, perceived discrimination, loneliness, 
and chronic burden) with the expression of inflammatory and immune system related genes 
identified using the Gene Ontology database including: chronic inflammatory response genes 
(GO: 0002544), inflammatory response genes (GO: 0006954), immune response (GO: 
GO:0006955), and the regulation of the inflammatory response (GO: 0002544). 
 
Hypothesis 2: We hypothesize that there will be an association between the social environmental 
factors with the expression of genes in the selected gene sets.  
 
Aim 3: Evaluate whether there exist racial/ethnic differences in gene expression for 
inflammatory and immune response genes and the extent to which the associations can be 
explained by racially/ethnically patterned social environmental factors.   
Hypothesis 3: There will be racial/ethnic differences in gene expression which will be partially 










CHAPTER II: Assessing the conserved transcriptional response to 





It has been well established that the social environment influences health. Social and 
psychosocial factors have been consistently associated with both acute and chronic diseases 
ranging from the common cold to cardiovascular disease and diabetes 2,22,69,70.  Research has now 
turned to understanding the ways in which these social exposures “get under the skin” and cause 
adverse biological effects that lead to these diseases. One of the mechanisms through which the 
social environment may increase disease risk is via impaired immune system functioning.  A 
large literature has documented associations of low socioeconomic status (SES) in both 
childhood and adulthood with inflammation in later life 29,41,42,71. Additionally, several 
psychosocial factors including discrimination, perceived stress, depression, and cynical distrust 
have also been associated with altered inflammatory processes 49,52,53,72,73. Inflammatory 
processes have in turn been associated with chronic diseases such as cardiovascular disease and 
diabetes 34,74–76. However, the precise biologic mechanisms linking low SES or psychosocial 
exposures to a heightened inflammatory response have yet to be determined. 
Recent studies provide preliminary evidence that exposure to adverse social 
environments is associated with differential gene expression, particularly in immune system 
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related genes. For example, Cole and colleagues report differential expression of 144 genes (209 
transcripts) between individuals with high levels of loneliness and low levels of loneliness where 
more lonely individuals overexpress proinflammatory genes and underexpress antiviral immune 
response genes48. Subsequent studies by Cole and others have found similar associations 
between low socioeconomic status 61, caregiver stress 62, well-being 63, positive vs. negative 
affect 64, and grief 65 with expression of immune system related genes.  Studies in animals have 
shown similar findings.  Maternal versus surrogate rearing was associated with differential 
expression of immune system genes in rhesus macaques 77.  In mice, differential expression of 
inflammatory genes was observed between mice exposed to repeated social defeat and control 
mice 61.   This response of altered gene expression in immune-system related genes in response 
to adverse social exposures has been coined the “conserved transcriptional response to adversity” 
(CTRA) and is categorized by an upregulation of proinflammatory genes and down regulation of 
Type 1 interferon and antibody synthesis genes 60,78. 
The promising preliminary findings in previous studies of the conserved transcriptional 
response to adversity motivated us to raise the larger question of whether expression of 
previously implicated genes would vary with a range of social environmental factors in a large, 
epidemiologic cohort. To our knowledge, there has not been a systematic, large epidemiological 
study of the relationship between social environmental factors and gene expression.  
In the present study, we use the Multi-Ethnic Study of Atherosclerosis to assess whether 
seven social and psychosocial factors (e.g. childhood socioeconomic status, adult socioeconomic 
status, loneliness, lifetime discrimination, chronic burden, perceived stress, and social support) 
are associated with expression of genes previously found to be related to social and psychosocial 
factors (Table 1). As the field of human social genomics is relatively new, there is not yet a 
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consensus on the best method for assessing the association between social exposures and gene 
expression.  The correlated nature of gene expression across the genome and the high probability 
of false positives from multiple testing make it difficult to identify ideal statistical methods to 
assess associations with social environmental factors.   In this paper, we examine three methods 
that provide different, but complementary insights into approaches to investigating the 
association between social environmental factors and genes expression by focusing on genes 
implicated as part of the conserved transcriptional response to adversity.  In the first approach, 
we employ a self-contained gene set enrichment test, Global Analysis of Covariance 
(ANCOVA), to globally assess whether expressions of any of the CTRA genes are associated 
with the exposure. Secondly, we use multivariable linear regression to identify which specific 
genes are significantly associated with the exposure. In the third approach, we use elastic net 
penalized regression as a variable selection procedure to extricate the genes that are the most 




Study sample  
The Multi-Ethnic Study of Atherosclerosis (MESA) was designed to investigate risk 
factors for the development and progression of subclinical cardiovascular disease 79. The 
baseline cohort was comprised of 6,814 adults aged 45-84 who self-identified as African-
American, Chinese-American, White, or Hispanic and were free from clinical cardiovascular 
disease. Participants were recruited from six field sites across the United States between 2000 
and 2002 (Baltimore, Maryland; Chicago, Illinois; Forsyth County, North Carolina; Los Angeles, 
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California; New York, New York).  Four follow-up examinations have been conducted with 
Exam 5, the fourth follow up, ending in December 2011. The response rate has been excellent 
with 78% participants returning for Exam 5. Each exam consisted of a clinic visit where 
questionnaires on demographic, psychosocial, and lifestyle factors were administered, and 
physical assessments including the blood draw needed for genetic analyses were conducted.  
Gene expression was collected solely in Exam 5 on a random sample of 1,264 
individuals80. There were three racial/ethnic groups represented in this subsample where 272 
participants were non-Hispanic Black, 402 were Hispanic, and 590 were non-Hispanic White. 
Participants were recruited from four of the six MESA study sites: Forsythe County, North 
Carolina (49 participants), New York, New York (424 participants) Baltimore, Maryland (317 
participants) and St. Paul, Minnesota (474 participants). Non-Hispanic Blacks were recruited 
mostly from the New York and Baltimore sites. Hispanics were recruited from the New York 
and Rochester sites.  Whites were recruited from all four sites. These individuals make up the 
study sample for the current study. 
 
Social environmental factors 
Adult Socioeconomic Status 
Highest level of education was collected in Exam 1 and was dichotomized as a measure 
of adult socioeconomic status. Respondents were considered highly educated if they had 






Childhood Socioeconomic Status 
Mother’s and father’s level of education were collected in Exam 2 to proxy childhood 
socioeconomic status.  A parent was considered highly educated if he or she had achieved at 
least a high school degree.  Childhood SES was dichotomized. The respondent was considered to 
have a high childhood SES if either parent had at least a high school degree.   
 
Perceived Stress 
Perceived stress was measured using Cohen’s the 4-item Perceived Stress Scale (PSS) in 
Exam 5 81,82 . The respondent was asked whether they felt: unable to control the important things 
in his or her life, confident about his or her ability to handle personal problems, things were 
going his or her way, or difficulties were piling up so high that he or she could not overcome 
them in the past month. Respondents answered on a five point Likert scale corresponding to the 
answer choices never, almost never, sometimes, fairly often, and very often. A summary measure 
was created by reverse coding the positive items (items 2 & 3) and summing the items such that 
a higher value indicated a higher level of perceived stress. 
 
Major or Lifetime Discrimination 
Major or lifetime discrimination was collected in Exam 1 and was adapted from the 
Detroit Area Study83. Respondents were asked about whether they ever had been fired or denied 
a promotion, not hired for a job, treated unfairly by the police, discouraged by a teacher from 
continuing education, prevented from moving into a neighborhood, or neighbors have made their 
life difficult 83.  A discrimination score was computed by summing the number of ‘yes’ 




Chronic burden was assessed using the Chronic Burden Scale in Exam 384. Participants 
were asked whether they had experienced ongoing problems in the following five domains: their 
own health, health of a loved one, job, relationship, financial problems. For affirmative 
responses, participants were subsequently asked whether this had been a problem for at least 6 
months and whether this burden was not very stressful, moderately stressful, or very stressful. To 
estimate overall chronic burden, we summed the number of domains for which the respondent 
had experienced a chronic burden for at least 6 months and reported that it was either moderately 
or very stressful. A higher score indicated a higher level of chronic burden. 
 
Social support 
Social support was measured in Exam 4 using a 4-item scale adapted from the Midlife in 
the United States (MIDUS) study85. The questions asked how much friends and family can be 
relied upon for help with a serious problem, how much friends and family can be opened up to to 
talk about worries, how often friends and family make too many demands on the respondent, and 
how often friends and family let them down.   Possible answer choices included: a lot, some, a 
little, not at all and were coded as 1, 2, 3, and 4 respectively. Positive items (items 1 & 2) were 
reverse coded and the sum of the 4 items was calculated to achieve an overall social support 
score where a higher score indicated greater social support. 
 
Loneliness 
Loneliness was measured in Exam 4 using a three item scale adapted from the UCLA 
Loneliness Scale86.  Participants were asked how often they lack companionship, feel left out, or 
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isolated from others.  Possible answer choices included: hardly ever, some of the time, and often 
and were coded as 1, 2, and 3 respectively.  A score was created by summing the three items. A 
higher score indicated a higher level of loneliness. 
 
Covariates 
Age, sex, and race/ethnicity were self-reported via questionnaire.  
 
Gene expression 
Gene expression data was collected from purified monocytes of 1,264 participants in 
MESA Exam 5.  Detailed methods have been previously described 80. Briefly, peripheral blood 
mononuclear cells (PBMCs) were separated within two hours of blood draw using Vautainer 
CPT cell separation tubes.  Monocytes were purified from the PBMCs using anti-CD14-coated 
magnetic beads. DNA and RNA were extracted using the AllPrep DNA/RNA Mini Kit. The 
resulting cRNA was hybridized to the Illumina HumanHT-12 v4 Expression BeadChip. This 
chip has probes for 47,231 transcripts (~31,000 genes), and is designed to assay 12 samples per 
chip. A stratified random sampling technique was used to assign samples to each chip avoid 
biases due to batch, chip, or position.   
 Preprocessing and quality controls steps were conducted to ensure accurate quantification 
of the gene expression data. Illumina’s proprietary software Genome Studio was used to correct 
for local background. The remaining preprocessing steps were conducted using Bioconductor 
packages in R.  Since the bead chip has multiple copies of each probe, a bead-type 
summarization (mean and variance) was produced for each transcripts using the beadarray 
package87. The negative controls on the array were used to compute the detection p-value.  The 
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limma package was used for background correction, quantile normalization, log2 transformation, 
and removal of control probes88.  Quality control criteria for elimination of a transcript 
included:  ‘detected’ expression levels in <10% of MESA samples (detection p-value cut-
off=0.01), probes that contain a SNP, probes with low variance across samples (<10th percentile), 
and probe overlap with a non-unique region.  
 
Gene Set Definition 
A systematic literature review was conducted in July 2015 to identify all primary studies 
that reported finding an association between a social or psychosocial factor and the “conserved 
transcriptional response to adversity.” Google Scholar and PubMed databases were used with the 
search term “conserved transcriptional response to adversity.” This search yielded a total of 63 
unique studies.  The following inclusion criteria were applied: primary study, gene expression as 
outcome, and a primate organism. These criteria resulted in 8 studies to be included in the 
analyses.  Since the 2007 study by Cole and colleagues was foundational in describing the 
conserved transcriptional response to adversity research, we also included this study.  Therefore, 
9 studies were included (Table 1).  Of these, 8 were conducted in humans and 1 in rhesus 
macaques.  We combined all the genes that were considered differentially expressed to compose 
a single gene set.  The HUGO Gene Nomenclature Committee (HGNC) Mulitsymbol Checker 
was used to identify all potential synonyms and previous names of genes.  Genes that had been 
withdrawn or did not match to an approved HGNC gene name were excluded.  We then used the 
BioMart ID Conversion tool to match gene names to the transcript identification number on the 
Illumina HumanHT-12 v4 gene chip. When a gene appeared in more than one study, we only 
included it once in the gene set (Appendix 1). There was some overlap in implicated genes 
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between studies (Appendix 2). For cases where a gene matched to more than one transcript, we 
included all transcripts in the analyses. The final gene set consisted of 1,854 transcripts 
representing 1,305 unique genes (Appendix 1). 
 
Table 1. Primary Studies of the Conserved Transcriptional Response to Adversity in Primates 
Study Exposure # significant 
genes 
Sample size 
Cole, Steven W., et al. 
(2007) 
Loneliness 144 14 
Miller, Gregory E., et 
al. (2008) 
Caregiving stress 542 21 
Cole, Steven W., et al. 
(2012) 
Maternal rearing vs. surrogate 
rearing 
132 9 rhesus macaques 








L., et al (2013): 
Hedonic and eudaimonic well-
being 
53* 84 
Powell, Nicole D., et 
al.  (2013) 
Socioeconomic status 387 60 







Wingo, A. and Gibson, 
G  (2015) 
Anxiety disorder 631 336 






Total number of unique genes (transcripts): 1,305 (1,854) 
*In the Fredrickson and Vedhara studies, 53 genes representing the conserved transcriptional 





We assessed the association between each social environmental factor and the entire set 
of gene expression levels from all previously implicated genes (1,854 transcripts from 1,305 
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unique genes) using a global test (Global ANCOVA)89.  This test has the null hypothesis that no 
genes in the gene set are associated with exposure status89,90.  
Briefly, a linear model where the outcome is the expression of one gene transcript is the 
building block of the Global ANCOVA model. Expression for the ith gene is expressed as  ?̃?(𝑖), 
n is the number of individuals, and d is the number of covariates. 
 
?̃?(𝑖) = 𝐶 ∙ 𝛽𝑖


















)   (1) 
 
C is a matrix of size n x (d+1) which represents the covariate values for each individual. The 
gene specific mean expression is quantified by 𝛽𝑖0. The regression coefficient vector, 𝛽𝑖
𝑡, reflects 
the influence of each covariate on expression of the ith gene. The residual for each individual is 
given by the 𝜉(𝑖) vector. 
In the Global ANCOVA model, expression of p genes is measured in n individuals. The 
linear model is extended to account for all genes under investigation in a gene set.  This 




















)    (2) 
 
The gene expression values of the entire gene set (?̃?), is expressed as an np column 
vector, representing gene expression of each gene for each individual. It is a function of the 
product ?̃? and 𝛽 plus 𝛯, where ?̃? is a np x (d+1)p sized diagonal block matrix representing the 
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covariate information for each individual, 𝛽 is a column vector of size (d+1)p which quantifies 
the relationship of each exposure and covariate on the expression of each gene in the gene set, 
and 𝛯 is np sized column vector which accounts for the noise for each individual for each gene in 
the gene set.  For each Global ANCOVA test in our study, there were 1,264 participants (n), one 
main social environmental factor of interest (each investigated in a separate model), and 4 
additional covariates (age, sex, study site, and race/ethnicity).   
To assess the null hypothesis, H0: β1=β2… βp=0, an F test was conducted using the 
residual sum of squares from reduced (covariate matrix excludes the exposure of interest) and 
full (covariate matrix contains the exposure of interest) models to determine the significance for 








     (3) 
 
where RSSRM is the residual sum of squares of the reduced model, RSSFM is the residual sum of 
squares of the full model, n is the number of samples, q is the number of parameters in the full 
model, and f is the difference in number of parameters between the full and reduced models. 
Since the assumption of independent homoscedastic gene expression is unlikely to hold 
and is necessary for the classical F-test, we used a permutation based approximation approach in 
order to assess significance of the Global ANCOVA tests using the strategy described in 
Hummel 200889. Briefly, we permuted the rows of covariate matrix of the reduced model 10,000 
times and calculated the residuals of the full model by fitting the residuals of the reduced model 
to the permuted design matrix to develop the resampled value of the F statistic. An empirical p-




Gene level analyses 
Multivariable linear regression 
While the global test evaluates the compound hypothesis that at least one gene in a 
particular set is differentially expressed by social environmental exposure, it is not designed to 
identify which gene in the set leads to the rejection of the null hypothesis. We conducted 
subsequent analyses estimating the regression coefficient for each gene in a significant gene set 
using the multivariable linear regression model in Equation 1. A false discovery rate correction 
for correlated data of 10%  was used to account for multiple testing91. 
 
Elastic net regression 
While examining single gene effects is common practice, it has low power to identify the 
key gene transcripts after adjustment for multiple testing. Moreover, a one at a time analysis can 
miss important correlation across gene transcripts. Ordinary least squares regression with all 
1,854 gene transcripts simultaneously in the model cannot be operationalized when the number 
of gene transcripts (p) exceeds the number of individuals (n).   
There are a number of alternative approaches that handle the curse of dimensionality (i.e. 
issues that arise in analyzing high dimensional data) by using penalization techniques92 . 
Whereas OLS identifies the best fit line by minimizing the residual sum of squares (i.e. 
argminβ|𝑦 − 𝑋𝛽| 2), penalized regression methods subject this term to an additional 
penalty/penalties to improve prediction and interpretation93,94.  Ridge regression is one such 














 where in our  present analysis,  the 1,854 gene transcript expressions that make up our CTRA 
gene set are the high dimensional predictor variables (𝑥) and the social environmental factor is 
the outcome (𝑦). For 𝑛 individuals and 𝑝 gene transcript expressions, let 𝑦𝑗 be the value of the 
social environmental factor for person 𝑗, 𝑥𝑗𝑖 be the gene expression value for person 𝑗 for gene 𝑖, 
and 𝛽𝑖 be the beta estimate corresponding gene 𝑖. Ridge regression can be viewed as a way to 
handle collinearity among the predictors and stabilize OLS when 𝑝 > 𝑛 .  The term ∑ 𝛽𝑖
2𝑝
𝑖=1  is 
often referred to as the L2 norm. The tuning parameter 𝜆 is optimally chosen by using cross-
validation techniques. Ridge regression shrinks the beta-coefficients towards zero and stabilizes 
the design matrix for the multivariable regression with correlated predictors. Ridge regression is 
particularly well-suited for prediction problems. It does not offer the option of variable selection 
or identifying important gene transcripts as it retains all the predictors in the model. 
Modern variable selection methods, in particular LASSO (least absolute shrinkage and 
selection operator) conducts both shrinkage and variable selection and has the ability to shrink 
the beta coefficients exactly to zero, thus performing variable selection93. In contrast to Ridge 
regression, LASSO minimizes the following penalized error: 
 












Here the L2 norm penalty in Ridge regression (∑ 𝛽𝑖
2𝑝
𝑖=1 )is replaced by L1 norm penalty 
(∑ |𝛽𝑖|
𝑝
𝑖=1 ). However, LASSO does not perform well when the predictors (𝑥) are correlated. 
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LASSO indiscriminately selects just one gene if a group of genes are highly correlated. Since 
genes in a biological pathway are expected to be correlated, selection of just one gene would 
preclude detection of biological processes.   
The elastic net is a hybrid of Ridge regression and LASSO and does a better job of 
conducting both variable selection and adjustment for correlation among predictors through use 
of both L2and L1 penalties. For high-dimensional, correlated data, the elastic net has been 
demonstrated to be superior to LASSO for selecting predictors that create the most parsimonious 
model94 with optimal prediction error.  In this study, because of the large number of gene 
transcripts (𝑝=1,854) that are potentially correlated and modest number of observations 
(𝑛=1,264), to fit a multivariable regression model, we use elastic net to identify the transcripts 
most strongly related to the social/psychosocial factor.  
The elastic net penalty is given by: 
 







+ 𝜆2 ∑ 𝛽𝑖







where in the present study n=1264 individuals and p=1854 gene transcripts. 
The two tuning parameters 𝜆1 and 𝜆2 control the trade-off between bias and variance
95. 
To numerically search for the optimal set of tuning parameters,  𝜆1 is often fixed on a grid of 
values and the optimal 𝜆2 is determined using leave one out cross validation
96. Elastic net 
penalized regression94 was employed using the ‘glmnet’ package in R97. In actual 











+ 𝜆  (𝛼 ∑ 𝛽𝑖







Where 𝜆 = 𝜆1 + 𝜆2, and 𝑤 = 𝜆1/(𝜆1 + 𝜆2).  Note that 𝛼 = 0 corresponds to LASSO and 𝛼 = 1  




To ensure comparability across the three statistical approaches, we adjusted the social 




SAS 9.3 and R were used to conduct statistical analyses.  
Results 
In the sample of 1,264 MESA participants with available gene expression data, the mean 
age was ~70 years and 51% of the sample was female.  For the socioeconomic variables, 33% of 
the total sample of adults had finished a level of schooling equal to a college degree or higher. 
Slightly over half of the sample (56%) had either a mother or father achieve at least a high school 
degree. Whites (49%) were more likely to have obtained a college degree than Blacks (27%) or 
Hispanics (13%) (p<0.001 and p<0.001 respectively). Blacks were significantly more likely to 
have a college degree that Hispanics (p<0.0001). The same pattern was observed for childhood 
SES where Whites (71%) were more likely to have at least one parent with a high school degree 
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compared to Blacks (55%) or Hispanics (31%)  (p<0.001 and p<0.001 respectively), and Blacks 
were significantly more likely to have a parent with a high school degree than Hispanics 
(p<0.0001). For most of the psychosocial exposures, the median scores were close to the 
minimum score indicating that most of the participants reported low levels of these exposures. 
There were not significant racial/ethnic differences in these scores except for major or lifetime 
discrimination (p<0.001). Tukey’s honest significance test indicated that Blacks reported higher 
levels than Whites (p<0.001) or Hispanics (p<0.001). There was not a significant difference 
between Whites and Hispanics (p=0.16).The correlation among the psychosocial exposures is 
presented in Appendix 3. The most correlated exposures were loneliness and chronic burden 
(r=0.36) and the least correlated exposures were major or life discrimination and perceived stress 






Table 2. Characteristics of the MESA Study Sample with Gene Expression Data 








Demographics     
Age mean  (SD) 69.6 (9.4) 69.6(9.0) 68.4(9.3) 70.2(9.5) 
Sex (% female) 51 60 50 48% 





    
Forsythe County, 
North Carolina  
49(4%) 1(0.3%) 0 48 (40%) 
New York, New 
York  
424(34%) 131(48%) 209 (52%) 84 (14%) 
Baltimore, 
Maryland  
317(25%) 140(51%) 0 177 (30%) 
Rochester, 
Minnesota  
474(38%) 0 193 (48%) 281 (48%) 
Total  1264(100%) 272 (100%) 402 (100%) 590 (100%) 
     
Socioeconomic 
Status 
    
High education- 
respondent* 
33% 27% 13% 49% 
High education- 
either parent** 
56% 55% 31% 71% 






    
Loneliness 3 (3-5) 3(3-4) 4(3-5) 3 (3-5) 
Lifetime 
Discrimination 
0 (0-1) 1(0-2) 0(0-1) 0 (0-1) 
Chronic Burden 1 (0-2) 1(0-2) 0(0-2) 1 (0-2) 
Perceived Stress  8 (5-10) 8(5-10) 8(5-10) 7 (6-10) 
Social support  9 (8-10) 9(8-10) 9(8-10) 9 (8-10) 
*High education for respondent indicates an educational level of a college or greater 





Gene set enrichment analyses 
To assess the association between each psychosocial factor and the entire set of 
previously implicated genes (1,854 transcripts from 1,305 unique genes), we conducted Global 
ANCOVA gene set enrichment tests (Table 3).  In global analyses, major or lifetime 
discrimination and chronic burden were significantly associated with the CTRA gene set 
(p=0.019 and p=0.047 respectively).  Loneliness and adult socioeconomic status were marginally 
significant (p=0.066 and 0.093 respectively). Associations between perceived stress, social 
support, and child socioeconomic status were not statistically significant.  
  
Single transcript analyses 
In the second approach, we employed multivariable linear regression analyses to identify 
the specific transcripts that were associated with the exposure (Table 3). At p<0.05, we found 
major or lifetime discrimination to be associated with the greatest number of transcripts (196) of 
any of the other social environmental factors. The list of transcripts significant at p<0.05 is given 
in Appendix 4. Generally, the greatest number of significant linear regression results was found 
for the exposures that were significant or marginally significant in global analyses (i.e. 
loneliness, major or lifetime discrimination, chronic burden, and adult socioeconomic status). 
However, no transcripts were significant after false discovery rate multiple testing correction. 
 
Shrinkage and Variable selection 
Elastic net regression was used to identify the gene transcripts most strongly associated 
with each social environmental factor. The number of transcripts selected for each factor is 
presented in Table 3 and the list of transcripts and corresponding gene name is available in 
Appendix 5. The correlation among selected genes is presented in Appendices 6-10, and a 
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comparison to linear regression findings is given in Appendices 11-17. The greatest number of 
transcripts was selected for loneliness (74) and the least were selected for perceived stress (0). In 
total, elastic net regression identified relationships for 156 unique transcripts across the seven 
social environmental factors. There was very little overlap in implicated transcripts across social 




In this study, we examined associations between seven social environmental factors with 
gene expression using a large, multi-ethnic cohort and three analytic approaches. We focused on 
genes whose expression varied with social environmental factors in previous conserved 
transcriptional response to adversity (CTRA) studies. The CTRA is characterized by differential 
expression in immune system related genes (i.e. proinflammatory, antiviral response, antibody 
Table 3. Results of the Association between Social Environmental Factors with the CTRA 










Loneliness 0.066 192 74 55 
Discrimination 0.019 196 27 27 
Perceived Stress 0.611 93 0 0 
Chronic Burden 0.047 175 12 2 
Social Support 0.662 70 8 7 
Adult SES 0.093 117 46 41 
Child SES 0.435 63 1 1 
# unique 
transcripts across 
all social factors  






584 150 128 
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synthesis) in response to exposure to unfavorable social environmental factors.  Since these 
studies have been limited to small sample sizes and lacked replication in a human cohort, a study 
designed to reproduce the findings in the CTRA literature was warranted.   Further, previous 
studies have varied in statistical approaches, cell type used from which DNA was extracted, and 
model organism which has limited the ability to make cross study comparisons. To our 
knowledge, the present study is the first large, epidemiologic investigation of previously 
published CTRA findings.  
As there is not yet a consensus on the best method for assessing the association between 
social environmental exposures and gene expression, we took three different analytical 
approaches to examine relationships between our seven exposures of interest with expression of 
previously implicated genes and make comparisons between results. Our statistical approaches 
were designed to account for correlation among gene expression, hypothesized confounders, and 
to minimize the number of statistical tests.  In the first approach, a self-contained gene set 
enrichment approach90 was employed to assess the relationship between social environmental 
factors with our CTRA gene set.  This global test informs whether any gene in an a priori defined 
set of genes is associated with an exposure. The Global ANCOVA test was the best suited gene 
set enrichment test for the research question since the analysis included both binary and 
continuous phenotypes, the availability original expression data, and information on potential 
confounders 89,98. Simulation studies indicate that the Global ANCOVA is a highly powered self-
contained gene set enrichment approach especially when using the permutation based p-value 
that helps to account for the unknown correlation structure and heteroscedasticity among gene 
expression89,98–101.  A gene set approach is useful above single gene approaches for two main 
reasons.  As a single test, concern for type I error is reduced for a gene set test compared to 
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single gene analyses approaches. Secondly, since genes exist in complex biological networks 
where small changes in gene expression typically occur across many genes, a gene set approach 
that evaluates groups of genes at a time better reflects the relationships between social 
environmental exposures and gene expression compared to single gene analysis techniques102. In 
the Global ANCOVA analyses, major or lifetime discrimination and chronic burden were found 
to be statistically significant (p=0.019 and p=0.047, respectively) while loneliness and adult 
socioeconomic status were found to be marginally significant (p=0.066 and p=0.093, 
respectively). Perceived stress, social support, and child SES were not significant. 
It is noteworthy that major or lifetime discrimination was statistically significant in global 
analyses (p=0.019). Discrimination is an important psychosocial stressor that has been associated 
with a range of mental and physical health measures3,103. Studies of the association between 
discrimination and protein level markers of inflammation have elicited mixed findings and 
indicate a complicated relationship. For example, a study by Lewis et. al found a significant 
relationship between everyday discrimination and CRP in a sample of older African American 
adults, while a study by Kershaw et. al did not find a significant association in a multiethnic 
sample49,50. Interestingly, in the same study Kershaw et al. did find significant associations with 
the inflammatory biomarker interleukin-6 (IL-6) highlighting the complex nature of the 
discrimination-inflammation relationship50. The differences between the Lewis and Kershaw 
studies may be in part due to sample composition 49,50.  Further evidence indicates that 
relationship between discrimination and inflammation may be modified by other factors such as 
sex and body mass index50,51. 
Chronic burden was also significant in global analyses (p=0.047).  Like discrimination, 
chronic burden has been found to associate with several health measures such as metabolic 
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syndrome and cardiovascular disease104,105. The relationship between chronic burden and altered 
immune system functioning has been well studied in the literature. Chronic stress can influence 
immune system functioning either directly through the hypothalamic-pituitary-adrenal axis 
(HPA) and sympathetic-adrenal-medullary (SAM) system or indirectly through risk 
behaviors5,72,73,106. There is some evidence that chronic stress affects the three processes that 
compose the conserved transcriptional response to adversity (i.e. inflammation, antibody 
synthesis, antiviral response)73,107,108. For example, chronic stress was found to be positively 
associated with the inflammatory biomarkers IL-6 and CRP in the MESA cohort73, a decreased 
ability to synthesize antibodies in response to an influenza vaccine among individuals caregiving 
for a sick loved one107, and stress of a parental caregiver trended toward association of interferon 
production in children108.  
We followed up with the global analyses by conducting multivariable linear regression 
analyses. To account for the number and correlation of the tests,  the false discovery rate multiple 
testing correction for correlated data was used 91. However, after employing this multiple testing 
correction no statistically significant relationships were identified and raise the possibility that it 
may be an insufficient approach for correlated, high-dimensional gene expression analyses. 
In the third analytic approach, elastic net penalized regression was used to select and 
jointly estimate the best set of CTRA gene transcripts associated with the social factors. 
Penalized regression techniques have been developed to enhance prediction ability and select 
important variables through the addition of a penalty term94.  The range of transcripts selected 
via elastic net across the seven social and psychosocial exposures was 0 for perceived stress to 
74 for loneliness. Across the seven exposures, there were a total of 150 unique transcripts 
selected via elastic net corresponding to 146 genes.  Expectedly, the gene list was enriched for 
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immune system related processes. Ten transcripts were selected for exactly two exposures (3 
between adult socioeconomic status and loneliness, 3 between chronic burden and loneliness, 2 
between discrimination and loneliness and 2 between support and loneliness). These 10 
transcripts corresponded to the following genes: SLC6A6, VNN1, SLC22A4, IFI6, IL12RB1, 
SART3, DPP7, VPS41, SEMA4C, and SHMT1109.  These genes have a myriad of functions, 
some with known involvement in the immune response and others that do not.  For example, 
IFI6 is involved in interferon gamma signaling, IL12RB1 is a receptor for interleukin 12, and 
DPP7 prevents apoptosis in lymphocytes.  On the other hand, SLC6A6 and SLC22A4 are 
transporters, SART3 is a tumor rejection antigen, VPS41 is involved in organelle development, 
SEMA4C is invoved in axon guidance, and SHMT1 is an enzyme with involvement in glycine, 
serine, and threonine metabolism109. One transcript was selected for three exposures (loneliness, 
adult socioeconomic status, and social support). This transcript corresponds to the gene for 
isocitrate dehydrogenase (IDH1), a metabolic enzyme that catalyzes oxidative decarboxylation 
of isocitrate to 2-oxoglutarate109. Mutations in this gene have been associated with different types 
of cancers, potentially through epigenetic modifications of both oncogenes and tumor suppressor 
genes110–112. 
 
Comparison between results of the three approaches 
The three methods that we used in this paper to investigate the conserved transcriptional 
response to adversity differ in the interpretation of the conclusions for the research question.  As 
a self-contained gene set enrichment test, we conclude from the Global ANCOVA that at least 
one transcript among the 1,854 investigated would be expected to be significantly associated 
with the social environmental factor. We therefore expected that linear regression findings would 
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indicate the strongest significant associations for the social environmental factors where the 
Global ANCOVA test result was significant. While none of the transcripts were significant after 
adjusting for multiple testing, we did find that the social environmental factors that were at least 
marginally significant in the Global ANCOVA  (major or lifetime discrimination, chronic 
burden, loneliness, and adult SES) did yield more significant linear regression results at p<0.05 
compared to exposures not significant in global analyses (Table 3). The linear regression 
findings did suggestively map on to the elastic net findings as well. Among the transcripts that 
were selected via elastic net most were found to have p-values less than 0.05 in linear regression 
analyses. Similarly, the exposures with the most transcripts selected in elastic net (loneliness, 
discrimination, chronic burden, and adult SES) also had the lower p-values in Global ANCOVA 
analyses. 
 
Comparison to previous studies 
Among the seven investigated exposures, loneliness and adult socioeconomic status were 
assessed in previous CTRA studies. In 2007, Cole found there to be at least a 30% difference in 
expression levels of 209 transcripts (144 genes) between high loneliness and low loneliness 
individuals48.  Comparatively, using the same measure of loneliness, the UCLA Loneliness 
Scale, we found marginal significance with the CTRA gene set in global analysis, no significant 
association after multiple testing adjustment in linear regression analyses, and 74 transcripts to 
be selected via elastic net. These 74 transcripts mapped onto 74 unique genes, only 6 of which 




Findings from a study of the association between adult socioeconomic status and gene 
expression were also included in our CTRA gene set61. In a sample of 60 individuals, 387 genes 
were found to be differentially expressed by 5-year occupational status.  In the present study, we 
used highest level of education as a measure of SES. Education is considered to be a stable 
measure of SES as education is mostly acquired by young adulthood and is impervious to 
variations in job status and income113. In the present the study, the 387 genes found to associate 
with occupational status were included in our CTRA gene set. Our results indicate marginal 
significance in global analyses, no transcripts significant after multiple testing in linear 
regression analyses, and 46 transcripts selected via elastic net. These 46 transcripts map onto 44 
unique genes. Only 4 genes were implicated in the Powell study (ETV3, GBGT1, MCEMP1, 
SLC31A2). Comparing the present results for both loneliness and adult socioeconomic status to 
that of previous studies highlights the difficulty in replicating single genes across studies.  
Differences in methodological approach likely account for part of the discrepancy 
between our findings and that of previous studies. Among the nine previous CTRA studies, there 
were two analytical approaches employed to assess relationships between social environmental 
factors and gene expression.  Seven of these studies use the Patient Rule Induction Method 
(PRIM) machine learning algorithm to establish an a priori definition of differential expression 
(e.g. 30 % difference in expression between low lonely and high lonely individuals)114.  
However, this approach of assessing single gene transcripts has garnered much criticism as 
findings typically fail to replicate in separate studies. Several explanations for this have been 
proposed. The signal to noise ratio inherent in microarray technology makes it difficult to detect 
true effects102. Secondly, gene expression, especially that of genes within the same biological 
pathway, tends to be correlated and statistical measures are needed to account for the unknown 
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correlation structure102. Thirdly, many of these studies have lacked replication in separate human 
cohort which subjects reported findings to type I error102.  
The remaining two CTRA studies used a contrast score based on an a priori selected 
group of genes that had been implicated in prior studies63.  The development of the contrast score 
is described in Fredrickson 201363.  Briefly, fifty-three genes were selected to be part of the 
contrast score representing three processes: proinflammation (19 genes), type I interferon (31 
genes) and antibody synthesis (3 genes)63. Generalized linear model analysis was conducted to 
produce a point estimate for the association between the exposure and transcript abundance (log2 
transformed).  This point estimate was multiplied by a signed contrast coefficient where 
proinflammatory genes were multiplied by +1 and type IFN and antibody synthesis genes were 
multiplied by -1. A two-tailed, one sample t-test determined whether the resulting average 
association measure significantly differed from 0. Use of this score has been subject to critique in 
the literature115,116. First, the criterion for selection of the 53 genes is unclear115. Secondly, in the 
original use of the score by Fredrickson and colleagues, the point estimates developed as the first 
step of generating the contrast score were based on independent generalized linear model 
analysis for each of the 53 genes with 17 predictor variables (including the phenotype of interest) 
despite only having a sample size of 80. Lastly, simply equally weighting genes, the contrast 
score does not account for the correlation among genes or potential for differential effect sizes 
115.  
Difference in sample composition and cell type may also be a reason for the lack of 
overlap between the present and previous studies. While previous studies tended to be mostly 
White and from the same geographic region, we had representation from 3 racial/ethnic groups 
(Hispanic, non-Hispanic Black, non-Hispanic White) from different regions of the country. Our 
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study also had a relatively balanced male to female ratio, whereas previous studies tended to be 
mostly female.  With a mean age of ~70 years, our sample was older than most of the previous 
studies. While it is important to understand how these relationships may exist across race and 
sex, the heterogeneity of our sample likely contributed to the lack of overlap. We did, however, 
statistically account for these variables in all models. Additionally, differences in cell type may 
help to account for the different findings between the present and previous studies. Gene 
expression was collected in monocytes in our study, whereas most of the previous studies used 
peripheral blood mononuclear cells (PBMCs).  
 
Significance  
The CTRA studies were an important stimulus to the emergence of the new field of 
human social genomics. This area has received widespread attention as it offers a biological 
mechanism (i.e. gene expression) that has the potential to partly explain the well documented 
relationships between the social environment and health. As a new area of research, it is 
important to be particularly meticulous in ensuring that methodological approaches are 
appropriate in accounting for the complex nature of gene expression within biological pathways. 
Without this level of rigor, inaccurate findings can pervade the literature.  To address these types 
of questions, multivariable and multivariate statistical tests that can account for complex and 
potentially unknown correlation structures are needed to comprehensive capture the social 
environment and the ways in which it affects biological functioning. This epidemiologic study 
suggests that the current approaches in small studies (i.e. differential expression, contrast score) 
are insufficient in uncovering the replicable relationships between the social environment and 
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gene expression in a separate, diverse human cohort. Studies such as present one are necessary to 
move the field of human social genomics forward.  
 
Strengths and limitations 
Use of the Multiethnic Study of Atherosclerosis dataset helps to overcome the limitations 
of previous studies in the literature in the following ways: 1) the large sample size (n=1,264) 
compared to previous studies allows increased power to detect differences in gene expression 2) 
the comprehensive collection of social and psychosocial risk factor and gene expression data 
makes MESA uniquely suited to address the research question and 3) gene expression was 
collected in monocytes, an important leukocyte of the innate immune system that prior research 
indicates is particularly sensitive to social environment exposures63,117.  
While there were notable strengths to this study, we acknowledge that there were some 
important limitations. In the interest of systematically identifying social sensitive genes, we 
limited our literature search to articles which referred to the “conserved transcriptional response 
to adversity.”  In doing this, we may have missed other genes in the literature whose expression 
is modified by social environment exposures but did not use this term in the published article.  A 
second limitation is the variation in time over which data was collected.  Social and psychosocial 
exposures were collected at various exams in the MESA study while gene expression was only 
collected in exam 5.  Therefore, there may be time between collection of the exposure and 
outcome. To minimize the bias this may introduce, we included data from the most recent exam 
available. Further, since we only had gene expression data available for one time point, we 







CHAPTER III: Social Regulation of the Inflammation Related Gene 




Epidemiologic evidence suggests that low-grade chronic inflammation is a risk factor for 
many common diseases. Of the 10 leading causes of death, there is evidence that inflammation is 
a risk factor for eight (i.e. cardiovascular disease, cancer, chronic lower respiratory diseases, 
stroke, Alzheimer’s disease, diabetes, nephritis, and influenza and pneumonia) 118. Prior studies 
have found that people with high levels of the inflammatory biomarker C-reactive protein (CRP) 
had 1.6 times the risk of ischemic heart disease and 1.3 times the risk of cerebrovascular disease 
compared to those with low levels 31.  Along the same lines, an elevated CRP level has been 
found to increase risk of mortality119,120. Understanding the factors that affect inflammation and 
the processes by which inflammation leads to disease will be important in reducing disease 
burden. 
Social and psychosocial factors have been found to influence multiple inflammatory 
pathways.  Low socioeconomic status (SES), a fundamental cause of disease, has been found to 
inversely associate with levels of several inflammatory biomarkers including CRP, IL-6, 
fibrinogen, sICAM1 and ET-12,38–40. These associations have been consistent across different 
measures of SES (e.g. education, income, job status) and for SES in both adulthood and 
childhood 29,41–43,71. Similarly, exposures to adverse psychosocial stressors such as 
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discrimination49 and chronic stress73 have been found to associate with inflammatory proteins. 
These studies suggest that the chronic inflammation may be a mechanism whereby adverse 
social and psychosocial exposures affect disease risk.  
The current understanding of the biological mechanisms through which social and 
psychosocial exposures “get under the skin” to affect inflammatory processes has been limited. 
Altered gene expression patterns may be one part of the complex biological cascade whereby 
exposure to social and psychosocial stress affects inflammation. Results from prior studies have 
documented differential expression of genes by exposure to social and psychosocial stress with 
an overrepresentation of these differences occurring in inflammation related genes. In a 2007 
study, Cole and colleagues report differential expression of 209 gene transcripts by loneliness 
status where more lonely individuals overexpressed proinflammatory genes. Subsequent studies 
have found associations between low socioeconomic status 61 caregiver stress 62 , well-being 63, 
positive vs. negative affect 64, and grief 65 with altered expression of inflammation related genes. 
This evidence suggests that the effect of social experiences on the inflammatory processes may 
be occurring at the gene level. 
While promising, previous studies have suffered from important methodological 
limitations that present the need for deeper research.  Most notably, the sample sizes were small, 
which makes statistical tests of the genome wide studies difficult. We expand upon this prior 
research in the present study by investigating associations between a range of social and 
psychosocial exposures and inflammatory gene expression using a larger, multiethnic cohort 
(n=1,264). Further, we focus on inflammatory and immune response genes specifically using the 







The Multi-Ethnic Study of Atherosclerosis (MESA) was designed to investigate risk 
factors for the development and progression of subclinical cardiovascular disease 79. The 
baseline cohort was comprised of 6,814 adults aged 45-84 who self-identified as African-
American, Chinese-American, Caucasian, or Hispanic and were free from clinical cardiovascular 
disease. Participants were recruited from six field sites across the United States between 2000 
and 2002 (Baltimore, Maryland; Chicago, Illinois; Forsyth County, North Carolina; Los Angeles, 
California; New York, New York).  Four follow-up examinations have been conducted with 
Exam 5, the fourth follow up ending in December 2011. The response rate has been excellent 
with 78% participants returning for Exam 5. Each exam consisted of a clinic visit where 
questionnaires on demographic, psychosocial, and lifestyle factors were administered, and 
physical assessments including the blood draw needed for genetic analyses were conducted. 
Gene expression was collected solely in Exam 5 on a random sample of 1,264 individuals from 
four of the MESA study sites80. These individuals make up the study sample for the current 
study. 
 
Social Environmental Factors 
Adult Socioeconomic Status 
Highest level of education was collected in Exam 1 and was dichotomized as a measure 
of adult socioeconomic status. Respondents were considered highly educated if they had 




Childhood Socioeconomic Status 
Mother’s and father’s level of education were collected in Exam 2 to proxy childhood 
socioeconomic status.  A parent was considered highly educated if he or she had achieved at 
least a high school degree.  Childhood SES was dichotomized. The respondent was considered to 
have a high childhood SES if either parent had at least a high school degree.   
 
Perceived Stress 
Perceived stress was measured using Cohen’s the 4-item Perceived Stress Scale (PSS) in 
Exam 5 81,82 . The respondent was asked whether they felt: unable to control the important things 
in his or her life, confident about his or her ability to handle personal problems, things were 
going his or her way, or difficulties were piling up so high that he or she could not overcome 
them in the past month. Respondents answered on a five point Likert scale corresponding to the 
answer choices never, almost never, sometimes, fairly often, and very often. A summary measure 
was created by reverse coding the positive items (items 2 & 3) and summing the items such that 
a higher value indicated a higher level of perceived stress. 
 
Major or Lifetime Discrimination 
Major or lifetime discrimination was collected in Exam 1 and was adapted from the 
Detroit Area Study83. Respondents were asked about whether they ever had been fired or denied 
a promotion, not hired for a job, treated unfairly by the police, discouraged by a teacher from 
continuing education, prevented from moving into a neighborhood, or neighbors have made their 
life difficult 83.  A discrimination score was computed by summing the number of ‘yes’ 





Chronic burden was assessed using the Chronic Burden Scale in Exam 384. Participants 
were asked whether they had experienced ongoing problems in the following five domains: their 
own health, health of a loved one, job, relationship, financial problems. For affirmative 
responses, participants were subsequently asked whether this had been a problem for at least 6 
months and whether this burden was not very stressful, moderately stressful, or very stressful. To 
estimate overall chronic burden, we summed the number of domains for which the respondent 
had experienced a chronic burden for at least 6 months and reported that it was either moderately 
or very stressful. A higher score indicated a higher level of chronic burden. 
 
Social Support 
Social support was measured in Exam 4 using a 4-item scale adapted from the MIDUS 
study85. The questions asked how much friends and family can be relied upon for help with a 
serious problem, how much friends and family can be opened up to to talk about worries, how 
often friends and family make too many demands on the respondent, and how often friends and 
family let them down.   Possible answer choices included: a lot, some, a little, not at all and were 
coded as 1, 2, 3, and 4 respectively. Positive items (items 1 & 2) were reverse coded and the sum 
of the 4 items was calculated to achieve an overall social support score where a higher score 







Loneliness was measured in Exam 4 using a three item scale adapted from the UCLA 
Loneliness Scale86.  Participants were asked how often they lack companionship, feel left out, or 
isolated from others.  Possible answer choices included: hardly ever, some of the time, and often 
and were coded as 1,2, and 3 respectively.  A score was created by summing the three items. A 
higher score indicated a higher level of loneliness. 
 
Covariates 
Age, sex, and race/ethnicity were self-reported via questionnaire.  
 
Gene expression 
Gene expression data was collected from purified monocytes of 1,264 participants in 
MESA Exam 5.  Detailed methods have been previously described 80. Briefly, peripheral blood 
mononuclear cells (PBMCs) were separated within two hours of blood draw using Vautainer 
CPT cell separation tubes.  Monocytes were purified from the PBMCs using anti-CD14-coated 
magnetic beads. DNA and RNA were extracted using the AllPrep DNA/RNA Mini Kit. The 
resulting cRNA was hybridized to the Illumina HumanHT-12 v4 Expression BeadChip. This 
chip has probes for 47,231 transcripts (~31,000 genes), and is designed to assay 12 samples per 
chip. A stratified random sampling technique was used to assign samples to each chip avoid 
biases due to batch, chip, or position.   
 Preprocessing and quality controls steps were conducted to ensure accurate quantification 
of the gene expression data. Illumina’s proprietary software Genome Studio was used to correct 
for local background. The remaining preprocessing steps were conducted using Bioconductor 
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packages in R.  Since the bead chip has multiple copies of each probe, a bead-type 
summarization (mean and variance) was produced for each transcripts using the beadarray 
package87. The negative controls on the array were used to compute the detection p-value.  The 
limma package was used for background correction, quantile normalization, log2 transformation, 
and removal of control probes88.  Quality control criteria for elimination of a transcript 
included:  ‘detected’ expression levels in <10% of MESA samples (detection p-value cut-
off=0.01), probes that contain a SNP, probes with low variance across samples (<10th percentile), 
and probe overlap with a non-unique region.  
 
Gene Set Generation 
Gene Ontology is a bioinformatics database that uses findings from over 100,000 peer 
reviewed scientific papers to annotate the functions of gene products.  Each gene is categorized 
by an associated biological process, cellular component, and/or molecular function. In the 
present analysis, we developed gene sets based on four inflammation related biological 
processes: chronic inflammatory response (GO: 0002544), inflammatory response (GO: 
0006964), regulation of inflammatory response (GO:0050727), and the immune response 
(GO:0006955).  The list of genes included in each investigated biological process is given in 
Appendix 17. Our genes sets were based on genes that were represented on the Illumina 
HumanHT-12 v4 Expression BeadChip used in the MESA study. For cases where a gene 
matched to more than one transcript, we included all transcripts in the analyses. Our final gene 
set consisted of 20 gene transcripts for chronic inflammation (corresponding to how many 
unique genes), 438 for the inflammatory response, 1251 for the immune response, and 192 for 
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regulation of the inflammatory response. There were some overlapping gene transcripts among 
the four categories (Appendix 18). 
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To statistically test the association between the social environmental exposures and gene 
expression, we used a two part analytic approach.  In the first part, we assessed the association 
between each of the seven social environmental factors with the each of the four gene sets using 
a global analysis (Global ANCOVA) for a total of independent 28 tests. The Global ANCOVA is 
self-contained gene set enrichment analysis that has the null hypothesis that no gene in a set of 
genes are associated with a given exposure. This method is described in detail in Hummel 
200889.   
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Briefly, given expression of p genes in n individuals with d covariates, this multivariate 



















)    (2) 
The gene expression values of the entire gene set (?̃?), is expressed as an np column 
vector, representing gene expression of each gene for each individual. It is a function of the 
product ?̃? and 𝛽 plus 𝛯, where ?̃? is a np x (d+1)p sized diagonal block matrix representing the 
covariate information for each individual, 𝛽 is a column vector of size (d+1)p which quantifies 
the relationship of each exposure and covariate on the expression of each gene in the gene set, 
and 𝛯 is np sized column vector which accounts for the noise for each individual for each gene in 
the gene set.  For each Global ANCOVA test in our study, there were 1,264 participants, one 
main psychosocial exposure of interest (each investigated in a separate model), and 4 additional 
covariates (age, sex, study site, and race/ethnicity).  A permutation based approximation 
approach was used in order to assess significance of the Global ANCOVA tests using the 
strategy described in Hummel 200889.  
In the second part of the approach we used multivariable linear regression and elastic net 
penalized regression techniques to identify which genes were driving significant Global 
ANCOVA findings. We limited these analyses to only instances where the social environmental 
factor was significantly associated with the gene set in Global ANCOVA analyses.  This strategy 
reduces total number of tests and lessens the concern for Type 1 error.  




?̃?(𝑖) = 𝐶 ∙ 𝛽𝑖




















where the outcome, the expression for the ith gene transcript, is expressed as ?̃?(𝑖), n is the 
number of individuals, and d is the number of covariates. C is a matrix of size n x (d+1) which 
represents the covariate values for each individual. The gene specific mean expression is 
quantified by 𝛽𝑖0. The regression coefficient vector, 𝛽𝑖
𝑡, reflects the influence of each covariate 
on expression of the ith gene transcript. The residual for each individual is given by the 𝜉(𝑖) 
vector. 
Penalized regression methods, such as elastic net, subject the minimization the residual 
sum of squares (i.e. argminβ|𝑦 − 𝑋𝛽| 2) used in OLS regression to additional penalties to 
improve prediction and interpretation above multivariable linear regression93,94.  Detailed 
methods of the elastic net are given in Zou and Hastie 200594. As a hybrid of the LASSO (least 
absolute shrinkage and selection operator) and ridge regression penalties, elastic net exploits 
their ability to conduct variable selection and adjustment for correlation among predictors 
respectively. 
For 𝑛 individuals and 𝑝 gene transcript expressions, let 𝑦𝑗 be the value of the 
psychosocial factor for person 𝑗, 𝑥𝑗𝑖 be the gene expression value for person 𝑗 for gene 𝑖, and 𝛽𝑖 
be the beta estimate corresponding gene 𝑖. The elastic net penalty is given by: 
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The two tuning parameters 𝜆1 and 𝜆2 control the trade-off between bias and variance
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In the sample of 1,264 MESA participants with available gene expression data, the mean 
age was ~70 years and 51% of the sample was female.  There were three racial/ethnic groups 
represented where 272 participants were non-Hispanic Black, 402 were Hispanic, and 590 were 
non-Hispanic White. Participants were recruited from four of the six MESA study sites: Forsythe 
County, North Carolina (49 participants), New York, New York (424 participants) Baltimore, 
Maryland (317 participants) and St. Paul, Minnesota (474 participants). Non-Hispanic Blacks 
were recruited mostly from the New York and Baltimore sites. Hispanics were recruited from the 
New York and Rochester sites.  Whites were recruited from all four sites. For the socioeconomic 
variables, 33% of the total sample of adults had finished a level of schooling equal to a college 
degree or higher. Slightly over half of the sample (56%) had either a mother or father achieve at 
least a high school degree. Whites (49%) were more likely to have obtained a college degree 
than Blacks (27%) or Hispanics (13%) (p<0.001 and p<0.001 respectively). Blacks were 
significantly more likely to have a college degree that Hispanics (p<0.0001). The same pattern 
was observed for childhood SES where Whites (71%) were more likely to have at least one 
parent with a high school degree compared to Blacks (55%) or Hispanics (31%)  (p<0.001 and 
p<0.001 respectively), and Blacks were significantly more likely to have a parent with a high 
school degree than Hispanics (p<0.0001). For most of the social and psychosocial exposures, the 
median scores were close to the minimum score indicating that most of the sample reported low 
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levels of these exposures. There were not significant racial/ethnic differences in these scores 
except for major or lifetime discrimination (p<0.001). Tukey’s honest significance test indicated 
that Blacks reported higher levels than Whites (p<0.001) or Hispanics (p<0.001). There was not 
a significant difference between Whites and Hispanics (p=0.16).The correlation among the 
psychosocial exposures is presented in Appendix 3. The most correlated exposures were 
loneliness and chronic burden (r=0.36) and the least correlated exposures were major or life 






Table 5. Characteristics of the MESA Study Sample with Gene Expression Data 








Demographics     
Age mean  (SD) 69.6 (9.4) 69.6(9.0) 68.4(9.3) 70.2(9.5) 
Sex (% female) 51 60 50 48% 









49(4%) 1(0.3%) 0 48 (40%) 
New York, New 
York  
424(34%) 131(48%) 209 (52%) 84 (14%) 
Baltimore, 
Maryland  
317(25%) 140(51%) 0 177 (30%) 
Rochester, 
Minnesota  
474(38%) 0 193 (48%) 281 (48%) 
Total  1264(100%) 272 (100%) 402 (100%) 590 (100%) 
     
Socioeconomic 
Status 
    
High education- 
respondent* 
33% 27% 13% 49% 
High education- 
either parent** 
56% 55% 31% 71% 






    




0 (0-1) 1(0-2) 0(0-1) 0 (0-1) 
Chronic Burden 1 (0-2) 1(0-2) 0(0-2) 1 (0-2) 
Perceived Stress  8 (5-10) 8(5-10) 8(5-10) 7 (6-10) 
Social support  9 (8-10) 9(8-10) 9(8-10) 9 (8-10) 
*High education for respondent indicates an educational level of a college or greater 






Gene set enrichment analyses 
For each of the seven social and psychosocial factors, we first conducted Global 
ANCOVA gene set enrichment tests for each of the four biological processes for a total of 28 
tests.  We found three (loneliness, discrimination, chronic burden) of the investigated exposures 
to be significantly associated with the chronic inflammation gene set at p<0.05 and an additional 
two exposures (perceived stress and social support) to be marginally significant at p<0.10 (Table 
6). Major or lifetime discrimination was significantly associated with the other three gene sets as 
well (i.e. inflammatory response, immune response, regulation of inflammatory response). No 
other social environmental factors were associated with these gene sets.  
 
Table 6. Global ANCOVA p-values for the Association between Social Environmental 
Factors and the Four Gene Ontology Biological Processes 













Loneliness 0.003 0.229 0.227 0.173 
Discrimination 0.045 0.029 0.041 0.025 
Perceived Stress 0.092 0.123 0.179 0.181 
Chronic Burden 0.002 0.188 0.135 0.312 
Social Support 0.053 0.571 0.599 0.344 
Adult SES 0.110 0.300 0.179 0.076 
Childhood SES 0.403 0.548 0.506 0.467 
 
 
Multivariable linear regression 
Multivariable linear regression was used to identify which gene transcripts were driving 
the significant associations from the Global ANCOVA analyses. Based on the Global ANCOVA 
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results, we conducted these analyses for each loneliness, major or lifetime discrimination, and 
chronic burden and each of the 20 transcripts of the chronic inflammation gene set. For 
loneliness and discrimination, we found significant associations at p<0.05 for 5 and 4 transcripts 
respectively (Table 7). Three of these transcripts corresponding to two unique genes (CX3CR1 
and VNN1) overlapped between exposures.  Despite significant Global ANCOVA results for 
chronic burden with the chronic inflammation gene set, we surprisingly did not detect significant 
results with any of the 20 transcripts in the linear regression single gene analyses.  
Since there were significant findings for major or lifetime discrimination and the other 
three gene sets in Global ANCOVA analyses, we also examined the regression relationship 
between major or lifetime discrimination and each of the 438 gene transcripts of the 
inflammatory response, 1251 gene transcripts of the immune response, and 192 gene transcripts 
of the regulation of the inflammatory response. For inflammatory response, immune response, 
and regulation of the inflammatory response, we found 12%, 11%, and 13.5% of investigated 
transcripts to be significant respectively, which exceeds the 5% that would be expected by 
chance alone (Appendix 19). However, none of the associations persisted after FDR multiple 
testing adjustment.  
 
Elastic Net 
Elastic net regression was also used to identify the gene transcripts most strongly 
associated with each social environmental factor. The number of transcripts selected via elastic 
net ranged from 3-42 dependent upon the exposure and gene set. The greatest number of 
transcripts selected was for discrimination and the immune response gene set, which also has the 
largest number of transcripts in the set (1251). The greatest proportion of transcripts was selected 
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for loneliness with the chronic inflammation gene set (12/20=0.60). The number of transcripts 
selected for each social environmental factor and gene set pair is presented in Table 7, the list of 
transcripts and corresponding gene name is available in Appendix 20, the correlation among 
selected genes in Appendices 21-26, and a comparison to linear regression findings in 
Appendices 27-32.  
 
Overlap between linear regression and elastic net penalized regression findings 
We used two complementary methods (i.e. multivariable linear regression and elastic net 
penalized regression) to identify the transcripts driving the significant association from the global 
analyses and assessed the overlap between these findings. The results indicate that transcripts 
that were selected via elastic net analyses were also likely to be significant at p<0.05 in linear 
regression analyses across exposures and gene sets except for the chronic burden exposure with 
the chronic inflammation gene set where there were no significant associations in linear 
regression analyses  (Table 7). In total, of the 53 unique gene transcripts that were selected in 





Table 7. Results from Linear Regression and Elastic Net Analyses  













5 12 4 
Chronic Burden Chronic 
Inflammation 
(k=20) 




4 3 3 
Discrimination Inflammatory 
Response(k=438) 




136 42 36 




26 15 15 
Overlap of total 
unique 
transcripts 
Total: 1407 153 53 43 




While longstanding evidence indicates that exposure to stressful experiences is associated 
with an impaired immune response and susceptibility to disease, we have yet to fully understand 
how external social experiences are internalized to disrupt normal biological functioning. In this 
study, we investigated the association between a range of social environmental factors with 
expression of immune system genes, with a particular focus on genes involved in the 
inflammatory response. The results of the present study provide evidence that social 
environmental factors may be influencing chronic inflammation via gene level processes and 
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highlights a biological mechanism (i.e. gene expression) whereby the social environment gets 
“under the skin” to affect an important risk factor for several high burden diseases.  Better 
understanding of the mechanisms through which these social environmental factors act 
biologically will enable the development of more precise prevention and treatment approaches. 
We took a two part approach to investigate the association between social environmental 
factors with gene expression. We first conducted global analyses to assess the association for 
each social environmental factor with each of the biological gene sets. In global analyses, we 
found significant associations between three of the seven investigated social environmental 
factors with expression of chronic inflammation gene set. Significant associations were detected 
for loneliness, major or lifetime discrimination, and chronic burden (p=0.003, p=0.045, p=0.002, 
respectively).  We also found marginally significant relationships for perceived stress and social 
support (p=0.092, p=0.053, respectively).  We did not find significant associations for adult or 
childhood socioeconomic status. In the second part of the approach, we used multivariable linear 
regression and elastic net penalized regression to identify which transcripts were the drivers of 
the significant associations in global analyses. These results ranged dependent upon exposure 
and set of genes.  
Our finding that loneliness was significantly associated with chronic inflammation is 
consistent with the literature.   Loneliness is a psychosocial stressor characterized by a subjective 
stressful feeling due to unmet needs of social connections. It has been found to associate with 
several chronic diseases (e.g. coronary heart disease, stroke) for which chronic inflammation is a 
known risk factor 46,47. While there have been several studies investigating the relationship 
between loneliness and inflammation at a protein level 28,121,122, studies on loneliness and gene 
expression have been limited. The small, extant literature suggests that loneliness does associate 
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with biological functioning at the gene level, and the patterns may be altered by behavioral 
treatments 48,123.   In the previously mentioned study by Cole and colleagues, 144 genes were 
found to be differentially expressed in a genome wide study between high lonely and low lonely 
individuals. The same measure of loneliness used in the Cole study, the UCLA loneliness scale, 
was also used in the present study. Of these 144 genes, 3 (IL1B, TNFAIP3, VNN1) were in the 
chronic inflammatory gene set. To identify which gene transcripts in the chronic inflammatory 
gene set were significantly associated with loneliness, we followed up the global analyses with 
linear regression and elastic net penalized regression. In linear regression analyses, we found 5 of 
the 20 transcripts to be significantly associated with loneliness at p<0.05. However, none were 
statistically significant after false discovery rate multiple testing correction. Four of these 5 
transcripts were among the 12 transcripts selected in elastic net, suggesting that a relationship 
may exist between loneliness and expression of these transcripts that the linear regression 
approach may have been ill powered to adequately detect. The 12 transcripts selected via elastic 
net correspond to 12 unique genes (IDO1, VNN1, THBS1, CAMP, IL1RN, CEBPB, 
ADORA2B, UNC13D, IL1B, LTA, CX3CR1, CCL5). These genes have a range of functions in 
the chronic inflammatory biological process. For example, CX3CR1 plays a role in leukocyte 
adhesion and migration, IL1B produces a protein product that is involved in cell proliferation, 
differentiation, and apoptosis, and THBS1 is a glycoprotein mediator of cell-to-cell and cell-to-
matrix interactions109. The present study builds upon the existing literature by providing 
evidence of associations between loneliness and gene expression in chronic inflammatory 
response genes while addressing some of the important limitations of previous work (e.g. small 
sample size, differing cell types).   
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Interestingly, the other two social environmental factors that were significant in global 
analyses- chronic burden and discrimination - were also implicated in the Aim 1 global analyses.  
As stated in Aim 1, chronic burden has been associated with altered immune functioning 
including inflammation.  This relationship is hypothesized to act directly through the 
hypothalamic-pituitary-adrenal axis (HPA) and sympathetic-adrenal-medullary (SAM) system or 
indirectly through risk behaviors 5,73,106.  In the MESA cohort, chronic burden has been found to 
significantly associate with inflammation as measured by IL-6 and CRP 73.  In the present study, 
we followed up the global analyses to identify which genes specifically were associated with 
chronic burden.  No gene transcripts were significant in linear regression analyses at p<0.05 and 
8 transcripts were selected in elastic net corresponding to 8 unique genes (VNN1, THBS1, 
IL1RN, ADORA2B, LTA, CX3CR1, CCL5, IDO1).  Interestingly, all 8 of these genes were also 
selected in the elastic net analyses assessing the association between loneliness and the chronic 
inflammatory genes. 
In global analyses, major or lifetime discrimination was the only measure that yielded 
significant findings across all four biological processes investigated (i.e. chronic inflammation, 
inflammatory response, immune response, and regulation of inflammatory processes).  
Discrimination, characterized by differential treatment of certain groups, has been associated 
with increased risk of morbidity and mortality103. Further, while it has consistently been found to 
adversely affect mental health outcomes, the literature on physical health outcomes is less 
conclusive with some studies showing a relationship and others showing no relationship 3,103,124. 
In the MESA cohort, there has been mixed findings on the relationship between discrimination 
and inflammation at the protein level. A study by Kershaw et. al found discrimination to be 
significantly associated with the inflammatory biomarker IL-6, but interestingly no significant 
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association was detected for CRP50. These findings were influenced by sex and body mass 
index50. Although the genes encoding CRP and IL-6 were not part of the chronic inflammatory 
gene set, we were able to provide evidence that discrimination affects chronic inflammatory 
processes at a gene level in global analyses. In linear regression analyses, four transcripts were 
significant at p<0.05, but like the relationships for loneliness and chronic burden there were no 
significant transcripts after multiple testing adjustment. Three transcripts were selected via 
elastic net (CX3CR1, VNN1, CHAMP1) all of which were significant at p<0.05 in linear 
regression analyses. Two of these three genes (i.e. CX3CR1, VNN1) were also selected in elastic 
net analyses for loneliness and chronic burden.    
Given that the Global ANCOVA test is designed to assess whether any gene transcript is 
associated with the exposure, the finding that loneliness and chronic burden were associated with 
the chronic inflammation gene set but not the other sets was unexpected since there was 
substantial overlap between the 20 transcripts that composed the chronic inflammatory gene set 
and the other gene sets (Table 4). It is likely that this is due to the common signal-to-noise ratio 
issue inherent to microarray studies102. With only 20 transcripts and a more focused biological 
process, we would expect to the chronic inflammatory gene set to be less susceptible to this issue 
compared to the other three investigated biological processes.  
This study has notable strengths which help to move the field of human social genomics 
forward. One strength of this current study is the sample size of 1,264 participants. Similar types 
of studies have been limited by very small sample sizes48,61–65,72,77,125.  The use of the MESA 
cohort makes the present study one of the largest human social genomics studies to date. 
Secondly, gene expression was measured in monocytes in MESA.  Since gene expression is cell 
type specific, it is important to have it measured in a cell type that is known to play a role in 
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inflammation. Monocytes are phagocytic leukocytes of the innate immune response, and 
evidence suggests that even among the various types of white blood cells that are part of the 
inflammatory response, monocytes, along with dendritic cells, are most susceptible to changes in 
gene expression with exposure to an adverse social environment117.  Third, our statistical 
approach was designed to account to the complexity of testing correlated variables. By using the 
permutation based approximation of the F distribution in the Global ANCOVA test, we 
accounted for the gene expressions being neither independent nor homoscedastic89.   In linear 
regression analyses, we employed false discovery rate multiple testing correction for correlated 
data to address issues related to the total number of statistical tests being conducted and the 
correlated nature of the gene expression outcomes.  Elastic net, which was used as a variable 
selection procedure, is designed select groups of correlated genes.  
This study is not without limitations. Most notably, we did not have a replication sample 
to verify the association between our implicated social environmental factors and gene 
expression. Replication reduces the concern for Type 1 error. Secondly, the variables -the social 
environmental factors, gene expression, and covariates-were collected at different times 
throughout the 5 MESA exams.  Because gene expression values can be transient across time, 
these values collected in Exam 5 may be different from the prior exams when most of the social 








CHAPTER IV: Social environmental contributors to racial/ethnic 
differences in gene expression 
Introduction 
 
Chronic inflammation has emerged as an important risk factor for eight of the top ten 
leading causes of death in the United States126–128. These diseases include cardiovascular disease, 
cancer, chronic lower respiratory disease, stroke, Alzheimer’s disease, diabetes, kidney disease, 
and influenza/pneumonia 129. Racial/ethnic disparities have been observed in seven of these 
diseases, where Blacks and Hispanics are disproportionally affected103 . This finding is consistent 
with studies that have demonstrated that Blacks and Hispanics are more likely to have adverse 
inflammatory profiles compared to non-Hispanic Whites 41,57. A wide range of evidence suggests 
that racially/ethnically patterned social and psychosocial stressors may be an important pathway 
through which race/ethnicity is associated with increased inflammation.  Blacks and Hispanics 
have consistently reported higher levels of stress in terms of frequency, longevity, and reactivity 
25. Social and psychosocial stress exposures have in turn been shown to have adverse effects on 
health including increased inflammation 49,73,130. Although a difference in exposure to social 
stressors has been hypothesized to influence the relationship between race/ethnicity and 
inflammation, the ways in which social environmental factors “get under the skin” to affect the 
biological process of inflammation could reflect many different types of mechanisms. 
One mechanism through which race/ethnicity may be associated with inflammation is 
through the influence of genetic and environmental factors on gene expression. Racial 
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differences in gene expression have been observed in many studies67,68. For example, using 
samples from HapMap, Storey et. al and Zhang et al. found gene expression differences between 
Whites and Yoruba Nigerians in 17% and 34% of genes respectively67,68.  Storey found that 
among differentially expressed genes, there was an enrichment of inflammation associated 
genes. Contemporaneously, exposure to adverse social exposures including loneliness, low 
socioeconomic status 61 caregiver stress 62, well-being 63, positive vs. negative affect 64, and grief 
65 have also been found to be associated with variation in the expression of inflammatory genes. 
Given the expensive nature of gene expression testing, most studies of social environmental 
factor influences on gene expression have been small (n<250 participants). 
In the present study, we use data from the Multi-Ethnic Study of Atherosclerosis to 
examine 1) racial/ethnic differences in a 
range of social environmental factors (e.g. 
childhood socioeconomic status, adult 
socioeconomic status, loneliness, major or 
lifetime discrimination, chronic burden, 
perceived stress, and social support 2) racial/ethnic differences in expression of inflammatory 
and immune response related genes and 3) the extent to which the social environmental 
exposures explain the association between race/ethnicity and gene expression. While it has been 
well documented that racial/ethnic differences in gene expression exist and an emerging 
literature in the field of human social genomics implicates associations between social 
environmental factors and gene expression as well, a dearth of research has investigated the 
influence of racially/ethnically patterned social environmental exposures on the relationship 
between race/ethnicity and gene expression. As racial/ethnic differences in gene expression are 
Figure 1 
Hypothesized Relationship between 
Race/Ethnicity and Inflammatory and 
Immune Response Genes 
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due to both inherited DNA sequence and environmental exposures in unknown quantities, this 
study helps to fill an important gap by investigating the contribution of the social environmental 




The Multi-Ethnic Study of Atherosclerosis (MESA) was designed to investigate risk 
factors for the development and progression of subclinical cardiovascular disease 79. The 
baseline cohort was comprised of 6,814 adults aged 45-84 who self-identified as African-
American, Chinese-American, White, or Hispanic and were free from clinical cardiovascular 
disease. Participants were recruited from six field sites across the United States between 2000 
and 2002 (Baltimore, Maryland; Chicago, Illinois; Forsyth County, North Carolina; Los Angeles, 
California; New York, New York).  Four follow-up examinations have been conducted with 
Exam 5, the fourth follow up ending in December 2011. The response rate has been excellent 
with 78% participants returning for Exam 5. Each exam consisted of a clinic visit where 
questionnaires on demographic, psychosocial, and lifestyle factors were administered, and 
physical assessments including the blood draw needed for genetic analyses were conducted. 
Gene expression was collected solely in Exam 5 on a random sample of 1,264 individuals from 







Social environmental factors 
Adult Socioeconomic Status 
Highest level of education was collected in Exam 1 and was dichotomized as a measure 
of adult socioeconomic status. Respondents were considered highly educated if they had 
obtained a college degree or higher. 
 
Childhood Socioeconomic Status 
Mother’s and father’s level of education were collected in Exam 2 to proxy childhood 
socioeconomic status.  A parent was considered highly educated if he or she had achieved at 
least a high school degree.  Childhood SES was dichotomized. The respondent was considered to 
have a high childhood SES if either parent had at least a high school degree.   
 
Perceived Stress 
Perceived stress was measured using Cohen’s the 4-item Perceived Stress Scale (PSS) in 
Exam 5 81,82 . The respondent was asked whether they felt: unable to control the important things 
in his or her life, confident about his or her ability to handle personal problems, things were 
going his or her way, or difficulties were piling up so high that he or she could not overcome 
them in the past month. Respondents answered on a five point Likert scale corresponding to the 
answer choices never, almost never, sometimes, fairly often, and very often. A summary measure 
was created by reverse coding the positive items (items 2 & 3) and summing the items such that 
a higher value indicated a higher level of perceived stress. 
 
Major or Lifetime Discrimination 
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Major or lifetime discrimination was collected in Exam 1 and was adapted from the 
Detroit Area Study83. Respondents were asked about whether they ever had been fired or denied 
a promotion, not hired for a job, treated unfairly by the police, discouraged by a teacher from 
continuing education, prevented from moving into a neighborhood, or neighbors have made their 
life difficult 83.  A discrimination score was computed by summing the number of ‘yes’ 
responses. A higher score indicated higher exposure to major or lifetime discrimination. 
 
Chronic Burden 
Chronic burden was assessed using the Chronic Burden Scale in Exam 384. Participants 
were asked whether they had experienced ongoing problems in the following five domains: their 
own health, health of a loved one, job, relationship, financial problems. For affirmative 
responses, participants were subsequently asked whether this had been a problem for at least 6 
months and whether this burden was not very stressful, moderately stressful, or very stressful. To 
estimate overall chronic burden, we summed the number of domains for which the respondent 
had experienced a chronic burden for at least 6 months and reported that it was either moderately 
or very stressful. A higher score indicated a higher level of chronic burden. 
 
Social Support 
Social support was measured in Exam 4 using a 4-item scale adapted from the Midlife inf 
the United States (MIDUS) study85. The questions asked how much friends and family can be 
relied upon for help with a serious problem, how much friends and family can be opened up to 
totalk about worries, how often friends and family make too many demands on the respondent, 
and how often friends and family let them down.   Possible answer choices included: a lot, some, 
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a little, not at all and were coded as 1,2,3, and 4 respectively. Positive items (items 1 & 2) were 
reverse coded and the sum of the 4 items was calculated to achieve an overall social support 
score where a higher score indicated greater social support. 
 
Loneliness 
Loneliness was measured in Exam 4 using a three item scale adapted from the UCLA 
Loneliness Scale86.  Participants were asked how often they lack companionship, feel left out, or 
isolated from others.  Possible answer choices included: hardly ever, some of the time, and often 
and were coded as 1,2, and 3 respectively.  A score was created by summing the three items. A 
higher score indicated a higher level of loneliness. 
 
Covariates: 
Age, sex, and race/ethnicity were self-reported via questionnaire.  
 
Gene Expression 
Gene expression data was collected from purified monocytes of 1,264 participants in 
MESA Exam 5.  Detailed methods have been previously described 80. Briefly, peripheral blood 
mononuclear cells (PBMCs) were separated within two hours of blood draw using Vautainer 
CPT cell separation tubes.  Monocytes were purified from the PBMCs using anti-CD14-coated 
magnetic beads. DNA and RNA were extracted using the AllPrep DNA/RNA Mini Kit. The 
resulting cRNA was hybridized to the Illumina HumanHT-12 v4 Expression BeadChip. This 
chip has probes for 47,231 transcripts (~31,000 genes), and is designed to assay 12 samples per 
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chip. A stratified random sampling technique was used to assign samples to each chip to avoid 
biases due to batch, chip, or position.   
 Preprocessing and quality controls steps were conducted to ensure accurate quantification 
of the gene expression data. Illumina’s proprietary software Genome Studio was used to correct 
for local background. The remaining preprocessing steps were conducted using Bioconductor 
packages in R.  Since the bead chip has multiple copies of each probe, a bead-type 
summarization (mean and variance) was produced for each transcripts using the beadarray 
package87. The negative controls on the array were used to compute the detection p-value.  The 
limma package was used for background correction, quantile normalization, log2 transformation, 
and removal of control probes88.  Quality control criteria for elimination of a transcript 
included:  ‘detected’ expression levels in <10% of MESA samples (detection p-value cut-
off=0.01), probes that contain a SNP, probes with low variance across samples (<10th percentile), 
and probe overlap with a non-unique region.  
 
Gene Set Definition 
Four gene sets derived from the Gene Ontology database were investigated: chronic 
inflammatory response (GO: 0002544, 20 transcripts), inflammatory response (GO:0006964, 438 
transcripts), regulation of inflammatory response (GO:0050727, 192 transcripts), and the  
immune response (GO:0006955, 1251 transcripts). The number of overlapping transcripts 
between the biological processes is presented below (Table 8) and the gene names are presented 
in Appendix 18. The cumulative total number of gene transcripts examined across these four 
biological processes was 1407 transcripts. 
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- 
k indicates the number of transcripts in the gene set 
 
Statistical Analyses: 
Racial differences in social environmental factors 
Bivariate tests were conducted to determine the social environmental factors for which 
racial differences existed.  Chi-square was used for categorical variables (childhood and adult 
socioeconomic status), and analysis of variance (ANOVA) was used for continuous variables 







Race differences in transcript expression 
Multivariable linear regression was employed to identify transcripts significantly 
associated with race/ethnicity.  Bonferroni correction was employed to adjust for multiple 
comparisons.  This adjustment tightly controls the family wise error rate (i.e. the probability of 
Type 1 error). It is employed by setting the p-value to the value of 0.05 divided by the number of 
tests. We did this individually for each of the five gene sets.  For the chronic inflammatory 
response (20 transcripts), inflammatory response (438 transcripts), regulation of inflammatory 
(192 transcripts) response, and immune response (1251 transcripts) gene sets, p-values were 
adjusted to 2.5x10-3, 1.1x10-4, 2.6x10-4, and 4.0x10-5, respectively.  
 
Race differences in transcript expression after accounting for social environmental factors 
Three linear regression models were used to investigate the extent to which the social 
environmental factor explained the effect of race/ethnicity on gene expression. 
 
Model 1: 𝑔𝑒𝑛𝑒𝑒𝑥𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛 =∝1+ 𝛽1𝑟𝑎𝑐𝑒/𝑒𝑡ℎ𝑛𝑖𝑐𝑖𝑡𝑦 
Model 2: 𝑔𝑒𝑛𝑒𝑒𝑥𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛 =∝2+ 𝛽2𝑟𝑎𝑐𝑒 𝑒𝑡ℎ𝑛𝑖𝑐𝑖𝑡𝑦⁄ + 𝛽3𝑠𝑜𝑐𝑖𝑎𝑙𝑓𝑎𝑐𝑡𝑜𝑟 
Model 3: 𝑔𝑒𝑛𝑒𝑒𝑥𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛 =∝3+  𝛽4𝑠𝑜𝑐𝑖𝑎𝑙𝑓𝑎𝑐𝑡𝑜𝑟 
 
In all models, gene expression was adjusted for age, sex, and chip prior to analyses, and the 
residuals were used. 
The effect of the social environmental factor on the association between race/ethnicity 
and gene expression was assessed in two ways.  First, the absolute value of the percent change in 
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beta estimate from the race/ethnicity only model (Model 1) to the model with race/ethnicity 




| ∗ 100 = ∆𝑝𝑒𝑟𝑐𝑒𝑛𝑡 𝑖𝑛 𝑒𝑓𝑓𝑒𝑐𝑡. 
Secondly, we compared the proportion in variability (𝑅2) in gene expression that can be 
attributed to race/ethnicity with and without accounting for racially/ethnically patterned social 
environmental factors. To minimize the total number of tests and reduce the concern for Type 1 
error, the above models were run only where there were racial/ethnic differences in both the 
social environmental factor and gene expression. 
 
Statistical software 




Among the social and psychosocial exposures, there were racial/ethnic differences for 
major or lifetime discrimination (p<0.001) and adult socioeconomic status (χ2 =144.15, p<0.001) 
Tukey’s honest significance test indicated that Blacks reported significantly higher levels of 
major or lifetime discrimination than Whites (p<0.001) or Hispanics (p<0.001). There was not a 
significant difference for major or lifetime discrimination between Whites and Hispanics 
(p=0.16). With respect to education attainment, a significantly greater percentage of non-
Hispanics Whites (49%) had obtained a bachelor’s degree or higher compared to Blacks (27%) 





Table 9. Characteristics of the MESA Study Sample with Gene Expression Data 








Demographics     
Age mean  (SD) 69.6 (9.4) 69.6(9.0) 68.4(9.3) 70.2(9.5) 
Sex (% female) 51 60 50 48% 





    
Forsythe County, 
North Carolina  
49(4%) 1(0.3%) 0 48 (40%) 
New York, New 
York  
424(34%) 131(48%) 209 (52%) 84 (14%) 
Baltimore, 
Maryland  
317(25%) 140(51%) 0 177 (30%) 
Rochester, 
Minnesota  
474(38%) 0 193 (48%) 281 (48%) 
Total  1264(100%) 272 (100%) 402 (100%) 590 (100%) 
     
Socioeconomic 
Status 
    
High education- 
respondent* 
33% 27% 13% 49% 
High education- 
either parent** 
56% 55% 31% 71% 






    
Loneliness 3 (3-5) 3(3-4) 4(3-5) 3 (3-5) 
Lifetime 
Discrimination 
0 (0-1) 1(0-2) 0(0-1) 0 (0-1) 
Chronic Burden 1 (0-2) 1(0-2) 0(0-2) 1 (0-2) 
Perceived Stress  8 (5-10) 8(5-10) 8(5-10) 7 (6-10) 
Social support  9 (8-10) 9(8-10) 9(8-10) 9 (8-10) 
*High education for respondent indicates an educational level of a college or greater 





Racial/ethnic differences in gene expression 
Using multivariable linear regression, we identified significant racial/ethnic differences in 
gene transcript expression in each of the four investigated gene sets (i.e. chronic inflammation, 
inflammatory response, immune response, and regulation of the inflammatory response) (Table 
10).  For each gene set, there were more transcripts differentially expressed between Blacks and 
Whites than Blacks and Hispanics or Hispanics and Whites. When combining all gene sets, there 
were Black/White differences in expression for 449 out of the 1407 (32%) genes, indicating that 
expression differences were most dissimilar between these two groups. Blacks and Hispanics 
were most similar yet still had 333 out of 1407 (19%) gene transcripts with significant mean 
differences. The corresponding gene names with racial/ethnic differences in gene expression are 
given in Appendix 33. 
Table 10. Racial/Ethnic Differences in Gene Transcript Expression (Bonferroni 
Adjusted) 

































449(32%) 270(19%) 333(24%) 
m(%)=number and percentage of transcripts with racial/ethnic differences within the gene set 
k = number of transcripts in the gene set 
Gene expression adjusted for age, sex, and chip 





To investigate whether the gene transcripts that were differentially expressed between 
Blacks and Whites were also differentially expressed between Black and Hispanics or Hispanics 
and Whites, we plotted the findings from Table 10 using Venn diagrams for all inflammatory 
gene sets (Figure 2). Overall, we found 3 out of 20 transcripts in the chronic inflammatory 
pathway, 50 out of 1251 in the immune response pathway, 19 in inflammatory response 
pathway, and 7 out of 192 transcripts in the in the regulation of the inflammatory response 
pathway overlapped for all racial/ethnic comparisons.  Interestingly, there tended to be more 
transcripts that were found to be differentially expressed across at least two race/ethnic 
comparisons than in just one racial/ethnic comparison alone. The gene names for each 








Racial/ethnic differences in gene expression after accounting for social environmental factors. 
Accounting for major or lifetime discrimination (Model 2) led to at least a 10% change in 
the race/ethnicity beta estimate (from Model 1) for 15 of the total 449 gene transcripts with 
expression differences by race  (~3%) in the Black/White comparison and 11 of the total 
270(~4%) in the Black/Hispanic comparison (Figures 3 and 4). Since there were significant 
racial/ethnic differences in adult socioeconomic status for all racial/ethnic comparisons, the 
Overlap among Transcripts Significantly Associated with Race/Ethnicity by 
Biological Process (Bonferroni Adjusted) 
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change in beta estimate was assessed for each the Black/White, Black/Hispanic, and 
Hispanic/White comparisons in gene expression when accounting for adult socioeconomic 
status. Across biological processes, accounting for adult socioeconomic status led to a change in 
the beta estimate for race/ethnicity for 6/449 (~1%) gene transcripts in the Black/White 
comparison, 6/270 (~2%) in the Black/Hispanic comparison, and 62/333 (19%) in the 
Hispanic/White comparison. Within all four biological processes (i.e. chronic inflammation, 
immune response, inflammatory response, regulation of the inflammatory response), there were a 
greater number of gene transcripts with at least a 10% difference in the Hispanic/White analyses 
compared to the Black/White or Black/Hispanic investigations (Figures 5-7).  In general, across 
racial/ethnic comparisons, there was little overlap in the transcripts with greater than a 10% 
change in beta estimate (Figures 3-7). 
In general, the proportion of variability that major or lifetime discrimination or adult 
socioeconomic status each explained was relatively small compared to that of race/ethnicity. 
Consequently, the proportion of variability (𝑅2) in gene expression explained by race/ethnicity 
was only modestly changed when accounting for the racially/ethnically patterned social 


































In this study we assessed racial and ethnic differences in gene expression and the extent 
to which these differences could be explained by racially/ethnically patterned social 
environmental factors. We specifically focused on genes involved in the inflammatory response 
since epidemiological evidence has pointed to chronic inflammation as a risk factor for several 
high burden, chronic diseases with known racial/ethnic disparities. Of the 1407 gene transcripts 
investigated, there were Black/White expression differences in 32%, Black/Hispanic differences 
in 19%, and Hispanic/White differences in 24% (Table 10). Further, there were racial/ethnic 
differences in two of the social environmental factors, major or lifetime discrimination and adult 
socioeconomic status. Although accounting for these social environmental factors led to at least a 
10% change in the beta estimate in a total of 100 unique gene transcripts, the proportion in 
variability in gene expression explained by including the racially/ethnically patterned social 
environmental factors was modest. As race/ethnicity is a complex, multi-faceted constructs 
where differences in gene expression result from the combination of both biologic and 
racially/ethnically patterned environmental factors, these findings raise the question of the extent 
to which accounting for a single aspect of the social environment can substantially explain 
racial/ethnic differences in gene expression.  
 
Racial/Ethnic Differences in Social Environmental Factors 
Our findings indicate significant racial/ethnic differences in major or lifetime 
discrimination where Blacks reported higher levels compared to Whites and Hispanics. This 
finding is consistent with the literature 131,132 and work in the MESA study specifically50. This 
was expected as it is well known that Blacks in the U.S. have been disproportionately subject to 
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structural and individual experiences of discrimination133. Interestingly, there were significant 
differences between Black and Hispanics but not Hispanics and Whites. This may be explained 
by heterogeneity in reports of discrimination among Hispanics by nativity134,135. We also found 
significant differences for adult socioeconomic status across all racial/ethnic comparisons were 
Whites were most likely to have achieved a college degree (49%), followed by Blacks (27%), 
and then Hispanics (13%). This measure was collected in the baseline MESA sample in from 
2000-2002.  This is consistent with data from the 2000 Census which indicates that Whites were 
more likely to graduate college (27%) than Blacks (14%) or Hispanics (10%). However, the 
MESA sample is more educated than the national population.  Despite studies that have found 
the contrary, we did not find racial/ethnic differences in childhood socioeconomic status, 
loneliness, perceived stress, chronic burden, or social support.   
 
Racial/Ethnic Differences in Inflammatory Gene Expression 
Even after employing the conservative Bonferroni multiple testing correction, we found 
that out of the 1407 of unique gene transcripts representing four different inflammatory 
processes, there were 449 (32%) with differential expression between Blacks and Whites, 270 
(19%) between Blacks and Hispanics, and 333 (24%) between Hispanics and Whites. The 
observed racial/ethnic differences in gene expression result from differences in inherited DNA 
sequence and the regulation of the genome by environmental factors. Mechanistically, genetic 
expression is influenced by a number of factors including DNA sequence, epigenetic 
modifications, and mRNA degradation68,136,137. Research investigating the contribution of genetic 
ancestry to racial/ethnic differences in gene expression is traditionally analyzed at the DNA 
sequence level by investigating differences in single nucleotide polymorphisms (SNPs) 67,68.  
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Over generations, allele frequency differences between races/ethnicities develop due to 
geographical, social, and political factors that produce assortative mating practices (i.e. sexual 
selection with similar individuals). Such allele frequency variations are a partial contributor to 
racial/ethnic differences in gene expression.  Despite the contribution of population substructure, 
it has observed that within group variations are greater than between group variation which 
indicates that allelic frequencies differences between race and ethnicities are insufficient in 
explaining complex phenotypic differences in race/ethnicity138. Environmental (e.g. physical, 
social) contributors play important roles as well. In a prototypic example, a study investigating 
comparing the effects of ethnicity and geographic residence (rural vs. urban environment) on 
gene expression found that more genes were differentially expressed by geographic residence 
than genetic ancestry139. Other studies have found that exposure to adverse social environments 
is associated with an upregulation of proinflammatory genes across social environmental 
measures (e.g. loneliness, socioeconomic status, caregiver stress) and across species (e.g. human, 
rhesus macaques, mice), a phenomenon coined the “conserved transcriptional response to 
adversity (CTRA).” However, whether the social environmental factors contribute to 
racial/ethnic differences in gene expression was not examined in these prior CTRA studies. 
 
Racial/Ethnic Differences in Inflammatory Gene Expression Accounting for Racially/Ethnically 
Patterned Social Environmental Factors 
In our central analyses, we examined the effect of accounting for the racially/ethnically 
patterned social environmental factors (i.e. major or lifetime discrimination and adult 
socioeconomic status) on the association between race/ethnicity and gene expression by: 1) 
assessing the percent change in beta coefficient with and without the social environmental factor 
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and 2) comparing the proportion of variability in gene expression explained by race/ethnicity 
with and without the social environmental factor. Of the 449 unique genes with Black/White 
differences in expression, there was at least a 10% change in the beta coefficient in 15 (~3%) 
after accounting for major or lifetime discrimination. These genes had various functions such as 
leukocyte chemotaxis (CCL5, CCL3, LGALS3), mitogen-activated protein kinase signaling 
(NDST1, CCL5, CCL3, PEBP1, RASA3), and apoptosis (LGALS3, TNFRSF21). Similarly, 
there was at least a 10% change in the beta coefficient in 11 or the 270 gene transcripts (~4%) for 
the Black/Hispanic comparison after accounting for major or lifetime discrimination. These 
genes also had a variety of functions including regulating leukocyte migration (CCL2, MYD88, 
CXCL8, LYN) and positive regulation of chemokine production (RIPK2, HIF1A, MYD88). 
Across race/ethnic comparisons, there was a range in the number of transcripts for which 
accounting for adult socioeconomic status led to at least a 10% change in the beta estimate 
(Figures 3-7). As in accounting for major or lifetime discrimination, these genes had a myriad of 
functions (e.g. regulating type 1 interferon production, leukocyte migration, and regulating 
cytokine production). Notably, compared to the other racial/ethnic comparisons accounting for 
adult socioeconomic status changed the beta estimate by at least 10% for the greatest number of 
gene transcripts in the Hispanics/Whites comparison. There are two main explanations for this 
finding. First, this can be attributed to the stark differences in adult SES between Hispanics and 
Whites.  In the MESA sample, 49% of Whites had a college degree whereas only 13% of 
Hispanics achieved this level of education. This gap is wider than the other racial/ethnic 
comparisons (i.e. Black/White and Black/Hispanic). Further, previous studies indicate that 
education does not confer the same advantage for Hispanics and Whites which also contributes 
to the observed differences140.  
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Next, the proportion of variability explained by race/ethnicity with and without the 
racially/ethnically patterned social environmental factors was examined. We found that major or 
lifetime discrimination and adult SES each only modestly increased the proportion of variability 
in gene expression explained by race/ethnicity (Appendix Figures 35-39). These findings were 
unexpected as we anticipated that racially/ethnically patterned social factors would explain a 
substantial part of the variability.  However, there are a number of reasons that may explain this 
finding. One reason may be that the measures used to assess major or lifetime discrimination and 
socioeconomic status may not have long term effects on gene expression. Major or lifetime 
discrimination was measured by whether the event had ever happened in the participant’s life. 
Therefore, the discriminatory event may have happened many years prior to the collection of the 
gene expression. A more recent measure of exposure to discriminatory experiences may be more 
likely to be associated with gene expression.  Similarly, we used having a college education as a 
measure of socioeconomic status due to its stability of not changing over the life course.  
However, our participants were an average of ~70 years old and the effects of a college 
education, which would have been likely acquired approximately 50 years earlier may have 
diminished. Another explanation of the findings is that a single dimension of the social 
environment may be small compared to overall effect of race/ethnicity. Experiences of major or 
lifetime discrimination and socioeconomic status are each only one construct that can account for 
the experience of being in a certain racial/ethnic category, yet these factors of the social 
environment work in concert with other racially-patterned aspects of the social environment. 
Summary measures that capture more aspects of the social environment would help to better 




Strengths and Limitations 
There were strengths and limitations of the present study. One of the main strengths of 
the study was the use to the large, racially/ethnically diverse sample from the Multi-Ethnic Study 
of Atherosclerosis. Since gene expression is cell type specific, it is imperative that appropriate 
cell types are used for the biological process under investigation. In MESA, gene expression was 
collected in monocytes, an important cell type of the inflammatory response. 
A second strength of the present study is the focus on inflammation related genes specifically. 
Most prior human social genomics studies have been conducted at a genome wide level and 
investigations of biological meaning of differentially expressed genes has been post hoc. 
However, by using the Gene Ontology database, we were able to use an a priori defined set 
inflammation and immune response related genes specifically. This study is not without 
limitations.  Most notably we not account for genetic ancestry when accounting for race/ethnic 
effects as the data was not yet available. Secondly, we did not account for within race/ethnic 
heterogeneity. This is most notable in Hispanics were nativity has been shown be associated with 
social environmental and overall health measures. 
 
Conclusion 
In order to reduce the burden of racial/ethnic health disparities, it is important that 
research uncovers the mechanisms that allow these disparities to persist. This study contributes 
to the growing body of human social genomics and health disparities literatures by assessing 
racial/ethnic differences in gene expression and the extent to which social environmental factors 
explain these associations. Prior human social genomics studies were unable to conduct such 
investigations as they were limited by small, racially/ethnically homogeneous samples. Further, 
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little work in the health disparities literature has focused on gene expression as a potential 
biological mediator in the relationship between race/ethnicity and health. To develop effective 
prevention and treatment approaches, studies such as the present one that investigate how 








CHAPTER V: Conclusion 
 
Review of Main Findings 
 
In this dissertation, data from the large, racially/ethnically diverse Multi-Ethnic Study of 
Atherosclerosis (MESA) was used to investigate the association between a range of social 
environmental factors and gene expression.  In aim 1, we hypothesized that expression of genes 
previously implicated as part of the conserved transcriptional response to adversity (CTRA) 
would be differentially expressed by seven a priori selected social environmental factors (i.e. 
adult socioeconomic status, child socioeconomic status, loneliness, major or lifetime 
discrimination, perceived stress, chronic burden, and social support) in MESA. Both global and 
gene level analyses were used to investigate this hypothesis.  We found that major or lifetime 
discrimination and chronic burden were significant with a CTRA gene set in global analyses.  In 
multivariable linear regression analyses, the number of transcripts associated with the social 
environmental factor at p<0.05 ranged from 70-196 dependent upon social environmental factor. 
However, none were significant after adjustment for multiple testing. A varying number of 
transcripts (0-74) were selected via elastic net, the number of which varied dependent of social 
environmental exposure. These findings provide some evidence that there may be a concerted, 
conserved response to social environmental factors at the gene level.  However, the 
characteristics (e.g. cumulative exposure, impact) of social environmental factors that associate 
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with gene expression has yet to be fully explored. This is further complicated by the difficulty in 
replicating individual gene associations across studies. 
In aim 2, we built upon aim 1 by investigating whether the same social environmental 
factors were associated with the expression of a broader set of physiologically defined immune 
system related gene sets derived from the Gene Ontology database.  Some genes investigated in 
this aim overlapped with genes investigated in aim 1 (Appendix 40). Due to its epidemiologic 
associations with several high burden diseases, in aim 2 we focused specifically on expression of 
genes involved in the inflammatory and immune response. In global analyses, we found major or 
lifetime discrimination to be significantly associated with each of the four investigated gene sets 
(i.e. chronic inflammation, inflammatory response, immune response, and regulation of the 
inflammatory response). Loneliness and chronic burden were also significantly associated with 
the chronic inflammatory gene set in global analyses. As in aim 1, there were not significant 
associations in the linear regression analyses after multiple testing and a varying number of 
transcripts selected in elastic net. Aim 2 analyses demonstrate that some social environmental 
factors are associated with expression of inflammation related genes, and exposure to major or 
lifetime discrimination may be especially influential in affecting inflammation and immune 
system related gene expression. 
In aim 3, we investigated the association between race/ethnicity with a priori defined sets 
of inflammatory and immune system related genes and the extent to which this association could 
be explained by racially/ethnically patterned social environmental factors (i.e. major or lifetime 
discrimination and adult socioeconomic status).  Accounting for a racially/ethnically pattered 
social environmental factor (i.e. major or lifetime discrimination, adult SES) in the association 
between race/ethnicity and gene expression changed the effect estimate by >10% for less than 
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5% of the inflammation and immune response genes investigated.  Across gene sets and 
racial/ethnic comparisons, race/ethnicity on average explained more of the variability in gene 
expression than the racially/ethnically pattern social environmental factors. The findings in aim 3 
indicate that accounting for a single dimension of the social environment may be small compared 
to the overall effect of race/ethnicity. 
Significance 
 
The conserved transcriptional response to adversity (CTRA) studies were an important 
stimulus to the emergence of the new field of human social genomics. The CTRA is categorized 
by and upregulation of proinflammatory genes and downregulation of Type 1 interferon and 
antibody synthesis genes in response to adverse social environmental exposures. This area has 
received widespread attention as it serves as a mechanism that has the potential to explain the 
well documented relationships between the social environment and health. One of the main 
shortcomings of these studies, however, is the lack of replication in a separate human cohort.  
Due to the infamous history of saturating the literature with false positive findings, replication is 
critical in genomic studies. Aim 1 of this dissertation served as a scientific evaluation of the 
reproducibility of the findings in the current CTRA literature. Our findings of aim 1 suggest that 
for some exposures (e.g. major or lifetime discrimination) but not others (e.g. perceived stress) 
there are differences in gene expression. This partially supports the idea of a conserved 
transcriptional response to adversity.  At the same time, the aim 1 findings highlight the 
analytical challenges of such studies, particularly as we did not reproduce any of the gene level 
associations in linear regression analysis. Single gene analyses are difficult to replicate in part 
due to interindividual heterogeneity in genomes and environments. Further, the high number of 
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statistical tests makes these types of studies prone to Type 1 error. As a new area of research, 
scientists must be particularly meticulous in ensuring that our methodological approaches are 
appropriate, even if cutting-edge or yet to be developed statistical models are needed. We 
addressed the multiple testing issue by first assessing global significance using a single test, the 
Global ANCOVA. In the linear regression analyses, we employed the multiple testing correction 
designed to account for correlated data. In elastic net, we were able to identify transcripts most 
robustly associated with the social environmental exposures. In contrast to OLS regression, 
elastic net is able to handle p>n investigations and account for multicollinearity. We were 
encouraged by discovering that many of the transcripts selected via elastic net tended to have 
lower p-values in the linear regression analysis, indicating suggestive associations between social 
environmental factors and gene expression that linear regression may have been ill powered to 
detect. The introduction of this the multi-faceted analytical approach in this dissertation to the 
human social genomics literature will help to move the field forward as we work towards 
identifying the best methods to address the complexity of the statistically assessing the 
relationship between social environment factors and the genome. 
By focusing specifically on a priori biologically defined gene sets, our aim 2 uniquely 
contributes to the human social genomics literature by investigating chronic inflammation 
specifically.  While other studies have focused on the entire genome or a subset of genes 
representing a few biological processes, we focus specifically on inflammation due to its known 
associations with chronic disease. This approach helps to reduce the dimensionality that is 
introduced by assessing the whole genome. Further, contrary to other previous studies that 
selected a small number of genes (i.e. range: 3-31) to represent a biological process in a contrast 
score, we assessed all of the genes available in the Gene Ontology database to give a more 
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comprehensive picture of the effect of social environmental factors on inflammatory gene 
expression.  
Aim 3 further adds to the human social genomics literature by assessing the association 
between race/ethnicity and gene expression and the extent to which these associations are 
explained by racially/ethnically pattered social factors. As racism has been deemed a 
fundamental cause of health equalities it is important to understand the mechanisms through 
which socially constructed racial and ethnic categorizations work to impact biological 
functioning and overall health. Consistent with previous literature, we found there to be 
racial/ethnicity differences in gene expression.  We also found that the investigated social 
environmental factors individually only explained a small part of the effect. Work by Phelan and 
Link posit that racism is associated with health only in part through socioeconomic status, but 
that a range of other socially patterned factors (e.g. access and quality of health care, 
discrimination, residential segregation) also contribute to the relationship23. Aim 3 highlighted 
the complexity of assessing the contribution of social environmental factors in explaining 
racial/ethnic differences in health. It is important to consider how such environmental factors act 
independently and together to affect gene expression. 
Implications 
 
The unveiling of the Precision Medicine Initiative has encouraged scientists to assess 
how differences in genes, environment, and lifestyles matter to best address the health needs of 
the individual141. With recent advancements in technology such as the completion of the Human 
Genome Project, decreasing costs of sequencing, and increased data storage ability, proponents 
of the initiative argue that an individualized approach to healthcare is now possible. Although 
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most of the attention has focused on genetic advancements, it is imperative that we understand 
the direct and indirect mechanisms through which environmental factors act on biological 
functioning and thereby overall health. By assessing the associations between social 
environmental factors and gene expression, this dissertation helps to lay the groundwork for 
future precision medicine efforts.  It will be important to consider the whole person, both in 
terms of biological and non-biological factors, to tailor effective prevention and treatment 
strategies (e.g. pharmacogenetic, behavioral, and psychological). Studies that investigate how 
social environmental factors “get under the skin” will be critical in these efforts. 
Strengths  
 
Use of the Multi-Ethnic Study of Atherosclerosis study to investigate the research 
questions of this dissertation was a valuable strength. With 1,264 participants, the sample size 
nearly doubled that of any previous conserved transcriptional response to adversity studies, 
providing greater power to detect gene expression differences.  Further compared to previous 
studies, the MESA study is more racial/ethically heterogeneous.  This enabled the investigation 
of racial/ethnic differences in gene expression and social environmental factors that may be 
influencing the relationship.  As a study that has focused mostly on social determinants of health 
measures, the social environmental measures collected in MESA are particularly thorough 
compared to other studies. The collection of gene expression data in monocytes in MESA was 
also an asset to the current investigation. Monocytes are phagocytic cells that are an important 
leukocyte of the innate immune system. Previous human social genomics studies have primarily 
collected gene expression in peripheral blood mononuclear cells (PBMCs), which are an 
assortment of leukocytes including monocytes, T cells, B cells, natural killer (NK) cells.  Since 
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gene expression is cell type specific, use of a variety of cell types in a single study is not ideal as 
associations that may be present with one cell type can be masked by non-significant 
associations in a different cell type.  Prior research indicates that among the cell types of 
PBMCs, monocytes are particularly sensitive to social environment exposures63,117. Use of solely 
monocytes in the MESA study enabled the greatest likelihood of detecting associations.   
The analytical approach employed is strength of this dissertation. Human social genomic 
studies are inherently complex due to interrogation of a high number of variables with an 
unknown correlation structure.  Our statistical approaches (i.e. Global ANCOVA, linear 
regression, and elastic net) were designed to account to the complexity of multivariate testing of 
correlated variables. By using the permutation based approximation of the F distribution in the 
Global ANCOVA test, we accounted for the gene expressions being neither independent nor 
homoscedastic89.   In linear regression analyses, we employed false discovery rate multiple 
testing correction for correlated data to address issues related to the total number of statistical 
tests being conducted and the correlated nature of the gene expression outcomes.  Elastic net, 
which was used as a variable selection procedure, is designed to address multicollinearity. 
Limitations 
 
While there were notable strengths to this study, we acknowledge that there were some 
important limitations. In the interest of systematically identifying social sensitive genes, we 
limited our literature search to articles that specifically used the term “conserved transcriptional 
response to adversity”.  In doing this, we may have missed other genes in the literature whose 
expression is modified by social environment exposures but did not use this term in the 
published article.   
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A second limitation is the variation in time over which data was collected.  Social 
environmental factors were collected at various exams in the MESA study while gene expression 
was only collected in Exam 5.  The baseline MESA exam was conducted in 2000 and Exam 5 
ended in 2012. Therefore, there is a potential gap of 12 years from collection of the social 
environmental exposure and the blood draw used to assess gene expression. To minimize the 
bias this may introduce, we included data from the most recent exam available. Further, since we 
only had gene expression data available for one time point, we cannot comment on the dynamic 
nature of the tested relationships. 
Future Work 
 
There are several areas in which further research is needed as we seek to understand the 
complex interplay between genomics, the environment, and lifestyle. Our developing knowledge 
surrounding epigenetic responses to environmental and lifestyle cues hints at epigenetics 
modifications as a likely mediator between the social environment and gene expression. For 
example, a recent study by Needham et. al found significant relationships between low 
socioeconomic status and methylation of stress related genes142. Future research should 
investigate the mediating and causal roles of epigenetic modifications in the pathway between 
the social environment and gene expression. 
Further, it will be increasingly important to understand how the environmental and 
lifestyles exposures work independently and in concert to affect the genome. Different social and 
psychosocial experiences may activate different genes and pathways.  This is consistent with the 
little overlap between the nine identified CTRA studies (despite implication of many of the same 
biological processes) investigated in Aim 1.  For example, similar types of exposures (e.g. 
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complicated and non-complicated grief, hedonic and eudemonic well-being) were associated 
with expression of different genes. Most extant studies, including this dissertation, have focused 
on a single social or psychosocial exposure at a time. However, the human social experience in 
composed of many interacting factors.  Future research should investigate how such factors work 
together to affect the genome. This study helps demonstrate that the previously used approaches 
(i.e. differential expression, contrast score) have been unable to uncover replicable relationships 
between the social environment and gene expression. Latent variable models and sequence 
kernel analysis could be used to better represent the complexity of the human environment as we 
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List of Conserved Transcriptional Response to Adversity (CTRA) Genes 
Illumina 
Transcript ID 
Gene Name Gene 
Symbol 
ILMN_1651433 deoxycytidine kinase DCK 
ILMN_1651496 histone cluster 1  H2bd HIST1H2B 
ILMN_1651499 Unnamed Transcript N/A 
ILMN_1651735 trans-golgi network protein 2 TGOLN2 
ILMN_1651826 brain abundant  membrane attached signal protein 1 BASP1 
ILMN_1651828 chaperonin containing TCP1  subunit 3 (gamma) CCT3 
ILMN_1652065 potassium large conductance calcium-activated channel  
subfamily M 
KCNMB1 




ILMN_1652198 cerebral cavernous malformation 2 CCM2 
ILMN_1652394 RAB2A  member RAS oncogene family RAB2A 
ILMN_1652777 CDC42 effector protein (Rho GTPase binding) 2 CDC42EP
2 
ILMN_1652790 CDC-like kinase 1 CLK1 
ILMN_1652806 ATP synthase  H+ transporting   mitochondrial Fo complex  
subunit F 
ATP5J 
ILMN_1652825 interleukin 10 receptor  alpha IL10RA 
ILMN_1652906 globoside alpha-1 3-N-acetylgalactosaminyltransferase 1 GBGT1 
ILMN_1653166 C-type lectin domain family 10  member A CLEC10A 
ILMN_1653266 DnaJ (Hsp40) homolog  subfamily B   member 14 DNAJB14 
ILMN_1653283 amyloid beta (A4) precursor protein APP 
ILMN_1653443 cyclin-dependent kinase 2 CDK2 
ILMN_1653466 hes family bHLH transcription factor 4 HES4 
ILMN_1653480 coiled-coil domain containing 125 CCDC125 
ILMN_1653708 coronin  actin binding protein   1B CORO1B 
ILMN_1653711 frizzled class receptor 2 FZD2 
ILMN_1653871 nicotinamide phosphoribosyltransferase NAMPT 
ILMN_1654262 zinc finger  matrin-type 3 ZMAT3 
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ILMN_1654504 C-type lectin domain family 7  member A CLEC7A 
ILMN_1654545 cleavage and polyadenylation specific factor 1  160kDa CPSF1 
ILMN_1654560 Unnamed Transcript 
ILMN_1654583 chromodomain helicase DNA binding protein 1 CHD1 
ILMN_1654685 multiple C2 domains  transmembrane 1 MCTP1 
ILMN_1654735 solute carrier organic anion transporter family  member 
3A1 
SLCO3A1 
ILMN_1654778 lymphocyte-specific protein 1 LSP1 
ILMN_1654812 unc-93 homolog B1 (C. elegans) UNC93B1 
ILMN_1654851 family with sequence similarity 134  member A FAM134A 
ILMN_1655077 PR domain containing 1  with ZNF domain PRDM1 
ILMN_1655177 phosphatidylinositol 4-kinase  catalytic   alpha PI4KA 
ILMN_1655414 tumor necrosis factor (ligand) superfamily  member 14 TNFSF14 
ILMN_1655422 ribosomal protein L17 RPL17 
ILMN_1655635 methyltransferase like 3 METTL3 
ILMN_1655930 elongation factor  RNA polymerase II  2 ELL2 
ILMN_1655961 SND1 intronic transcript 1 (non-protein coding) SND1-IT1 
ILMN_1656011 regulator of G-protein signaling 1 RGS1 
ILMN_1656184 Unnamed Transcript 
ILMN_1656254 Unnamed Transcript 
ILMN_1656310 indoleamine 2 3-dioxygenase 1 IDO1 
ILMN_1656486 DnaJ (Hsp40) homolog  subfamily C   member 10 DNAJC10 
ILMN_1656761 TGFB-induced factor homeobox 1 TGIF1 
ILMN_1657619 DnaJ (Hsp40) homolog  subfamily B   member 14 DNAJB14 
ILMN_1657790 serine/arginine-rich splicing factor 11 SRSF11 
ILMN_1657797 fibroblast growth factor (acidic) intracellular binding 
protein 
FIBP 
ILMN_1657857 transmembrane protein 14C TMEM14
C 
ILMN_1657862 adenosylhomocysteinase AHCY 
ILMN_1657871 radical S-adenosyl methionine domain containing 2 RSAD2 
ILMN_1657977 methionine sulfoxide reductase B2 MSRB2 
ILMN_1658015 muscleblind-like splicing regulator 2 MBNL2 
ILMN_1658182 mex-3 RNA binding family member C MEX3C 
ILMN_1658247 2'-5'-oligoadenylate synthetase 1  40/46kDa OAS1 
ILMN_1658494 regulator of cell cycle RGCC 
ILMN_1658504 choline kinase alpha CHKA 
ILMN_1658798 multiple EGF-like-domains 9 MEGF9 
ILMN_1658884 ATPase  class VI   type 11B ATP11B 
ILMN_1658920 multiple C2 domains  transmembrane 1 MCTP1 
ILMN_1659058 protein phosphatase 1  regulatory subunit 10 PPP1R10 
ILMN_1659122 Kruppel-like factor 10 KLF10 
109 
 
ILMN_1659189 chromosome 9 open reading frame 89 C9orf89 
ILMN_1659227 CD79a molecule  immunoglobulin-associated alpha CD79A 
ILMN_1659257 tumor necrosis factor receptor superfamily  member 8 TNFRSF8 
ILMN_1659285 proteasome (prosome  macropain) assembly chaperone 1 PSMG1 
ILMN_1659463 apoptotic peptidase activating factor 1 APAF1 
ILMN_1659524 NADH dehydrogenase (ubiquinone) complex I  assembly 
factor 4 
NDUFAF4 
ILMN_1659620 Unnamed Transcript 
ILMN_1659688 lectin  galactoside-binding   soluble  3 binding protein LGALS3B
P 
ILMN_1659913 interferon stimulated exonuclease gene 20kDa ISG20 
ILMN_1659923 guanine nucleotide binding protein (G protein)  q 
polypeptide 
GNAQ 
ILMN_1659936 protein phosphatase 1  regulatory subunit 15A PPP1R15A 
ILMN_1659960 interleukin 4 induced 1 IL4I1 
ILMN_1659990 hypoxia inducible lipid droplet-associated HILPDA 
ILMN_1660027 Fc fragment of IgG  low affinity IIb   receptor (CD32) FCGR2B 
ILMN_1660270 Unnamed Transcript 
ILMN_1660440 abhydrolase domain containing 17B ABHD17B 
ILMN_1660462 mucolipin 2 MCOLN2 
ILMN_1660579 cytokine receptor-like factor 3 CRLF3 
ILMN_1660582 ligase III  DNA   ATP-dependent LIG3 
ILMN_1660635 lactamase  beta 2 LACTB2 
ILMN_1660661 t-complex 1 TCP1 
ILMN_1660847 6-phosphofructo-2-kinase/fructose-2 6-biphosphatase 3 PFKFB3 
ILMN_1661197 cardiotrophin-like cytokine factor 1 CLCF1 
ILMN_1661409 family with sequence similarity 208  member A FAM208A 
ILMN_1661432 nucleoporin 43kDa NUP43 
ILMN_1661439 flotillin 1 FLOT1 
ILMN_1661589 CD151 molecule (Raph blood group) CD151 
ILMN_1661599 DNA-damage-inducible transcript 4 DDIT4 
ILMN_1661646 B-cell scaffold protein with ankyrin repeats 1 BANK1 
ILMN_1661695 interleukin-1 receptor-associated kinase 3 IRAK3 
ILMN_1661833 ankyrin repeat domain 12 ANKRD12 
ILMN_1662358 MX dynamin-like GTPase 1 MX1 
ILMN_1662417 leucine-rich pentatricopeptide repeat containing LRPPRC 
ILMN_1662451 Fc fragment of IgE  low affinity II   receptor for (CD23) FCER2 
ILMN_1662488 mediator complex subunit 23 MED23 
ILMN_1662617 protein phosphatase 2  regulatory subunit B''   gamma PPP2R3C 
ILMN_1662795 carbonic anhydrase II CA2 
ILMN_1662865 calcineurin-like phosphoesterase domain containing 1 CPPED1 
ILMN_1662896 WD repeat domain 11 WDR11 
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ILMN_1662973 CD82 molecule CD82 
ILMN_1663090 SON DNA binding protein SON 
ILMN_1663142 C-type lectin domain family 12  member A CLEC12A 
ILMN_1663149 signal recognition particle 54kDa SRP54 
ILMN_1663159 Unnamed Transcript 
ILMN_1663356 rabphilin 3A RPH3A 
ILMN_1663484 Unnamed Transcript 
ILMN_1663493 Unnamed Transcript 
ILMN_1663646 Dmx-like 1 DMXL1 
ILMN_1663664 mitochondrial ribosomal protein S10 MRPS10 
ILMN_1663866 transforming growth factor  beta-induced   68kDa TGFBI 
ILMN_1664006 amylo-alpha-1  6-glucosidase   4-alpha-glucanotransferase AGL 
ILMN_1664016 Rho/Rac guanine nucleotide exchange factor (GEF) 18 ARHGEF1
8 
ILMN_1664068 endoplasmic reticulum-golgi intermediate compartment 
(ERGIC) 1 
ERGIC1 
ILMN_1664094 purinergic receptor P2Y  G-protein coupled  13 P2RY13 
ILMN_1664098 Fas-activated serine/threonine kinase FASTK 
ILMN_1664371 Unnamed Transcript 
ILMN_1664449 ALG5  dolichyl-phosphate beta-glucosyltransferase ALG5 
ILMN_1664525 purinergic receptor P2Y  G-protein coupled  13 P2RY13 
ILMN_1664543 interferon-induced protein with tetratricopeptide repeats 3 IFIT3 
ILMN_1664644 autophagy related 16-like 2 (S. cerevisiae) ATG16L2 
ILMN_1664691 dual adaptor of phosphotyrosine and 3-phosphoinositides DAPP1 
ILMN_1665049 spastic paraplegia 11 (autosomal recessive) SPG11 
ILMN_1665065 serine incorporator 3 SERINC3 
ILMN_1665100 prostaglandin-endoperoxide synthase 1 (prostaglandin G/H 
synthase a 
PTGS1 
ILMN_1665117 chromosome 6 open reading frame 89 C6orf89 
ILMN_1665192 nudix (nucleoside diphosphate linked moiety X)-type motif 
6 
NUDT6 
ILMN_1665217 centrosomal protein 19kDa CEP19 
ILMN_1665243 FK506 binding protein 14  22 kDa FKBP14 
ILMN_1665428 gasdermin D GSDMD 
ILMN_1665559 cyclin-dependent kinase 2 CDK2 
ILMN_1665583 tubulin  beta class I TUBB 
ILMN_1665859 RAB27A  member RAS oncogene family RAB27A 
ILMN_1665964 GRB2-associated binding protein 2 GAB2 
ILMN_1666007 trafficking protein particle complex 6B TRAPPC6
B 
ILMN_1666122 heart development protein with EGF-like domains 1 HEG1 
ILMN_1666269 cathepsin Z CTSZ 
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ILMN_1666364 coenzyme Q10 homolog A (S. cerevisiae) COQ10A 
ILMN_1666552 zinc finger protein 75a ZNF75A 
ILMN_1666733 chemokine (C-X-C motif) ligand 8 CXCL8 
ILMN_1666742 chromosome 9 open reading frame 72 C9orf72 
ILMN_1666932 Fc fragment of IgG  low affinity IIa   receptor (CD32) FCGR2A 
ILMN_1667068 zinc finger CCCH-type  antiviral 1 ZC3HAV1 
ILMN_1667460 sulfatase 2 SULF2 
ILMN_1667476 lymphotoxin beta receptor (TNFR superfamily  member 3) LTBR 
ILMN_1667594 Kruppel-like factor 10 KLF10 
ILMN_1667711 phospholipase A2  group XVI PLA2G16 
ILMN_1667796 Unnamed Transcript 
ILMN_1667883 THO complex 5 THOC5 
ILMN_1667893 tensin 3 TNS3 
ILMN_1668134 glutathione S-transferase mu 1 GSTM1 
ILMN_1668345 OAF homolog (Drosophila) OAF 
ILMN_1668463 Unnamed Transcript 
ILMN_1668484 leucine rich repeat containing 47 LRRC47 
ILMN_1668525 nuclear receptor subfamily 3  group C   member 1 
(glucocorticoid re 
NR3C1 
ILMN_1668526 GTPase  very large interferon inducible pseudogene 1 GVINP1 
ILMN_1668605 N-acylethanolamine acid amidase NAAA 
ILMN_1668721 cyclin D3 CCND3 
ILMN_1668979 DnaJ (Hsp40) homolog  subfamily B   member 14 DNAJB14 
ILMN_1669062 Unnamed Transcript 
ILMN_1669189 Ras association (RalGDS/AF-6) domain family member 5 RASSF5 
ILMN_1669376 DNA-damage regulated autophagy modulator 1 DRAM1 
ILMN_1669377 adaptor-related protein complex 4  beta 1 subunit AP4B1 
ILMN_1669523 FBJ murine osteosarcoma viral oncogene homolog FOS 
ILMN_1669572 ring finger protein 126 RNF126 
ILMN_1669674 canopy FGF signaling regulator 3 CNPY3 
ILMN_1669727 WW domain containing adaptor with coiled-coil WAC 
ILMN_1669888 cystatin A (stefin A) CSTA 
ILMN_1670037 polymerase (RNA) II (DNA directed) polypeptide L  
7.6kDa 
POLR2L 
ILMN_1670134 fatty acid desaturase 1 FADS1 
ILMN_1670145 deafness  autosomal dominant 5 DFNA5 




ILMN_1670322 FCH domain only 2 FCHO2 
ILMN_1670439 forty-two-three domain containing 1 FYTTD1 
ILMN_1670576 interferon regulatory factor 5 IRF5 
ILMN_1670875 protein phosphatase  Mg2+/Mn2+ dependent   1D PPM1D 
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ILMN_1670899 fibrillin 2 FBN2 
ILMN_1670925 cytochrome b5 domain containing 1 CYB5D1 
ILMN_1670926 carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) 
sulfotransferase 
CHST15 
ILMN_1670970 protein phosphatase 3  catalytic subunit   alpha isozyme PPP3CA 
ILMN_1671048 zinc finger protein 644 ZNF644 
ILMN_1671067 mediator complex subunit 13 MED13 
ILMN_1671250 chloride intracellular channel 4 CLIC4 
ILMN_1671404 supervillin SVIL 
ILMN_1671509 chemokine (C-C motif) ligand 3 CCL3 
ILMN_1671703 actin  alpha 2   smooth muscle  aorta ACTA2 
ILMN_1671731 arginine vasopressin-induced 1 AVPI1 
ILMN_1671766 coagulation factor XII (Hageman factor) F12 
ILMN_1671818 urotensin 2 UTS2 
ILMN_1671891 phosphotyrosine interaction domain containing 1 PID1 
ILMN_1671932 SAMM50 sorting and assembly machinery component SAMM50 
ILMN_1672004 transducer of ERBB2 1 TOB1 
ILMN_1672122 prolyl 4-hydroxylase  transmembrane (endoplasmic 
reticulum) 
P4HTM 
ILMN_1672124 family with sequence similarity 198  member B FAM198B 
ILMN_1672295 zinc finger CCCH-type containing 12A ZC3H12A 
ILMN_1672417 protein tyrosine phosphatase  receptor type   C-associated 
protein 
PTPRCAP 
ILMN_1672503 dihydropyrimidinase-like 2 DPYSL2 
ILMN_1672606 2'-5'-oligoadenylate synthetase 1  40/46kDa OAS1 
ILMN_1672650 pyruvate kinase  muscle PKM 
ILMN_1672660 myelin basic protein MBP 
ILMN_1672947 calpastatin CAST 
ILMN_1673023 E1A binding protein p400 EP400 
ILMN_1673113 coagulation factor II (thrombin) receptor-like 1 F2RL1 
ILMN_1673119 AF4/FMR2 family  member 1 AFF1 
ILMN_1673352 interferon induced transmembrane protein 2 IFITM2 
ILMN_1673478 family with sequence similarity 13  member B FAM13B 
ILMN_1673586 solute carrier family 6 (neurotransmitter transporter)  
member 6 
SLC6A6 
ILMN_1673960 methionine adenosyltransferase II  beta MAT2B 
ILMN_1673966 polymerase (RNA) III (DNA directed) polypeptide F  39 
kDa 
POLR3F 
ILMN_1674063 2'-5'-oligoadenylate synthetase 2  69/71kDa OAS2 
ILMN_1674128 CWC22 spliceosome-associated protein CWC22 
ILMN_1674160 bridging integrator 1 BIN1 
ILMN_1674297 host cell factor C2 HCFC2 
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ILMN_1674302 phosphoribosyl pyrophosphate amidotransferase PPAT 
ILMN_1674394 adipocyte plasma membrane associated protein APMAP 
ILMN_1674574 vanin 1 VNN1 
ILMN_1674811 2'-5'-oligoadenylate synthetase-like OASL 
ILMN_1674985 transmembrane protein 51 TMEM51 
ILMN_1675085 ubiquitin-like modifier activating enzyme 6 UBA6 
ILMN_1675124 DEAD (Asp-Glu-Ala-Asp) box helicase 17 DDX17 
ILMN_1675156 cell division cycle 42 CDC42 




ILMN_1675365 La ribonucleoprotein domain family  member 4 LARP4 
ILMN_1675448 ZFP36 ring finger protein-like 1 ZFP36L1 
ILMN_1675556 XK  Kell blood group complex subunit-related family   
member 8 
XKR8 
ILMN_1675640 2'-5'-oligoadenylate synthetase 1  40/46kDa OAS1 
ILMN_1675669 inhibitor of Bruton agammaglobulinemia tyrosine kinase IBTK 
ILMN_1675693 protein phosphatase 2  catalytic subunit   beta isozyme PPP2CB 
ILMN_1675695 PDS5  regulator of cohesion maintenance   homolog B (S. 
cerevisiae) 
PDS5B 
ILMN_1675756 potassium inwardly-rectifying channel  subfamily J   
member 15 
KCNJ15 
ILMN_1675844 WD repeat domain 1 WDR1 
ILMN_1675956 lysosomal trafficking regulator LYST 
ILMN_1676254 myotubularin related protein 3 MTMR3 
ILMN_1676448 WD repeat and FYVE domain containing 1 WDFY1 
ILMN_1676718 Unnamed Transcript 
ILMN_1676984 DNA-damage-inducible transcript 3 DDIT3 
ILMN_1677200 cytoplasmic FMR1 interacting protein 2 CYFIP2 
ILMN_1677466 dual specificity phosphatase 6 DUSP6 
ILMN_1677511 prostaglandin-endoperoxide synthase 2 (prostaglandin G/H 
synthase a 
PTGS2 
ILMN_1677574 polypeptide N-acetylgalactosaminyltransferase 6 GALNT6 
ILMN_1677607 sterol-C5-desaturase SC5D 
ILMN_1677843 RAB24  member RAS oncogene family RAB24 
ILMN_1677920 lactotransferrin LTF 
ILMN_1678293 Unnamed Transcript 
ILMN_1678490 Rab interacting lysosomal protein-like 2 RILPL2 
ILMN_1678517 acyl-CoA synthetase long-chain family member 5 ACSL5 
ILMN_1678546 peroxisomal biogenesis factor 11 beta PEX11B 





ILMN_1678833 chemokine (C-C motif) receptor 1 CCR1 
ILMN_1678974 mitochondrial ribosomal protein L43 MRPL43 
ILMN_1679232 kinase D-interacting substrate  220kDa KIDINS22 
ILMN_1679268 pellino E3 ubiquitin protein ligase 1 PELI1 
ILMN_1679655 WD repeat domain 82 WDR82 
ILMN_1679666 secretoglobin  family 3A   member 1 SCGB3A1 
ILMN_1679727 CDC-like kinase 1 CLK1 
ILMN_1679929 Kruppel-like factor 13 KLF13 




ILMN_1680246 methionine adenosyltransferase II  beta MAT2B 
ILMN_1680397 chemokine (C-X-C motif) receptor 2 CXCR2 
ILMN_1680424 cathepsin G CTSG 
ILMN_1680465 ADP-ribosylation factor-like 5B ARL5B 
ILMN_1680618 v-myc avian myelocytomatosis viral oncogene homolog MYC 
ILMN_1680624 cellular repressor of E1A-stimulated genes 1 CREG1 
ILMN_1680687 N-ethylmaleimide-sensitive factor NSF 
ILMN_1681301 absent in melanoma 2 AIM2 
ILMN_1681461 RAB27A  member RAS oncogene family RAB27A 
ILMN_1681678 CTD (carboxy-terminal domain  RNA polymerase II   
polypeptide A) sm 
CTDSP1 
ILMN_1681721 2'-5'-oligoadenylate synthetase-like OASL 
ILMN_1682081 ring finger protein 19B RNF19B 
ILMN_1682098 proteasome (prosome  macropain) subunit   alpha type 4 PSMA4 
ILMN_1682147 hook microtubule-tethering protein 2 HOOK2 
ILMN_1682180 valosin containing protein (p97)/p47 complex interacting 
protein 1 
VCPIP1 
ILMN_1682323 DEAD (Asp-Glu-Ala-Asp) box polypeptide 51 DDX51 
ILMN_1682494 arginine/serine-rich coiled-coil 1 RSRC1 
ILMN_1682501 CCR4-NOT transcription complex  subunit 1 CNOT1 
ILMN_1682636 chemokine (C-X-C motif) ligand 2 CXCL2 
ILMN_1682717 immediate early response 3 IER3 
ILMN_1682781 TEA domain family member 2 TEAD2 
ILMN_1682928 carboxypeptidase  vitellogenic-like CPVL 
ILMN_1682930 signal-induced proliferation-associated 1 SIPA1 
ILMN_1682938 ADP-ribosylation factor 3 ARF3 
ILMN_1682993 natural killer cell granule protein 7 NKG7 
ILMN_1683023 platelet derived growth factor C PDGFC 
ILMN_1683026 proteasome (prosome  macropain) subunit   beta type 10 PSMB10 
ILMN_1683127 zinc finger protein 281 ZNF281 





ILMN_1683313 ST3 beta-galactoside alpha-2 3-sialyltransferase 1 ST3GAL1 
ILMN_1683595 methyl-CpG binding domain protein 1 MBD1 
ILMN_1683786 Unnamed Transcript 
ILMN_1683792 leucine aminopeptidase 3 LAP3 
ILMN_1684585 acyl-CoA synthetase long-chain family member 1 ACSL1 
ILMN_1684887 SAM domain  SH3 domain and nuclear localization signals 
1 
SAMSN1 
ILMN_1684982 pyruvate dehydrogenase kinase  isozyme 4 PDK4 
ILMN_1685009 integrin  alpha M (complement component 3 receptor 3 
subunit) 
ITGAM 
ILMN_1685057 solute carrier family 22 (organic cation/zwitterion 
transporter)  m 
SLC22A4 
ILMN_1685122 collagen  type IX   alpha 2 COL9A2 
ILMN_1685289 chromosome 16 open reading frame 58 C16orf58 
ILMN_1685327 Unnamed Transcript 
ILMN_1685445 notch 2 N-terminal like NOTCH2
NL 
ILMN_1685521 killer cell lectin-like receptor subfamily F  member 1 KLRF1 
ILMN_1685625 uncoupling protein 2 (mitochondrial  proton carrier) UCP2 
ILMN_1685678 eukaryotic translation elongation factor 1 beta 2 EEF1B2 
ILMN_1685810 nuclear factor of activated T-cells  cytoplasmic   
calcineurin-depe 
NFATC3 
ILMN_1685824 UDP-Gal:betaGlcNAc beta 1 4- galactosyltransferase   
polypeptide 5 
B4GALT5 
ILMN_1686116 thrombospondin 1 THBS1 
ILMN_1686135 centrosomal protein 95kDa CEP95 
ILMN_1686283 cat eye syndrome chromosome region  candidate 1 CECR1 
ILMN_1686573 defensin  beta 1 DEFB1 
ILMN_1686623 colony stimulating factor 1 receptor CSF1R 
ILMN_1686645 UTP14  U3 small nucleolar ribonucleoprotein   homolog C 
(yeast) 
UTP14C 
ILMN_1686697 F-box protein 38 FBXO38 
ILMN_1686862 H2.0-like homeobox HLX 
ILMN_1686884 interleukin 1 receptor accessory protein IL1RAP 
ILMN_1686981 sulfatase 2 SULF2 
ILMN_1686989 insulin induced gene 1 INSIG1 
ILMN_1687140 StAR-related lipid transfer (START) domain containing 7 STARD7 
ILMN_1687247 spermatogenesis associated 20 SPATA20 
ILMN_1687301 versican VCAN 
ILMN_1687306 lectin  galactoside-binding   soluble 2 LGALS2 
ILMN_1687315 retinoid X receptor  alpha RXRA 
ILMN_1687384 interferon  alpha-inducible protein 6 IFI6 
ILMN_1687410 oxysterol binding protein-like 11 OSBPL11 
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ILMN_1687519 synaptosomal-associated protein  23kDa SNAP23 
ILMN_1687533 sema domain  immunoglobulin domain (Ig)   
transmembrane domain (TM) 
SEMA4D 
ILMN_1687757 Unnamed Transcript 
ILMN_1687785 pyrophosphatase (inorganic) 2 PPA2 
ILMN_1687941 ring finger protein 4 RNF4 
ILMN_1687998 lysophosphatidylglycerol acyltransferase 1 LPGAT1 
ILMN_1688098 TBC1 domain family  member 4 TBC1D4 
ILMN_1688152 interleukin 27 receptor  alpha IL27RA 
ILMN_1688231 triggering receptor expressed on myeloid cells 1 TREM1 
ILMN_1688373 leukocyte specific transcript 1 LST1 
ILMN_1688452 leucine carboxyl methyltransferase 1 LCMT1 
ILMN_1688580 cathelicidin antimicrobial peptide CAMP 
ILMN_1688698 zinc finger E-box binding homeobox 2 ZEB2 
ILMN_1688753 phosphatidylserine synthase 1 PTDSS1 
ILMN_1688959 CD27 molecule CD27 
ILMN_1689029 WD repeat domain 7 WDR7 
ILMN_1689160 dipeptidase 2 DPEP2 
ILMN_1689274 non imprinted in Prader-Willi/Angelman syndrome 1 NIPA1 
ILMN_1689400 CDC-like kinase 1 CLK1 
ILMN_1689734 interleukin 1 receptor antagonist IL1RN 
ILMN_1689836 complement component 5a receptor 1 C5AR1 
ILMN_1689953 CD81 molecule CD81 
ILMN_1690105 signal transducer and activator of transcription 1  91kDa STAT1 
ILMN_1690136 Nipped-B homolog (Drosophila) NIPBL 
ILMN_1690476 QKI  KH domain containing   RNA binding QKI 
ILMN_1690610 RALY heterogeneous nuclear ribonucleoprotein RALY 
ILMN_1690761 surfeit 4 SURF4 
ILMN_1690783 triggering receptor expressed on myeloid cells-like 1 TREML1 
ILMN_1690822 VAMP (vesicle-associated membrane protein)-associated 
protein A  33 
VAPA 
ILMN_1690921 signal transducer and activator of transcription 2  113kDa STAT2 
ILMN_1690999 mediator complex subunit 23 MED23 
ILMN_1691071 Fc receptor-like A FCRLA 
ILMN_1691151 choline kinase alpha CHKA 
ILMN_1691276 CXXC finger protein 1 CXXC1 
ILMN_1691364 signal transducer and activator of transcription 1  91kDa STAT1 
ILMN_1691508 plasminogen activator  urokinase receptor PLAUR 
ILMN_1691693 
 
ILMN_1691717 rhomboid 5 homolog 2 (Drosophila) RHBDF2 





ILMN_1691846 G0/G1 switch 2 G0S2 
ILMN_1691861 Fas-activated serine/threonine kinase FASTK 
ILMN_1691892 transgelin 2 TAGLN2 
ILMN_1692145 zinc finger protein 14 ZNF14 
ILMN_1692177 TSC22 domain family  member 1 TSC22D1 
ILMN_1692191 guanine nucleotide binding protein (G protein) alpha 12 GNA12 
ILMN_1692223 lipocalin 2 LCN2 
ILMN_1692260 v-maf avian musculoaponeurotic fibrosarcoma oncogene 
homolog G 
MAFG 
ILMN_1692271 cerebral cavernous malformation 2 CCM2 
ILMN_1692705 RecQ helicase-like RECQL 
ILMN_1692742 DENN/MADD domain containing 3 DENND3 
ILMN_1692962 CTD (carboxy-terminal domain  RNA polymerase II   
polypeptide A) sm 
CTDSP2 
ILMN_1693045 transmembrane emp24 protein transport domain containing 
1 
TMED1 
ILMN_1693136 vesicle transport through interaction with t-SNAREs 1B VTI1B 
ILMN_1693220 A kinase (PRKA) anchor protein 11 AKAP11 
ILMN_1693242 zinc finger protein 296 ZNF296 
ILMN_1693317 trafficking protein particle complex 12 TRAPPC1
2 
ILMN_1693338 cytochrome P450  family 1   subfamily B  polypeptide 1 CYP1B1 
ILMN_1693352 mitochondrial ribosomal protein L20 MRPL20 
ILMN_1693352 mitochondrial ribosomal protein L20 MRPL20 
ILMN_1693552 CD300a molecule CD300A 
ILMN_1693650 FES proto-oncogene  tyrosine kinase FES 
ILMN_1693771 aspartate beta-hydroxylase ASPH 
ILMN_1693905 histone acetyltransferase 1 HAT1 
ILMN_1694058 interferon induced transmembrane protein 4 pseudogene IFITM4P 
ILMN_1694058 interferon induced transmembrane protein 4 pseudogene IFITM4P 
ILMN_1694268 hes family bHLH transcription factor 6 HES6 
ILMN_1694274 NADH dehydrogenase (ubiquinone) 1  subcomplex 
unknown  2  14.5kDa 
NDUFC2 
ILMN_1694311 nudix (nucleoside diphosphate linked moiety X)-type motif 
6 
NUDT6 
ILMN_1694587 eukaryotic translation elongation factor 1 beta 2 EEF1B2 
ILMN_1694603 SWI/SNF related  matrix associated   actin dependent 
regulator of c 
SMARCC
1 
ILMN_1694731 chloride channel  voltage-sensitive 7 CLCN7 
ILMN_1694757 cathepsin L CTSL 
ILMN_1694877 caspase 6  apoptosis-related cysteine peptidase CASP6 
ILMN_1694966 asialoglycoprotein receptor 2 ASGR2 
ILMN_1695316 solute carrier family 39 (zinc transporter)  member 8 SLC39A8 
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ILMN_1695404 lymphocyte antigen 6 complex  locus E LY6E 
ILMN_1695423 CD9 molecule CD9 
ILMN_1695509 protein tyrosine phosphatase  non-receptor type 12 PTPN12 
ILMN_1695585 ribosomal protein S26 RPS26 
ILMN_1695585 ribosomal protein S26 RPS26 
ILMN_1695590 adrenoceptor beta 2  surface ADRB2 
ILMN_1695640 protein tyrosine phosphatase  non-receptor type 22 
(lymphoid) 
PTPN22 
ILMN_1695711 family with sequence similarity 105  member A FAM105A 
ILMN_1695744 leukocyte immunoglobulin-like receptor  subfamily B 
(with TM and IT 
LILRB2 
ILMN_1695827 protein phosphatase 1  catalytic subunit   alpha isozyme PPP1CA 
ILMN_1696021 karyopherin alpha 6 (importin alpha 7) KPNA6 
ILMN_1696041 cell division cycle 42 CDC42 
ILMN_1696318 uncharacterized LOC100130691 LOC10013 
ILMN_1696360 cathepsin B CTSB 
ILMN_1696419 stomatin STOM 
ILMN_1696420 bromodomain containing 7 BRD7 
ILMN_1696432 isocitrate dehydrogenase 1 (NADP+)  soluble IDH1 
ILMN_1696463 Spi-1 proto-oncogene SPI1 
ILMN_1696512 alpha hemoglobin stabilizing protein AHSP 
ILMN_1696584 orosomucoid 1 ORM1 
ILMN_1696654 interferon-induced protein with tetratricopeptide repeats 5 IFIT5 
ILMN_1696749 lamin A/C LMNA 
ILMN_1696806 Unnamed Transcript 
ILMN_1696933 NLR family  pyrin domain containing 3 NLRP3 
ILMN_1696975 ubiquitin specific peptidase 1 USP1 
ILMN_1697268 elastin microfibril interfacer 2 EMILIN2 
ILMN_1697309 neutrophil cytosolic factor 1 NCF1 
ILMN_1697469 serine/arginine-rich splicing factor 6 SRSF6 
ILMN_1697957 KIAA0930 KIAA0930 
ILMN_1698243 chromosome 1 open reading frame 85 C1orf85 
ILMN_1698246 Unnamed Transcript 
ILMN_1698365 NHL repeat containing 3 NHLRC3 
ILMN_1699071 MAP3K7 C-terminal like MAP3K7C
L 
ILMN_1699358 guanine nucleotide binding protein (G protein) alpha 12 GNA12 
ILMN_1699423 zinc finger protein 146 ZNF146 
ILMN_1699570 tumor protein D52-like 2 TPD52L2 
ILMN_1699695 tumor necrosis factor receptor superfamily  member 21 TNFRSF2
1 
ILMN_1699836 lymphocyte-specific protein 1 LSP1 
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ILMN_1699878 RAB27A  member RAS oncogene family RAB27A 
ILMN_1699908 interleukin 12 receptor  beta 1 IL12RB1 
ILMN_1700047 aminolevulinate  delta-   synthase 1 ALAS1 
ILMN_1700147 pre-B lymphocyte 3 VPREB3 
ILMN_1700202 transmembrane protein 135 TMEM135 
ILMN_1700306 OCIA domain containing 2 OCIAD2 
ILMN_1700340 asialoglycoprotein receptor 2 ASGR2 
ILMN_1700413 v-maf avian musculoaponeurotic fibrosarcoma oncogene 
homolog F 
MAFF 
ILMN_1700428 major histocompatibility complex  class II   DO beta HLA-DOB 
ILMN_1700549 ER lipid raft associated 2 ERLIN2 
ILMN_1700584 immediate early response 2 IER2 
ILMN_1700610 C-type lectin domain family 7  member A CLEC7A 
ILMN_1700628 DEAD (Asp-Glu-Ala-Asp) box helicase 24 DDX24 
ILMN_1700695 solute carrier family 44 (choline transporter)  member 1 SLC44A1 
ILMN_1701006 hexamethylene bis-acetamide inducible 2 HEXIM2 
ILMN_1701111 glycerophosphocholine phosphodiesterase GDE1 homolog 
(S. cerevisiae 
GPCPD1 
ILMN_1701114 guanylate binding protein 1  interferon-inducible GBP1 
ILMN_1701114 guanylate binding protein 1  interferon-inducible GBP1 
ILMN_1701195 phospholipase A2  group VII (platelet-activating factor 
acetylhydro 
PLA2G7 
ILMN_1701237 SH2 domain containing 1B SH2D1B 
ILMN_1701466 peroxisomal biogenesis factor 16 PEX16 
ILMN_1701711 bromodomain containing 8 BRD8 
ILMN_1701789 interferon-induced protein with tetratricopeptide repeats 3 IFIT3 
ILMN_1701906 CD300c molecule CD300C 
ILMN_1701930 eukaryotic translation elongation factor 1 beta 2 EEF1B2 
ILMN_1701933 synuclein  alpha (non A4 component of amyloid precursor) SNCA 
ILMN_1702114 Unnamed Transcript 
ILMN_1702301 dedicator of cytokinesis 10 DOCK10 
ILMN_1702592 WD repeat domain 73 WDR73 
ILMN_1702635 kelch domain containing 10 KLHDC10 
ILMN_1702691 tumor necrosis factor  alpha-induced protein 3 TNFAIP3 
ILMN_1702759 thioredoxin-related transmembrane protein 4 TMX4 
ILMN_1702763 zinc finger  MYM-type 1 ZMYM1 
ILMN_1702787 sema domain  immunoglobulin domain (Ig)   
transmembrane domain (TM) 
SEMA4A 
ILMN_1703108 ubiquitin-conjugating enzyme E2L 6 UBE2L6 
ILMN_1703123 cysteine-serine-rich nuclear protein 1 CSRNP1 
ILMN_1703180 ets variant 3 ETV3 
ILMN_1703229 Unnamed Transcript 
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ILMN_1703305 twinfilin actin-binding protein 2 TWF2 
ILMN_1703330 fem-1 homolog c (C. elegans) FEM1C 
ILMN_1703427 SON DNA binding protein SON 
ILMN_1703617 AHA1  activator of heat shock 90kDa protein ATPase 
homolog 1 (yeast 
AHSA1 
ILMN_1703622 peptidylprolyl isomerase B (cyclophilin B) PPIB 
ILMN_1703650 TNFAIP3 interacting protein 1 TNIP1 
ILMN_1703697 LanC lantibiotic synthetase component C-like 1 (bacterial) LANCL1 
ILMN_1703891 TBC1 domain family  member 9 (with GRAM domain) TBC1D9 
ILMN_1703946 adenosine A2b receptor ADORA2
B 
ILMN_1703949 karyopherin (importin) beta 1 KPNB1 
ILMN_1704236 MYC associated factor X MAX 
ILMN_1704404 proteasome (prosome  macropain) 26S subunit   non-
ATPase 13 
PSMD13 
ILMN_1704672 nucleic acid binding protein 2 NABP2 
ILMN_1704713 casein kinase 1  gamma 1 CSNK1G1 
ILMN_1704730 CD93 molecule CD93 
ILMN_1704797 C-type lectin domain family 10  member A CLEC10A 
ILMN_1704980 ERI1 exoribonuclease family member 3 ERI3 
ILMN_1704985 cytochrome P450  family 27   subfamily A  polypeptide 1 CYP27A1 
ILMN_1705111 fibronectin type III domain containing 3A FNDC3A 
ILMN_1705141 calcyclin binding protein CACYBP 
ILMN_1705266 v-rel avian reticuloendotheliosis viral oncogene homolog A RELA 
ILMN_1705663 Dmx-like 2 DMXL2 
ILMN_1705686 neurogranin (protein kinase C substrate  RC3) NRGN 
ILMN_1705783 nuclear RNA export factor 1 NXF1 
ILMN_1705928 small nuclear ribonucleoprotein 200kDa (U5) SNRNP20
0 
ILMN_1706015 family with sequence similarity 43  member A FAM43A 
ILMN_1706217 toll-like receptor 4 TLR4 
ILMN_1706261 solute carrier organic anion transporter family  member 
3A1 
SLCO3A1 
ILMN_1706413 ribosomal RNA adenine dimethylase domain containing 1 RRNAD1 
ILMN_1706502 eukaryotic translation initiation factor 2-alpha kinase 2 EIF2AK2 
ILMN_1706523 Fc fragment of IgG  low affinity IIa   receptor (CD32) FCGR2A 
ILMN_1706546 MYC associated factor X MAX 
ILMN_1706553 SMG7 nonsense mediated mRNA decay factor SMG7 
ILMN_1706635 elastase  neutrophil expressed ELANE 
ILMN_1706784 H2A histone family  member V H2AFV 
ILMN_1707062 REV1  polymerase (DNA directed) REV1 
ILMN_1707077 sortilin 1 SORT1 
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ILMN_1707137 chromosome 17 open reading frame 97 C17orf97 
ILMN_1707312 nuclear factor  interleukin 3 regulated NFIL3 
ILMN_1707336 actin related protein 2/3 complex  subunit 4   20kDa ARPC4 
ILMN_1707339 BTG family  member 3 BTG3 
ILMN_1707481 zinc finger and BTB domain containing 44 ZBTB44 
ILMN_1707551 arylformamidase AFMID 
ILMN_1707695 interferon-induced protein with tetratricopeptide repeats 1 IFIT1 
ILMN_1707815 Unnamed Transcript 
ILMN_1708041 pleckstrin homology domain containing  family F (with 
FYVE domain) 
PLEKHF1 
ILMN_1708164 eukaryotic translation initiation factor 3  subunit A EIF3A 
ILMN_1708340 death-associated protein kinase 1 DAPK1 
ILMN_1708348 ADAM metallopeptidase domain 8 ADAM8 
ILMN_1708416 ADP-ribosylation factor-like 6 interacting protein 1 ARL6IP1 
ILMN_1708721 RAB GTPase activating protein 1-like RABGAP1
L 
ILMN_1708728 H2A histone family  member J H2AFJ 
ILMN_1708779 granulysin GNLY 
ILMN_1708881 RAB20  member RAS oncogene family RAB20 
ILMN_1708934 adrenomedullin ADM 
ILMN_1708946 vacuolar protein sorting 4 homolog A (S. cerevisiae) VPS4A 
ILMN_1709032 FYVE and coiled-coil domain containing 1 FYCO1 
ILMN_1709233 coagulation factor V (proaccelerin  labile factor) F5 
ILMN_1709333 2'-5'-oligoadenylate synthetase 2  69/71kDa OAS2 
ILMN_1709334 transmembrane 9 superfamily member 1 TM9SF1 
ILMN_1709439 charged multivesicular body protein 1A CHMP1A 
ILMN_1709683 Ras association (RalGDS/AF-6) domain family member 2 RASSF2 
ILMN_1709817 solute carrier family 35  member A5 SLC35A5 
ILMN_1710017 CD79b molecule  immunoglobulin-associated beta CD79B 
ILMN_1710150 embryonic ectoderm development EED 
ILMN_1710280 tubulin  beta 1 class VI TUBB1 
ILMN_1710514 B-cell CLL/lymphoma 3 BCL3 
ILMN_1710734 granzyme K (granzyme 3; tryptase II) GZMK 
ILMN_1710937 interferon  gamma-inducible protein 16 IFI16 
ILMN_1711048 zinc finger and BTB domain containing 17 ZBTB17 
ILMN_1711189 exosome component 10 EXOSC10 
ILMN_1711199 zinc finger protein 331 ZNF331 
ILMN_1711414 mitochondrial ribosomal protein S27 MRPS27 
ILMN_1711453 Unnamed Transcript 
ILMN_1711490 Rho GTPase activating protein 26 ARHGAP2
6 
ILMN_1711493 PML-RARA regulated adaptor molecule 1 PRAM1 
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ILMN_1711786 nuclear factor  erythroid 2 NFE2 
ILMN_1711799 chromosome 9 open reading frame 40 C9orf40 
ILMN_1711828 ankyrin repeat domain 10 ANKRD10 
ILMN_1712019 ankyrin repeat domain 17 ANKRD17 
ILMN_1712026 NLR family  pyrin domain containing 3 NLRP3 
ILMN_1712400 serpin peptidase inhibitor  clade B (ovalbumin)   member 6 SERPINB6 
ILMN_1712532 caspase recruitment domain family  member 9 CARD9 
ILMN_1712577 family with sequence similarity 174  member A FAM174A 
ILMN_1712673 SAM and SH3 domain containing 1 SASH1 
ILMN_1712773 sperm associated antigen 1 SPAG1 
ILMN_1712918 NAD(P)H dehydrogenase  quinone 2 NQO2 
ILMN_1712944 amino-terminal enhancer of split AES 
ILMN_1712959 dual specificity phosphatase 2 DUSP2 
ILMN_1713124 aldo-keto reductase family 1  member C3 AKR1C3 
ILMN_1713162 glutathione S-transferase mu 2 (muscle) GSTM2 
ILMN_1713163 SWI/SNF related  matrix associated   actin dependent 
regulator of c 
SMARCA
5 
ILMN_1713266 family with sequence similarity 46  member C FAM46C 
ILMN_1713505 Niemann-Pick disease  type C1 NPC1 
ILMN_1713603 protein kinase C  beta PRKCB 
ILMN_1713668 translin-associated factor X TSNAX 
ILMN_1713749 coronin  actin binding protein   1A CORO1A 
ILMN_1713752 serine incorporator 3 SERINC3 
ILMN_1713803 chromosome 17 open reading frame 97 C17orf97 
ILMN_1714093 required for meiotic nuclear division 5 homolog A (S. 
cerevisiae) 
RMND5A 
ILMN_1714159 leucine zipper protein 1 LUZP1 
ILMN_1714393 RAB24  member RAS oncogene family RAB24 
ILMN_1714418 family with sequence similarity 101  member B FAM101B 
ILMN_1714650 RAS guanyl releasing protein 4 RASGRP4 
ILMN_1714896 squamous cell carcinoma antigen recognized by T cells 3 SART3 
ILMN_1714965 nuclear factor of kappa light polypeptide gene enhancer in 
B-cells 
NFKB1 
ILMN_1715068 aquaporin 9 AQP9 
ILMN_1715169 major histocompatibility complex  class II   DR beta 1 HLA-
DRB1 
ILMN_1715416 nucleoporin 188kDa NUP188 
ILMN_1715636 eukaryotic translation initiation factor 3  subunit B EIF3B 
ILMN_1715969 solute carrier family 25 (mitochondrial iron transporter)  
member 3 
SLC25A37 
ILMN_1715991 serum deprivation response SDPR 
ILMN_1716105 NLR family  pyrin domain containing 12 NLRP12 
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ILMN_1716276 Unnamed Transcript 
ILMN_1716446 B-cell CLL/lymphoma 10 BCL10 
ILMN_1716563 protein kinase C  beta PRKCB 
ILMN_1717063 F-box protein 9 FBXO9 
ILMN_1717163 coagulation factor XIII  A1 polypeptide F13A1 
ILMN_1717180 myotubularin related protein 6 MTMR6 
ILMN_1717261 major histocompatibility complex  class II   DR beta 3 HLA-
DRB3 
ILMN_1717313 nuclear factor of kappa light polypeptide gene enhancer in 
B-cells 
NFKBIE 
ILMN_1717639 salt-inducible kinase 1 SIK1 
ILMN_1717809 ring finger protein 24 RNF24 
ILMN_1717973 Unnamed Transcript 
ILMN_1718023 acylaminoacyl-peptide hydrolase APEH 
ILMN_1718042 zinc finger protein 549 ZNF549 
ILMN_1718063 lipase A  lysosomal acid   cholesterol esterase LIPA 
ILMN_1718558 poly (ADP-ribose) polymerase family  member 12 PARP12 
ILMN_1718565 cyclin-dependent kinase inhibitor 1C (p57  Kip2) CDKN1C 
ILMN_1718633 low density lipoprotein receptor-related protein 5-like LRP5L 
ILMN_1718718 McKusick-Kaufman syndrome MKKS 
ILMN_1718807 structural maintenance of chromosomes 3 SMC3 
ILMN_1718932 5-methyltetrahydrofolate-homocysteine methyltransferase 
reductase 
MTRR 
ILMN_1718936 leukocyte specific transcript 1 LST1 
ILMN_1718960 serpin peptidase inhibitor  clade B (ovalbumin)   member 8 SERPINB8 
ILMN_1718977 growth arrest and DNA-damage-inducible  beta GADD45B 
ILMN_1719163 zinc finger protein 557 ZNF557 
ILMN_1719185 Unnamed Transcript 
ILMN_1719232 DiGeorge syndrome critical region gene 14 DGCR14 
ILMN_1719316 transmembrane emp24 protein transport domain containing 
3 
TMED3 
ILMN_1719392 fumarate hydratase FH 
ILMN_1719433 CD1d molecule CD1D 
ILMN_1719611 
 
ILMN_1719627 solute carrier family 27 (fatty acid transporter)  member 3 SLC27A3 
ILMN_1719695 nuclear factor of kappa light polypeptide gene enhancer in 
B-cells 
NFKBIZ 
ILMN_1719905 toll-like receptor 10 TLR10 
ILMN_1720048 chemokine (C-C motif) ligand 2 CCL2 
ILMN_1720088 splicing regulatory glutamine/lysine-rich protein 1 SREK1 
ILMN_1720158 v-ets avian erythroblastosis virus E26 oncogene homolog 2 ETS2 
ILMN_1720303 osteopetrosis associated transmembrane protein 1 OSTM1 
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ILMN_1720373 solute carrier family 7 (amino acid transporter light chain  
L syst 
SLC7A5 
ILMN_1720513 SET binding protein 1 SETBP1 
ILMN_1720623 synaptotagmin-like 3 SYTL3 
ILMN_1720771 syntaxin 11 STX11 
ILMN_1720996 solute carrier family 12 (sodium/potassium/chloride 
transporter)  m 
SLC12A2 
ILMN_1721008 deoxyuridine triphosphatase DUT 
ILMN_1721026 SAM domain and HD domain 1 SAMHD1 
ILMN_1721081 Sp4 transcription factor SP4 
ILMN_1721138 GrpE-like 2  mitochondrial (E. coli) GRPEL2 
ILMN_1721868 karyopherin alpha 2 (RAG cohort 1  importin alpha 1) KPNA2 
ILMN_1721876 TIMP metallopeptidase inhibitor 2 TIMP2 
ILMN_1721978 caspase recruitment domain family  member 11 CARD11 
ILMN_1722059 scaffold attachment factor B SAFB 




ILMN_1722294 copine VIII CPNE8 
ILMN_1722502 chaperonin containing TCP1  subunit 6A (zeta 1) CCT6A 
ILMN_1722532 lysine (K)-specific demethylase 3A KDM3A 
ILMN_1722622 CD163 molecule CD163 
ILMN_1722698 ring finger and CHY zinc finger domain containing 1  E3 
ubiquitin p 
RCHY1 
ILMN_1722811 cyclin-dependent kinase inhibitor 1B (p27  Kip1) CDKN1B 
ILMN_1722838 mitochondrial ribosomal protein L46 MRPL46 
ILMN_1722981 toll-like receptor 5 TLR5 
ILMN_1723035 oxidized low density lipoprotein (lectin-like) receptor 1 OLR1 
ILMN_1723043 napsin B aspartic peptidase  pseudogene NAPSB 
ILMN_1723115 C-type lectin domain family 4  member F CLEC4F 
ILMN_1723480 bone marrow stromal cell antigen 2 BST2 
ILMN_1723486 hexokinase 2 HK2 
ILMN_1723912 interferon-induced protein 44-like IFI44L 
ILMN_1723969 phospholipase C  beta 1 (phosphoinositide-specific) PLCB1 
ILMN_1724250 granulin GRN 
ILMN_1724495 SEC14 and spectrin domains 1 SESTD1 
ILMN_1724658 BCL2/adenovirus E1B 19kDa interacting protein 3 BNIP3 
ILMN_1724837 zinc finger CCCH-type  antiviral 1 ZC3HAV1 
ILMN_1724984 eukaryotic translation initiation factor 2-alpha kinase 3 EIF2AK3 
ILMN_1725175 FOS-like antigen 2 FOSL2 
ILMN_1725244 histone acetyltransferase 1 HAT1 
ILMN_1726189 membrane-spanning 4-domains  subfamily A   member 14 MS4A14 
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ILMN_1726288 transmembrane protein 106B TMEM106
B 
ILMN_1726289 KIAA1551 KIAA1551 
ILMN_1726545 leukocyte immunoglobulin-like receptor  subfamily A 
(with TM domain 
LILRA5 
ILMN_1726574 calcyclin binding protein CACYBP 
ILMN_1726597 family with sequence similarity 65  member B FAM65B 
ILMN_1726693 general transcription factor IIH  polypeptide 1   62kDa GTF2H1 
ILMN_1726769 CNDP dipeptidase 2 (metallopeptidase M20 family) CNDP2 
ILMN_1727051 DEAD (Asp-Glu-Ala-Asp) box polypeptide 19A DDX19A 
ILMN_1727098 protein phosphatase 1  regulatory subunit 16B PPP1R16B 
ILMN_1727150 dehydrogenase/reductase (SDR family) member 9 DHRS9 
ILMN_1727271 tryptophanyl-tRNA synthetase WARS 
ILMN_1727761 glucocorticoid modulatory element binding protein 1 GMEB1 
ILMN_1727762 caspase 1  apoptosis-related cysteine peptidase CASP1 
ILMN_1727965 aldehyde dehydrogenase 3 family  member B1 ALDH3B1 
ILMN_1728047 aldo-keto reductase family 1  member A1 (aldehyde 
reductase) 
AKR1A1 
ILMN_1728071 Kirsten rat sarcoma viral oncogene homolog KRAS 
ILMN_1728106 tumor necrosis factor TNF 
ILMN_1728163 CTD (carboxy-terminal domain  RNA polymerase II   
polypeptide A) sm 
CTDSP1 
ILMN_1728298 SH3 domain binding kinase 1 SBK1 
ILMN_1728471 ADP-ribosylation factor guanine nucleotide-exchange 
factor 1 (brefe 
ARFGEF1 
ILMN_1728478 chemokine (C-X-C motif) ligand 16 CXCL16 
ILMN_1728498 poly(rC) binding protein 4 PCBP4 
ILMN_1728662 aldehyde dehydrogenase 3 family  member B1 ALDH3B1 
ILMN_1728677 cAMP responsive element binding protein 5 CREB5 
ILMN_1728698 glycerophosphodiester phosphodiesterase 1 GDE1 
ILMN_1728984 proliferation-associated 2G4  38kDa PA2G4 
ILMN_1729175 F-box protein 3 FBXO3 




ILMN_1729453 tetraspanin 9 TSPAN9 
ILMN_1729563 UDP-glucose 6-dehydrogenase UGDH 
ILMN_1729691 solute carrier family 16  member 6 SLC16A6 
ILMN_1729775 optic atrophy 1 (autosomal dominant) OPA1 
ILMN_1729915 paired immunoglobin-like type 2 receptor alpha PILRA 
ILMN_1729973 zinc finger CCCH-type  antiviral 1 ZC3HAV1 
ILMN_1729976 chromosome alignment maintaining phosphoprotein 1 CHAMP1 
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ILMN_1730084 catechol-O-methyltransferase COMT 
ILMN_1730118 zinc finger protein 644 ZNF644 
ILMN_1730307 mediator complex subunit 16 MED16 
ILMN_1730416 cytochrome c  somatic CYCS 
ILMN_1730454 folate receptor 3 (gamma) FOLR3 
ILMN_1730628 ribonuclease  RNase A family   2 (liver  eosinophil-derived 
neuroto 
RNASE2 
ILMN_1730631 chromosome 2 open reading frame 44 C2orf44 
ILMN_1730639 solute carrier family 22  member 15 SLC22A15 
ILMN_1730660 lectin  galactoside-binding   soluble 3 LGALS3 
ILMN_1730816 G protein-coupled receptor 162 GPR162 
ILMN_1730986 mucosa associated lymphoid tissue lymphoma 
translocation gene 1 
MALT1 
ILMN_1731048 toll-like receptor 1 TLR1 
ILMN_1731107 coiled-coil domain containing 92 CCDC92 
ILMN_1731113 zinc finger and BTB domain containing 43 ZBTB43 
ILMN_1731123 ring finger protein 7 RNF7 
ILMN_1731233 granzyme H (cathepsin G-like 2  protein h-CCPX) GZMH 
ILMN_1731714 cAMP responsive element binding protein 5 CREB5 
ILMN_1732198 urotensin 2 UTS2 
ILMN_1732216 asparaginyl-tRNA synthetase NARS 
ILMN_1732296 inhibitor of DNA binding 3  dominant negative helix-loop-
helix prot 
ID3 
ILMN_1732452 mitogen-activated protein kinase-activated protein kinase 3 MAPKAP
K3 
ILMN_1732475 serine/threonine/tyrosine interacting protein STYX 
ILMN_1732575 SEC14-like 1 (S. cerevisiae) SEC14L1 
ILMN_1732688 deoxyuridine triphosphatase DUT 
ILMN_1732810 sorting nexin 17 SNX17 
ILMN_1733221 sema domain  immunoglobulin domain (Ig)   
transmembrane domain (TM) 
SEMA4D 
ILMN_1733248 nuclear receptor binding protein 2 NRBP2 
ILMN_1733270 CD163 molecule CD163 
ILMN_1733956 isoleucyl-tRNA synthetase IARS 
ILMN_1733997 
 
ILMN_1733998 dehydrogenase/reductase (SDR family) member 9 DHRS9 
ILMN_1734748 leukocyte immunoglobulin-like receptor  subfamily A 
(with TM domain 
LILRA1 
ILMN_1734855 selectin P ligand SELPLG 
ILMN_1734878 CD79a molecule  immunoglobulin-associated alpha CD79A 
ILMN_1735151 eukaryotic translation initiation factor 5A2 EIF5A2 
ILMN_1735333 neighbor of BRCA1 gene 1 NBR1 
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ILMN_1735453 family with sequence similarity 98  member A FAM98A 
ILMN_1735792 rhomboid 5 homolog 2 (Drosophila) RHBDF2 
ILMN_1735908 UTP15  U3 small nucleolar ribonucleoprotein   homolog 
(S. cerevisia 
UTP15 
ILMN_1736068 CCR4-NOT transcription complex  subunit 8 CNOT8 
ILMN_1736180 frequently rearranged in advanced T-cell lymphomas 1 FRAT1 
ILMN_1736568 caspase 2  apoptosis-related cysteine peptidase CASP2 
ILMN_1736585 transmembrane emp24-like trafficking protein 10 (yeast) TMED10 
ILMN_1736700 aldolase A  fructose-bisphosphate ALDOA 
ILMN_1736729 2'-5'-oligoadenylate synthetase 2  69/71kDa OAS2 
ILMN_1736863 transmembrane protein 140 TMEM140 
ILMN_1736982 phosphatase and actin regulator 1 PHACTR1 
ILMN_1737003 Unnamed Transcript 
ILMN_1737025 phospholipase C-like 2 PLCL2 
ILMN_1737084 taxilin alpha TXLNA 
ILMN_1737164 transmembrane 9 superfamily member 1 TM9SF1 
ILMN_1737252 neuregulin 1 NRG1 
ILMN_1737254 ubiquitin specific peptidase 1 USP1 
ILMN_1737314 B-cell CLL/lymphoma 6 BCL6 
ILMN_1737394 lamin A/C LMNA 
ILMN_1737396 proteasome (prosome  macropain) 26S subunit   non-
ATPase 14 
PSMD14 
ILMN_1737514 kynureninase KYNU 
ILMN_1737627 mitogen-activated protein kinase 14 MAPK14 
ILMN_1737705 UHRF1 binding protein 1-like UHRF1BP
1 
ILMN_1737813 ERI1 exoribonuclease family member 3 ERI3 
ILMN_1737947 LSM5 homolog  U6 small nuclear RNA associated (S. 
cerevisiae) 
LSM5 
ILMN_1738207 cytokine inducible SH2-containing protein CISH 
ILMN_1738424 cell division cycle 42 CDC42 
ILMN_1738632 protein kinase  cAMP-dependent   regulatory  type I  alpha PRKAR1A 
ILMN_1738725 leukemia inhibitory factor LIF 
ILMN_1738909 TROVE domain family  member 2 TROVE2 
ILMN_1738921 acetyl-CoA acyltransferase 1 ACAA1 
ILMN_1738992 myeloid cell nuclear differentiation antigen MNDA 
ILMN_1739001 tumor-associated calcium signal transducer 2 TACSTD2 
ILMN_1739032 transmembrane protein 70 TMEM70 
ILMN_1739151 mannosyl (alpha-1 6-)-glycoprotein beta-1  2-N-
acetylglucosaminyltr 
MGAT2 
ILMN_1739586 fasciculation and elongation protein zeta 2 (zygin II) FEZ2 
ILMN_1739605 LY6/PLAUR domain containing 3 LYPD3 
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ILMN_1739641 myotubularin related protein 3 MTMR3 
ILMN_1739674 Unnamed Transcript 
ILMN_1739815 NLR family  pyrin domain containing 12 NLRP12 
ILMN_1740015 CD14 molecule CD14 
ILMN_1740171 dual specificity phosphatase 11 (RNA/RNP complex 1-
interacting) 
DUSP11 
ILMN_1740319 interferon  alpha-inducible protein 27-like 2 IFI27L2 
ILMN_1740426 RAS  dexamethasone-induced 1 RASD1 
ILMN_1740572 transcobalamin II TCN2 
ILMN_1740597 cyclin-dependent kinase inhibitor 2D (p19  inhibits CDK4) CDKN2D 
ILMN_1740604 RAB11 family interacting protein 5 (class I) RAB11FIP 
ILMN_1740633 perforin 1 (pore forming protein) PRF1 
ILMN_1740737 decapping enzyme  scavenger DCPS 
ILMN_1740742 uroporphyrinogen decarboxylase UROD 
ILMN_1740819 StAR-related lipid transfer (START) domain containing 7 STARD7 
ILMN_1740875 formyl peptide receptor 2 FPR2 
ILMN_1741003 annexin A5 ANXA5 
ILMN_1741148 aldolase A  fructose-bisphosphate ALDOA 
ILMN_1741159 mitogen-activated protein kinase kinase kinase 8 MAP3K8 
ILMN_1741165 solute carrier family 11 (proton-coupled divalent metal ion 
transpo 
SLC11A1 
ILMN_1741464 hook microtubule-tethering protein 3 HOOK3 
ILMN_1741881 chromosome 9 open reading frame 72 C9orf72 
ILMN_1741917 osteoclast associated  immunoglobulin-like receptor OSCAR 
ILMN_1741942 syntaxin 16 STX16 
ILMN_1742052 serpin peptidase inhibitor  clade B (ovalbumin)   member 9 SERPINB9 
ILMN_1742324 SUN domain containing ossification factor SUCO 
ILMN_1742332 potassium channel tetramerization domain containing 12 KCTD12 
ILMN_1742400 centrosomal protein 350kDa CEP350 
ILMN_1742544 myocyte enhancer factor 2C MEF2C 
ILMN_1742618 XIAP associated factor 1 XAF1 
ILMN_1742981 tubulin  alpha 1a TUBA1A 
ILMN_1743145 endoplasmic reticulum aminopeptidase 2 ERAP2 
ILMN_1743187 chromosome 6 open reading frame 120 C6orf120 
ILMN_1743241 ADP-ribosylation factor-like 4A ARL4A 
ILMN_1743290 glycoprotein IX (platelet) GP9 
ILMN_1743619 neural precursor cell expressed  developmentally down-
regulated 9 
NEDD9 
ILMN_1743966 B-cell CLL/lymphoma 9-like BCL9L 
ILMN_1744113 tumor necrosis factor  alpha-induced protein 8-like 2 TNFAIP8L 
ILMN_1744517 glucosamine (N-acetyl)-6-sulfatase GNS 
ILMN_1744649 proteasome (prosome  macropain) subunit   beta type 5 PSMB5 
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ILMN_1744963 ERO1-like (S. cerevisiae) ERO1L 
ILMN_1745075 ribosomal protein  large   P0 RPLP0 
ILMN_1745103 C-type lectin domain family 1  member B CLEC1B 
ILMN_1745242 phospholipid scramblase 1 PLSCR1 
ILMN_1745356 chemokine (C-X-C motif) ligand 9 CXCL9 
ILMN_1745374 interferon-induced protein 35 IFI35 
ILMN_1745397 2'-5'-oligoadenylate synthetase 3  100kDa OAS3 
ILMN_1745423 UTP3  small subunit (SSU) processome component   
homolog (S. cerevi 
UTP3 
ILMN_1745573 tetratricopeptide repeat domain 13 TTC13 
ILMN_1745772 activating signal cointegrator 1 complex subunit 3 ASCC3 
ILMN_1745788 chemokine (C-X3-C motif) receptor 1 CX3CR1 
ILMN_1745964 interleukin-1 receptor-associated kinase 2 IRAK2 
ILMN_1745994 growth arrest-specific 7 GAS7 
ILMN_1746243 testis derived transcript (3 LIM domains) TES 
ILMN_1746317 nucleoporin like 1 NUPL1 
ILMN_1746426 translocase of outer mitochondrial membrane 70 homolog 
A (S. cerevi 
TOMM70
A 
ILMN_1746517 kynureninase KYNU 
ILMN_1746664 WD repeat and SOCS box containing 2 WSB2 
ILMN_1746696 PDS5  regulator of cohesion maintenance   homolog B (S. 
cerevisiae) 
PDS5B 
ILMN_1746836 platelet-activating factor receptor PTAFR 
ILMN_1746846 tubulin tyrosine ligase-like family  member 4 TTLL4 
ILMN_1747052 integrin  alpha 4 (antigen CD49D   alpha 4 subunit of 
VLA-4 recepto 
ITGA4 
ILMN_1747058 trafficking protein particle complex 2-like TRAPPC2
L 
ILMN_1747195 proteasome (prosome  macropain) subunit   beta type 8 PSMB8 
ILMN_1747355 Unnamed Transcript 
ILMN_1747504 AT hook containing transcription factor 1 AHCTF1 
ILMN_1747598 protein phosphatase 1  regulatory (inhibitor) subunit 11 PPP1R11 
ILMN_1747622 CD33 molecule CD33 
ILMN_1747630 DEK proto-oncogene DEK 
ILMN_1747744 lipoma HMGIC fusion partner-like 2 LHFPL2 
ILMN_1747870 CD3e molecule  epsilon associated protein CD3EAP 
ILMN_1748077 DEAD (Asp-Glu-Ala-Asp) box polypeptide 59 DDX59 
ILMN_1748147 mitochondrial tRNA translation optimization 1 MTO1 
ILMN_1748473 GTPase  IMAP family member 4 GIMAP4 
ILMN_1748883 cyclin-dependent kinase inhibitor 2D (p19  inhibits CDK4) CDKN2D 
ILMN_1748911 synaptosomal-associated protein  23kDa SNAP23 
ILMN_1748915 S100 calcium binding protein A12 S100A12 
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ILMN_1749011 NECAP endocytosis associated 2 NECAP2 
ILMN_1749078 TIMP metallopeptidase inhibitor 2 TIMP2 
ILMN_1749253 tubulin  delta 1 TUBD1 
ILMN_1749317 cilia and flagella associated protein 74 CFAP74 
ILMN_1749368 histone cluster 1  H3h HIST1H3
H 
ILMN_1749419 protein kinase  AMP-activated   gamma 2 non-catalytic 
subunit 
PRKAG2 
ILMN_1749641 F-box protein 3 FBXO3 
ILMN_1750075 cyclin D binding myb-like transcription factor 1 DMTF1 
ILMN_1750273 ribosomal protein L23a pseudogene 7 RPL23AP7 
ILMN_1750395 methyl-CpG binding domain protein 2 MBD2 
ILMN_1750400 chromosome 19 open reading frame 66 C19orf66 
ILMN_1750401 chromosome 17 open reading frame 62 C17orf62 
ILMN_1750636 ribosomal protein S26 RPS26 
ILMN_1750805 Rho GTPase activating protein 30 ARHGAP3
0 
ILMN_1751072 signal recognition particle receptor  B subunit SRPRB 
ILMN_1751079 transporter 1  ATP-binding cassette   sub-family B 
(MDR/TAP) 
TAP1 
ILMN_1751164 Rho GTPase activating protein 30 ARHGAP3
0 
ILMN_1751400 src kinase associated phosphoprotein 1 SKAP1 
ILMN_1751589 NudC domain containing 2 NUDCD2 
ILMN_1751607 FBJ murine osteosarcoma viral oncogene homolog B FOSB 
ILMN_1752249 piezo-type mechanosensitive ion channel component 1 PIEZO1 
ILMN_1752478 dehydrogenase/reductase (SDR family) member 3 DHRS3 
ILMN_1752526 ring finger protein 144B RNF144B 
ILMN_1752591 leptin receptor overlapping transcript-like 1 LEPROTL
1 
ILMN_1752606 Unnamed Transcript 
ILMN_1752932 myelin protein zero-like 2 MPZL2 
ILMN_1753064 tetratricopeptide repeat domain 13 TTC13 
ILMN_1753111 nicotinamide phosphoribosyltransferase NAMPT 
ILMN_1753498 CoA synthase COASY 
ILMN_1753613 homeobox A5 HOXA5 
ILMN_1753663 ADP-ribosylation factor-like 4A ARL4A 
ILMN_1753805 protein kinase D2 PRKD2 
ILMN_1754421 NADH dehydrogenase (ubiquinone) complex I  assembly 
factor 1 
NDUFAF1 
ILMN_1754788 guanosine monophosphate reductase 2 GMPR2 
ILMN_1755115 ribosomal protein L23 RPL23 
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ILMN_1755983 nuclear factor of activated T-cells  cytoplasmic   
calcineurin-depe 
NFATC3 
ILMN_1756086 integrator complex subunit 3 INTS3 
ILMN_1756417 ankyrin repeat domain 37 ANKRD37 
ILMN_1756723 dipeptidyl-peptidase 7 DPP7 
ILMN_1756779 clathrin  heavy chain (Hc) CLTC 
ILMN_1756806 myeloid cell leukemia 1 MCL1 
ILMN_1756928 reticulon 1 RTN1 
ILMN_1756942 Sp3 transcription factor SP3 
ILMN_1757165 limb development membrane protein 1-like LMBR1L 
ILMN_1757186 GTPase  IMAP family member 1 GIMAP1 
ILMN_1757347 KIAA0930 KIAA0930 
ILMN_1757361 neutrophil cytosolic factor 4  40kDa NCF4 
ILMN_1757406 histone cluster 1  H1c HIST1H1C 
ILMN_1757467 H1 histone family  member 0 H1F0 
ILMN_1757627 zinc finger  MYND-type containing 19 ZMYND1
9 
ILMN_1758146 signal-regulatory protein alpha SIRPA 
ILMN_1758323 acid phosphatase  prostate ACPP 
ILMN_1758418 tumor necrosis factor (ligand) superfamily  member 13b TNFSF13
B 
ILMN_1758619 S-antigen; retina and pineal gland (arrestin) SAG 
ILMN_1758623 histone cluster 1  H2bd HIST1H2B 
ILMN_1758673 solute carrier family 44 (choline transporter)  member 1 SLC44A1 
ILMN_1758719 neural precursor cell expressed  developmentally down-
regulated 9 
NEDD9 
ILMN_1758735 NLR family  pyrin domain containing 12 NLRP12 
ILMN_1758778 centriolin CNTRL 
ILMN_1758895 cathepsin K CTSK 
ILMN_1758906 guanine nucleotide binding protein (G protein)  alpha 13 GNA13 
ILMN_1758918 bromodomain containing 2 BRD2 
ILMN_1758928 Unnamed Transcript 
ILMN_1758938 solute carrier family 31 (copper transporter)  member 2 SLC31A2 
ILMN_1758939 receptor-interacting serine-threonine kinase 2 RIPK2 
ILMN_1758963 NAD kinase NADK 
ILMN_1759008 zinc finger protein 689 ZNF689 
ILMN_1759084 integrator complex subunit 8 INTS8 
ILMN_1759787 thrombomodulin THBD 
ILMN_1759801 dipeptidyl-peptidase 8 DPP8 
ILMN_1759818 sortilin-related receptor  L(DLR class) A repeats containing SORL1 
ILMN_1759952 proteasome (prosome  macropain) subunit   alpha type 5 PSMA5 
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ILMN_1759983 down-regulator of transcription 1  TBP-binding (negative 
cofactor 2 
DR1 
ILMN_1760062 interferon-induced protein 44 IFI44 
ILMN_1760189 NLR family  apoptosis inhibitory protein NAIP 
ILMN_1760280 nuclear transport factor 2-like export factor 1 NXT1 
ILMN_1760849 neuropilin (NRP) and tolloid (TLL)-like 2 NETO2 
ILMN_1761260 cordon-bleu WH2 repeat protein-like 1 COBLL1 
ILMN_1761411 minichromosome maintenance complex binding protein MCMBP 
ILMN_1761778 tumor necrosis factor (ligand) superfamily  member 8 TNFSF8 
ILMN_1761833 solute carrier family 40 (iron-regulated transporter)  
member 1 
SLC40A1 
ILMN_1761941 family with sequence similarity 198  member B FAM198B 
ILMN_1761945 fibroblast growth factor binding protein 2 FGFBP2 
ILMN_1761968 protein phosphatase 1  regulatory (inhibitor) subunit 14A PPP1R14A 
ILMN_1762255 glutathione S-transferase mu 1 GSTM1 
ILMN_1762594 nucleotide-binding oligomerization domain containing 2 NOD2 
ILMN_1762674 nucleoporin 43kDa NUP43 
ILMN_1762678 N-myristoyltransferase 1 NMT1 
ILMN_1762713 mast cell-expressed membrane protein 1 MCEMP1 
ILMN_1762888 methyltransferase like 21A METTL21
A 
ILMN_1762899 early growth response 1 EGR1 
ILMN_1762972 chromodomain helicase DNA binding protein 9 CHD9 
ILMN_1763080 glutaminyl-tRNA synthetase QARS 
ILMN_1763144 sialidase 1 (lysosomal sialidase) NEU1 
ILMN_1763436 senataxin SETX 
ILMN_1763627 transportin 1 TNPO1 
ILMN_1763730 adaptor protein  phosphotyrosine interaction   PH domain 
and leucin 
APPL1 
ILMN_1763837 alanyl (membrane) aminopeptidase ANPEP 
ILMN_1764177 jumonji  AT rich interactive domain 2 JARID2 
ILMN_1764414 son of sevenless homolog 2 (Drosophila) SOS2 
ILMN_1764709 v-maf avian musculoaponeurotic fibrosarcoma oncogene 
homolog B 
MAFB 
ILMN_1764891 zinc finger protein 384 ZNF384 
ILMN_1764945 adaptor-related protein complex 3  delta 1 subunit AP3D1 
ILMN_1765019 SAC1 suppressor of actin mutations 1-like (yeast) SACM1L 
ILMN_1765165 vacuolar protein sorting 13 homolog B (yeast) VPS13B 
ILMN_1765547 interferon regulatory factor 2 IRF2 
ILMN_1765578 TCDD-inducible poly(ADP-ribose) polymerase TIPARP 
ILMN_1765801 glucosidase  alpha; acid GAA 
ILMN_1765825 DDB1 and CUL4 associated factor 11 DCAF11 
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ILMN_1766054 ATP-binding cassette  sub-family A (ABC1)   member 1 ABCA1 
ILMN_1766085 v-rel avian reticuloendotheliosis viral oncogene homolog REL 
ILMN_1766123 fragile histidine triad FHIT 
ILMN_1766125 lon peptidase 1  mitochondrial LONP1 
ILMN_1766165 synuclein  alpha (non A4 component of amyloid precursor) SNCA 
ILMN_1766169 branched chain amino-acid transaminase 1  cytosolic BCAT1 
ILMN_1766269 histocompatibility (minor) 13 HM13 
ILMN_1766275 phosphatidylinositol-4 5-bisphosphate 3-kinase   catalytic 
subunit 
PIK3CD 
ILMN_1766487 leucine rich repeat containing 25 LRRC25 
ILMN_1766657 stomatin STOM 
ILMN_1766718 LysM  putative peptidoglycan-binding   domain containing 
3 
LYSMD3 
ILMN_1766736 bactericidal/permeability-increasing protein BPI 
ILMN_1766762 dynein  light chain   roadblock-type 1 DYNLRB1 
ILMN_1766814 thymidine kinase 2  mitochondrial TK2 
ILMN_1767006 proteasome (prosome  macropain) subunit   beta type 8 PSMB8 
ILMN_1767139 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 
13 
NDUFA13 
ILMN_1767193 complement component (3b/4b) receptor 1 (Knops blood 
group) 
CR1 
ILMN_1767281 pro-platelet basic protein (chemokine (C-X-C motif) ligand 
7) 
PPBP 
ILMN_1768020 HAUS augmin-like complex  subunit 8 HAUS8 
ILMN_1768357 reticulon 1 RTN1 
ILMN_1768391 ADP-ribosylation factor-like 4C ARL4C 
ILMN_1768393 small nuclear ribonucleoprotein D1 polypeptide 16kDa SNRPD1 
ILMN_1768470 eukaryotic translation initiation factor 4 gamma 1 EIF4G1 
ILMN_1768510 mannosidase  alpha   class 2B  member 2 MAN2B2 
ILMN_1768534 basic helix-loop-helix family  member e40 BHLHE40 
ILMN_1768582 protein phosphatase 2  catalytic subunit   beta isozyme PPP2CB 
ILMN_1768754 Unnamed Transcript 
ILMN_1768773 Unnamed Transcript 
ILMN_1768913 translin TSN 
ILMN_1768958 RAS guanyl releasing protein 1 (calcium and DAG-
regulated) 
RASGRP1 
ILMN_1768969 lamin B receptor LBR 
ILMN_1768973 histone cluster 2  H2ac HIST2H2
A 
ILMN_1769135 dipeptidyl-peptidase 7 DPP7 
ILMN_1769299 myotubularin related protein 11 MTMR11 
ILMN_1769383 Unnamed Transcript 
ILMN_1769520 ubiquitin-conjugating enzyme E2L 6 UBE2L6 
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ILMN_1769546 Ras and Rab interactor 2 RIN2 
ILMN_1769665 RAB5C  member RAS oncogene family RAB5C 
ILMN_1769931 splicing factor proline/glutamine-rich SFPQ 
ILMN_1770071 interferon induced transmembrane protein 4 pseudogene IFITM4P 
ILMN_1770071 interferon induced transmembrane protein 4 pseudogene IFITM4P 
ILMN_1770085 BTG family  member 2 BTG2 
ILMN_1770260 nuclear factor of kappa light polypeptide gene enhancer in 
B-cells 
NFKBIZ 
ILMN_1770425 CDP-diacylglycerol--inositol 3-phosphatidyltransferase CDIPT 
ILMN_1770977 transmembrane protein 134 TMEM134 
ILMN_1771333 CD47 molecule CD47 
ILMN_1771627 zinc finger  MIZ-type containing 1 ZMIZ1 
ILMN_1771664 C-type lectin domain family 4  member E CLEC4E 
ILMN_1771695 regulator of chromosome condensation (RCC1) and BTB 
(POZ) domain co 
RCBTB2 
ILMN_1772387 toll-like receptor 2 TLR2 
ILMN_1772540 ATM interactor ATMIN 
ILMN_1772692 dicer 1  ribonuclease type III DICER1 
ILMN_1772814 nemo-like kinase NLK 
ILMN_1772876 zinc finger protein 395 ZNF395 
ILMN_1772929 ATP synthase  H+ transporting   mitochondrial Fo complex  
subunit F 
ATP5J 
ILMN_1772964 chemokine (C-C motif) ligand 8 CCL8 
ILMN_1773245 chemokine (C-C motif) ligand 3-like 1 CCL3L1 
ILMN_1773313 Unnamed Transcript 
ILMN_1773352 chemokine (C-C motif) ligand 5 CCL5 
ILMN_1773485 QKI  KH domain containing   RNA binding QKI 
ILMN_1773620 SWI/SNF related  matrix associated   actin dependent 
regulator of c 
SMARCC
2 
ILMN_1773780 family with sequence similarity 173  member A FAM173A 
ILMN_1773935 transmembrane protein 165 TMEM165 
ILMN_1773963 guanine nucleotide binding protein (G protein)  alpha 15 
(Gq class) 
GNA15 
ILMN_1774077 guanylate binding protein 2  interferon-inducible GBP2 
ILMN_1774083 TP53 regulated inhibitor of apoptosis 1 TRIAP1 
ILMN_1774513 Unnamed Transcript 
ILMN_1774661 small nuclear ribonucleoprotein polypeptides B and B1 SNRPB 
ILMN_1774761 chemokine (C-C motif) receptor 2 CCR2 
ILMN_1774874 interleukin 1 receptor antagonist IL1RN 
ILMN_1774938 aldo-keto reductase family 1  member A1 (aldehyde 
reductase) 
AKR1A1 
ILMN_1775016 myelin protein zero-like 2 MPZL2 
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ILMN_1775085 zinc finger protein 232 ZNF232 
ILMN_1775304 DnaJ (Hsp40) homolog  subfamily B   member 1 DNAJB1 
ILMN_1775327 pyruvate kinase  muscle PKM 
ILMN_1775501 interleukin 1  beta IL1B 
ILMN_1775508 cylindromatosis (turban tumor syndrome) CYLD 
ILMN_1775780 urotensin 2 UTS2 
ILMN_1776021 eukaryotic translation initiation factor 4H EIF4H 
ILMN_1776073 chaperonin containing TCP1  subunit 4 (delta) CCT4 
ILMN_1776119 ATP-binding cassette  sub-family C (CFTR/MRP)   
member 10 
ABCC10 
ILMN_1776347 t-complex 1 TCP1 
ILMN_1776487 transcriptional adaptor 1 TADA1 
ILMN_1776649 leucine-rich repeat kinase 2 LRRK2 
ILMN_1776678 GTPase  IMAP family member 7 GIMAP7 
ILMN_1776777 adenosine deaminase  RNA-specific ADAR 
ILMN_1777058 Unnamed Transcript 
ILMN_1777139 MAK16 homolog (S. cerevisiae) MAK16 
ILMN_1777190 complement factor D (adipsin) CFD 
ILMN_1777325 signal transducer and activator of transcription 1  91kDa STAT1 
ILMN_1777461 chemokine (C-C motif) receptor 2 CCR2 
ILMN_1777663 topoisomerase (DNA) II beta 180kDa TOP2B 
ILMN_1777881 tetraspanin 17 TSPAN17 
ILMN_1777906 MAP7 domain containing 1 MAP7D1 
ILMN_1778136 zinc finger  MYND-type containing 15 ZMYND1
5 
ILMN_1778236 protein tyrosine phosphatase  non-receptor type 11 PTPN11 
ILMN_1778321 solute carrier family 2 (facilitated glucose transporter)  
member 6 
SLC2A6 
ILMN_1778444 FK506 binding protein 5 FKBP5 
ILMN_1778464 trafficking protein particle complex 10 TRAPPC1
0 
ILMN_1778488 WD repeat domain 41 WDR41 
ILMN_1778756 sulfotransferase family  cytosolic   1A  phenol-preferring  
member 
SULT1A1 
ILMN_1778764 BUB3 mitotic checkpoint protein BUB3 
ILMN_1779015 zinc finger protein 467 ZNF467 
ILMN_1779252 tripartite motif containing 22 TRIM22 
ILMN_1779264 proteasome (prosome  macropain) assembly chaperone 1 PSMG1 
ILMN_1779410 VAMP (vesicle-associated membrane protein)-associated 
protein A  33 
VAPA 
ILMN_1779677 zinc finger  CCHC domain containing 6 ZCCHC6 
ILMN_1779751 chromosome 7 open reading frame 55 C7orf55 
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ILMN_1779857 Kruppel-like factor 4 (gut) KLF4 
ILMN_1780132 pellino E3 ubiquitin protein ligase family member 2 PELI2 
ILMN_1780302 dynein  cytoplasmic 1   heavy chain 1 DYNC1H1 
ILMN_1780334 potassium inwardly-rectifying channel  subfamily J   
member 2 
KCNJ2 
ILMN_1780368 G protein-coupled receptor 18 GPR18 
ILMN_1780546 oncostatin M OSM 
ILMN_1780582 CD83 molecule CD83 
ILMN_1780601 egf-like module containing  mucin-like   hormone receptor-
like 1 
EMR1 
ILMN_1780659 nudix (nucleoside diphosphate linked moiety X)-type motif 
6 
NUDT6 
ILMN_1780913 protein phosphatase 2  regulatory subunit B'   gamma PPP2R5C 
ILMN_1781373 interferon induced with helicase C domain 1 IFIH1 
ILMN_1781416 frequently rearranged in advanced T-cell lymphomas 1 FRAT1 
ILMN_1782015 Fc receptor-like B FCRLB 
ILMN_1782069 trafficking protein  kinesin binding 1 TRAK1 
ILMN_1782085 diphthamine biosynthesis 6 DPH6 
ILMN_1782305 nuclear receptor subfamily 4  group A   member 2 NR4A2 
ILMN_1782331 Unnamed Transcript 
ILMN_1782352 VENT homeobox VENTX 
ILMN_1782419 guanine nucleotide binding protein (G protein)  gamma 11 GNG11 
ILMN_1782488 ribonuclease H2  subunit B RNASEH2
B 
ILMN_1782551 E2F transcription factor 5  p130-binding E2F5 
ILMN_1782633 Unnamed Transcript 
ILMN_1782704 CD19 molecule CD19 
ILMN_1782729 C-type lectin-like 1 CLECL1 
ILMN_1782741 CD300 molecule-like family member b CD300LB 
ILMN_1783627 calpastatin CAST 
ILMN_1783675 ankyrin repeat and SOCS box containing 8 ASB8 
ILMN_1783695 glutamyl-prolyl-tRNA synthetase EPRS 
ILMN_1783852 CD164 molecule  sialomucin CD164 
ILMN_1783956 ATPase  class I   type 8B  member 4 ATP8B4 
ILMN_1784203 acrosin binding protein ACRBP 
ILMN_1784218 DEAD (Asp-Glu-Ala-Asp) box polypeptide 23 DDX23 
ILMN_1784287 transforming growth factor  beta receptor III TGFBR3 
ILMN_1784352 cerebral cavernous malformation 2 CCM2 
ILMN_1784602 cyclin-dependent kinase inhibitor 1A (p21  Cip1) CDKN1A 
ILMN_1784651 N-acetylgalactosaminidase  alpha- NAGA 
ILMN_1784709 glucosamine-6-phosphate deaminase 1 GNPDA1 
ILMN_1784737 sphingosine-1-phosphate receptor 4 S1PR4 
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ILMN_1784766 minichromosome maintenance complex component 3 
associated protein 
MCM3AP 
ILMN_1784863 CD36 molecule (thrombospondin receptor) CD36 
ILMN_1784871 fatty acid synthase FASN 
ILMN_1785005 neutrophil cytosolic factor 4  40kDa NCF4 
ILMN_1785113 methylmalonyl CoA mutase MUT 
ILMN_1785141 microtubule associated monooxygenase  calponin and LIM 
domain conta 
MICAL2 
ILMN_1785175 SWAP switching B-cell complex 70kDa subunit SWAP70 
ILMN_1785345 G protein-coupled receptor 84 GPR84 
ILMN_1785439 CD79b molecule  immunoglobulin-associated beta CD79B 
ILMN_1785660 signal recognition particle receptor (docking protein) SRPR 
ILMN_1785661 abhydrolase domain containing 17B ABHD17B 
ILMN_1785703 leiomodin 3 (fetal) LMOD3 
ILMN_1785711 Unnamed Transcript 
ILMN_1785732 tumor necrosis factor  alpha-induced protein 6 TNFAIP6 
ILMN_1785852 nucleic acid binding protein 1 NABP1 
ILMN_1786015 CCCTC-binding factor (zinc finger protein) CTCF 
ILMN_1786065 ubiquitin-like with PHD and ring finger domains 1 UHRF1 
ILMN_1786275 poly(A) polymerase gamma PAPOLG 
ILMN_1786347 transportin 1 TNPO1 
ILMN_1786658 bolA family member 3 BOLA3 
ILMN_1786722 zinc finger protein 385A ZNF385A 
ILMN_1786823 intercellular adhesion molecule 2 ICAM2 
ILMN_1787064 ankyrin repeat domain 17 ANKRD17 
ILMN_1787127 solute carrier family 43 (amino acid system L transporter)  
member 
SLC43A2 
ILMN_1787212 cyclin-dependent kinase inhibitor 1A (p21  Cip1) CDKN1A 
ILMN_1787410 eukaryotic translation initiation factor 6 EIF6 
ILMN_1787461 runt-related transcription factor 3 RUNX3 
ILMN_1787509 helicase with zinc finger 2  transcriptional coactivator HELZ2 
ILMN_1787529 complement component 3a receptor 1 C3AR1 




ILMN_1787813 solute carrier family 5 (sodium/myo-inositol cotransporter)  
member 
SLC5A3 
ILMN_1787879 ADP-ribosylation factor-like 2 ARL2 
ILMN_1787897 chemokine (C-X-C motif) ligand 1 (melanoma growth 
stimulating activ 
CXCL1 
ILMN_1788002 mitogen-activated protein kinase 14 MAPK14 
ILMN_1788213 frequently rearranged in advanced T-cell lymphomas 2 FRAT2 
ILMN_1788416 abhydrolase domain containing 17C ABHD17C 
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ILMN_1788531 signaling threshold regulating transmembrane adaptor 1 SIT1 
ILMN_1788547 glutamate-cysteine ligase  modifier subunit GCLM 
ILMN_1788689 pleckstrin homology domain interacting protein PHIP 
ILMN_1788841 T-cell leukemia/lymphoma 1A TCL1A 
ILMN_1789136 Unnamed Transcript 
ILMN_1789244 SRY (sex determining region Y)-box 8 SOX8 
ILMN_1789283 protein phosphatase 2  regulatory subunit B'   gamma PPP2R5C 
ILMN_1789342 NADH dehydrogenase (ubiquinone) Fe-S protein 2  49kDa 
(NADH-coenzym 
NDUFS2 
ILMN_1789436 DENN/MADD domain containing 1B DENND1
B 
ILMN_1789596 ets variant 6 ETV6 
ILMN_1789627 Unnamed Transcript 
ILMN_1789781 Pim-3 proto-oncogene  serine/threonine kinase PIM3 
ILMN_1789955 proline-rich nuclear receptor coactivator 1 PNRC1 
ILMN_1789990 ADP-ribosylation factor guanine nucleotide-exchange 
factor 2 (brefe 
ARFGEF2 
ILMN_1790228 furin (paired basic amino acid cleaving enzyme) FURIN 
ILMN_1790230 zinc finger protein 181 ZNF181 
ILMN_1790555 coiled-coil domain containing 146 CCDC146 
ILMN_1790689 cysteine-rich secretory protein LCCL domain containing 2 CRISPLD2 
ILMN_1790692 granulysin GNLY 
ILMN_1790741 ring finger protein 126 RNF126 
ILMN_1790757 adenylosuccinate lyase ADSL 
ILMN_1790782 mediator complex subunit 16 MED16 
ILMN_1790909 nuclear factor  erythroid 2-like 2 NFE2L2 
ILMN_1791329 Fc receptor-like 2 FCRL2 
ILMN_1791396 Unnamed Transcript 
ILMN_1791483 phosphodiesterase 4D  cAMP-specific PDE4D 
ILMN_1791511 transmembrane protein 176A TMEM176
A 
ILMN_1791759 chemokine (C-X-C motif) ligand 10 CXCL10 
ILMN_1791770 SWI/SNF related  matrix associated   actin dependent 
regulator of c 
SMARCC
2 
ILMN_1792072 fucosyltransferase 4 (alpha (1 3) fucosyltransferase   
myeloid-spec 
FUT4 
ILMN_1792518 syntaxin 7 STX7 
ILMN_1792922 superoxide dismutase 2  mitochondrial SOD2 
ILMN_1793474 insulin induced gene 1 INSIG1 
ILMN_1793563 dynactin 1 DCTN1 
ILMN_1793743 disrupted in renal carcinoma 2 DIRC2 
ILMN_1793859 aldehyde dehydrogenase 2 family (mitochondrial) ALDH2 
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ILMN_1793990 inhibitor of DNA binding 2  dominant negative helix-loop-
helix prot 
ID2 
ILMN_1794038 family with sequence similarity 49  member A FAM49A 
ILMN_1794165 phosphogluconate dehydrogenase PGD 
ILMN_1794740 CD151 molecule (Raph blood group) CD151 
ILMN_1794781 vav 2 guanine nucleotide exchange factor VAV2 
ILMN_1794782 ATP-binding cassette  sub-family G (WHITE)   member 1 ABCG1 
ILMN_1794875 1-acylglycerol-3-phosphate O-acyltransferase 9 AGPAT9 
ILMN_1795715 dihydropyrimidine dehydrogenase DPYD 
ILMN_1795719 replication protein A1  70kDa RPA1 
ILMN_1795846 protein phosphatase 2  regulatory subunit B'   gamma PPP2R5C 
ILMN_1796075 vacuolar protein sorting 41 homolog (S. cerevisiae) VPS41 
ILMN_1796094 CD36 molecule (thrombospondin receptor) CD36 
ILMN_1796210 peroxisome proliferator-activated receptor gamma  
coactivator-relat 
PPRC1 
ILMN_1796316 matrix metallopeptidase 9 (gelatinase B  92kDa gelatinase   
92kDa t 
MMP9 
ILMN_1796409 complement component 1  q subcomponent   B chain C1QB 
ILMN_1796642 neutrophil cytosolic factor 2 NCF2 
ILMN_1796669 presenilin 1 PSEN1 
ILMN_1796813 embryonic ectoderm development EED 
ILMN_1796962 protein phosphatase 3  regulatory subunit B   alpha PPP3R1 
ILMN_1797001 DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 DDX58 
ILMN_1797310 ATPase  H+ transporting   lysosomal 34kDa  V1 subunit D ATP6V1D 
ILMN_1797341 AT rich interactive domain 1A (SWI-like) ARID1A 
ILMN_1797656 activating signal cointegrator 1 complex subunit 3 ASCC3 
ILMN_1797731 membrane-spanning 4-domains  subfamily A   member 6A MS4A6A 
ILMN_1797822 sel-1 suppressor of lin-12-like 3 (C. elegans) SEL1L3 
ILMN_1797895 free fatty acid receptor 2 FFAR2 
ILMN_1798085 EP300 interacting inhibitor of differentiation 2B EID2B 
ILMN_1798177 churchill domain containing 1 CHURC1 
ILMN_1798181 interferon regulatory factor 7 IRF7 
ILMN_1798233 proteasome (prosome  macropain) subunit   beta type 9 PSMB9 
ILMN_1798270 single-pass membrane protein with coiled-coil domains 4 SMCO4 
ILMN_1798360 atypical chemokine receptor 3 ACKR3 
ILMN_1798706 G protein-coupled receptor 183 GPR183 
ILMN_1799030 CKLF-like MARVEL transmembrane domain containing 2 CMTM2 
ILMN_1799062 nuclear factor of kappa light polypeptide gene enhancer in 
B-cells 
NFKB2 
ILMN_1799103 small nuclear ribonucleoprotein polypeptides B and B1 SNRPB 
ILMN_1799467 sterile alpha motif domain containing 9-like SAMD9L 
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ILMN_1799601 UHRF1 binding protein 1-like UHRF1BP
1 
ILMN_1799725 dedicator of cytokinesis 2 DOCK2 
ILMN_1799765 Unnamed Transcript 
ILMN_1799856 Unnamed Transcript 
ILMN_1800451 mediator complex subunit 16 MED16 
ILMN_1800540 CD55 molecule  decay accelerating factor for complement 
(Cromer blo 
CD55 
ILMN_1800602 grancalcin  EF-hand calcium binding protein GCA 
ILMN_1800912 zinc finger protein 106 ZNF106 
ILMN_1800951 ataxin 1 ATXN1 
ILMN_1801077 perilipin 2 PLIN2 
ILMN_1801098 Unnamed Transcript 
ILMN_1801156 rearranged L-myc fusion RLF 
ILMN_1801205 glycoprotein (transmembrane) nmb GPNMB 
ILMN_1801216 S100 calcium binding protein P S100P 
ILMN_1801246 interferon induced transmembrane protein 1 IFITM1 
ILMN_1801246 interferon induced transmembrane protein 1 IFITM1 
ILMN_1801307 tumor necrosis factor (ligand) superfamily  member 10 TNFSF10 
ILMN_1801504 runt-related transcription factor 1 RUNX1 
ILMN_1801616 epithelial membrane protein 1 EMP1 
ILMN_1801710 amyloid beta (A4) precursor protein-binding  family B   
member 1 in 
APBB1IP 
ILMN_1802257 phosphatidylcholine transfer protein PCTP 
ILMN_1802404 ATP-binding cassette  sub-family C (CFTR/MRP)   
member 1 
ABCC1 
ILMN_1802457 MYC associated factor X MAX 
ILMN_1802831 myotubularin related protein 12 MTMR12 
ILMN_1803476 potassium channel tetramerization domain containing 20 KCTD20 
ILMN_1803615 megakaryocyte-associated tyrosine kinase MATK 
ILMN_1803788 lectin  galactoside-binding   soluble 3 LGALS3 
ILMN_1803819 IQ motif containing GTPase activating protein 1 IQGAP1 
ILMN_1803853 nucleolar protein 7  27kDa NOL7 
ILMN_1803882 vascular endothelial growth factor A VEGFA 
ILMN_1803925 myotubularin related protein 3 MTMR3 
ILMN_1803945 HLA complex P5 (non-protein coding) HCP5 
ILMN_1803977 polypeptide N-acetylgalactosaminyltransferase 1 GALNT1 
ILMN_1803988 myeloid cell leukemia 1 MCL1 
ILMN_1803997 serologically defined colon cancer antigen 3 SDCCAG3 
ILMN_1804174 Fc fragment of IgG  low affinity IIb   receptor (CD32) FCGR2B 
ILMN_1804448 musashi RNA-binding protein 2 MSI2 
ILMN_1804854 catenin (cadherin-associated protein)  alpha 1   102kDa CTNNA1 
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ILMN_1805104 4-aminobutyrate aminotransferase ABAT 
ILMN_1805175 transforming growth factor  alpha TGFA 
ILMN_1805228 leucine-rich alpha-2-glycoprotein 1 LRG1 
ILMN_1805410 chromosome 15 open reading frame 48 C15orf48 
ILMN_1806023 jun proto-oncogene JUN 
ILMN_1806184 mediator complex subunit 13 MED13 
ILMN_1806408 acyl-CoA dehydrogenase  very long chain ACADVL 
ILMN_1806906 signal sequence receptor  gamma (translocon-associated 
protein gamm 
SSR3 
ILMN_1806908 protein kinase C  beta PRKCB 
ILMN_1806999 B9 protein domain 2 B9D2 
ILMN_1807042 myristoylated alanine-rich protein kinase C substrate MARCKS 
ILMN_1807074 macrophage migration inhibitory factor (glycosylation-
inhibiting fa 
MIF 
ILMN_1807277 interferon  gamma-inducible protein 30 IFI30 
ILMN_1807277 interferon  gamma-inducible protein 30 IFI30 
ILMN_1807300 polycystic kidney disease 2 (autosomal dominant) PKD2 
ILMN_1807372 adenosine A2a receptor ADORA2
A 
ILMN_1807596 ubiquitin associated protein 1 UBAP1 
ILMN_1807662 insulin-like growth factor 2 receptor IGF2R 
ILMN_1807833 histocompatibility (minor) 13 HM13 
ILMN_1808132 Fas cell surface death receptor FAS 
ILMN_1808405 major histocompatibility complex  class II   DQ alpha 1 HLA-
DQA1 
ILMN_1808548 Unnamed Transcript 
ILMN_1808587 zinc finger homeobox 3 ZFHX3 
ILMN_1808707 fascin actin-bundling protein 1 FSCN1 
ILMN_1808768 Rho-associated  coiled-coil containing protein kinase 1 ROCK1 
ILMN_1809027 ATP5S-like ATP5SL 
ILMN_1809040 low density lipoprotein receptor adaptor protein 1 LDLRAP1 
ILMN_1809086 5'-3' exoribonuclease 1 XRN1 
ILMN_1809139 AT hook containing transcription factor 1 AHCTF1 
ILMN_1809147 family with sequence similarity 118  member A FAM118A 
ILMN_1809193 presenilin 1 PSEN1 
ILMN_1809467 vesicle-associated membrane protein 5 VAMP5 
ILMN_1809522 NACC family member 2  BEN and BTB (POZ) domain 
containing 
NACC2 
ILMN_1809582 vacuolar protein sorting 13 homolog C (S. cerevisiae) VPS13C 
ILMN_1809607 peptidylprolyl isomerase F PPIF 
ILMN_1809695 calcium/calmodulin-dependent protein kinase II gamma CAMK2G 
ILMN_1809866 WD repeat domain 74 WDR74 
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ILMN_1809931 N-myc downstream regulated 1 NDRG1 
ILMN_1810058 RAB  member of RAS oncogene family-like 2B RABL2B 
ILMN_1810214 jun D proto-oncogene JUND 
ILMN_1810254 meiosis inhibitor 1 MEI1 
ILMN_1810274 homeobox B2 HOXB2 
ILMN_1810289 myoferlin MYOF 
ILMN_1810385 ATR serine/threonine kinase ATR 
ILMN_1810418 lamin B receptor LBR 
ILMN_1810486 RAB34  member RAS oncogene family RAB34 
ILMN_1810680 Unnamed Transcript 
ILMN_1810838 metadherin MTDH 
ILMN_1810941 catechol-O-methyltransferase COMT 
ILMN_1811171 G protein-coupled receptor 132 GPR132 
ILMN_1811258 v-rel avian reticuloendotheliosis viral oncogene homolog B RELB 
ILMN_1811328 dipeptidyl-peptidase 7 DPP7 
ILMN_1811702 granulin GRN 
ILMN_1811933 serine hydroxymethyltransferase 1 (soluble) SHMT1 
ILMN_1811954 neuregulin 1 NRG1 
ILMN_1811972 MYC binding protein 2  E3 ubiquitin protein ligase MYCBP2 
ILMN_1812139 Ras association (RalGDS/AF-6) domain family member 2 RASSF2 
ILMN_1812191 chromosome 12 open reading frame 57 C12orf57 
ILMN_1812384 nuclear receptor subfamily 3  group C   member 1 
(glucocorticoid re 
NR3C1 
ILMN_1812433 haptoglobin HP 
ILMN_1812995 cathepsin L CTSL 
ILMN_1813314 histone cluster 1  H2bk HIST1H2B 
ILMN_1813379 tumor necrosis factor receptor superfamily  member 9 TNFRSF9 
ILMN_1813399 ATPase  Ca++ transporting   plasma membrane 1 ATP2B1 
ILMN_1813604 NADH dehydrogenase (ubiquinone) 1 beta subcomplex 7   
18kDa 
NDUFB7 
ILMN_1813775 cyclin G associated kinase GAK 
ILMN_1813795 Ras association (RalGDS/AF-6) domain family member 5 RASSF5 
ILMN_1813817 mitochondrial ribosomal protein L55 MRPL55 
ILMN_1814305 sterile alpha motif domain containing 9 SAMD9 
ILMN_1814650 trafficking protein particle complex 4 TRAPPC4 
ILMN_1815023 Pim-1 proto-oncogene  serine/threonine kinase PIM1 
ILMN_1815086 ninjurin 1 NINJ1 
ILMN_1815148 mannosidase  alpha   class 2A  member 2 MAN2A2 
ILMN_1815283 Unnamed Transcript 
ILMN_1815527 hemoglobin  delta HBD 
ILMN_1815656 serine incorporator 3 SERINC3 
ILMN_1815733 eukaryotic translation initiation factor 5 EIF5 
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ILMN_1815758 GRB2-associated binding protein 2 GAB2 
ILMN_1815890 interleukin 12 receptor  beta 1 IL12RB1 
ILMN_1837935 transportin 1 TNPO1 
ILMN_2038775 tubulin  beta 2A class IIa TUBB2A 
ILMN_2041190 coagulation factor II (thrombin) receptor-like 1 F2RL1 
ILMN_2041327 mitochondrial ribosomal protein L37 MRPL37 
ILMN_2044226 protein phosphatase 3  catalytic subunit   alpha isozyme PPP3CA 
ILMN_2046024 dual specificity phosphatase 11 (RNA/RNP complex 1-
interacting) 
DUSP11 
ILMN_2048607 ankyrin repeat domain 9 ANKRD9 
ILMN_2048822 NudC domain containing 2 NUDCD2 
ILMN_2049364 methyltransferase like 21A METTL21
A 
ILMN_2050911 solute carrier family 22 (organic cation/zwitterion 
transporter)  m 
SLC22A4 
ILMN_2051900 EP300 interacting inhibitor of differentiation 2B EID2B 
ILMN_2052891 polycystic kidney disease 2 (autosomal dominant) PKD2 
ILMN_2053103 solute carrier family 40 (iron-regulated transporter)  
member 1 
SLC40A1 
ILMN_2053415 low density lipoprotein receptor LDLR 
ILMN_2054019 ISG15 ubiquitin-like modifier ISG15 
ILMN_2054442 zinc finger protein 146 ZNF146 
ILMN_2055781 killer cell lectin-like receptor subfamily F  member 1 KLRF1 
ILMN_2056167 oligosaccharyltransferase complex subunit (non-catalytic) OSTC 
ILMN_2058782 interferon  alpha-inducible protein 27 IFI27 
ILMN_2059452 solute carrier family 12 (sodium/potassium/chloride 
transporter)  m 
SLC12A2 
ILMN_2059886 tetratricopeptide repeat domain 38 TTC38 
ILMN_2060115 sortilin-related receptor  L(DLR class) A repeats containing SORL1 
ILMN_2062001 hook microtubule-tethering protein 3 HOOK3 
ILMN_2062370 nucleolar protein 8 NOL8 
ILMN_2063586 chloride intracellular channel 4 CLIC4 
ILMN_2064898 cytochrome c oxidase assembly factor 3 COA3 
ILMN_2067607 transmembrane protein 106B TMEM106
B 
ILMN_2067708 transcription factor B2  mitochondrial TFB2M 
ILMN_2067709 transcription factor B2  mitochondrial TFB2M 
ILMN_2072178 enoyl CoA hydratase domain containing 3 ECHDC3 
ILMN_2073157 amylase  alpha 2B (pancreatic) AMY2B 
ILMN_2074401 LysM  putative peptidoglycan-binding   domain containing 
3 
LYSMD3 
ILMN_2080637 zinc finger and BTB domain containing 44 ZBTB44 
ILMN_2081988 LanC lantibiotic synthetase component C-like 1 (bacterial) LANCL1 
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ILMN_2082762 small nucleolar RNA  C/D box 68 SNORD68 
ILMN_2082810 bromodomain containing 7 BRD7 
ILMN_2083469 insulin receptor substrate 2 IRS2 
ILMN_2083833 CCR4-NOT transcription complex  subunit 6-like CNOT6L 
ILMN_2083946 transforming growth factor  alpha TGFA 
ILMN_2084353 mannose-6-phosphate receptor (cation dependent) M6PR 
ILMN_2085012 transmembrane protein 176B TMEM176
B 
ILMN_2085760 actin related protein 2/3 complex  subunit 1B   41kDa ARPC1B 
ILMN_2085862 solute carrier family 15 (oligopeptide transporter)  member 
3 
SLC15A3 
ILMN_2086077 jun B proto-oncogene JUNB 
ILMN_2086095 inhibitor of DNA binding 2  dominant negative helix-loop-
helix prot 
ID2 
ILMN_2087303 XK  Kell blood group complex subunit-related family   
member 8 
XKR8 
ILMN_2087575 zinc finger CCCH-type containing 4 ZC3H4 
ILMN_2087646 H2.0-like homeobox HLX 
ILMN_2088437 chemokine (C-X3-C motif) receptor 1 CX3CR1 
ILMN_2088612 exportin 4 XPO4 
ILMN_2090105 transgelin 2 TAGLN2 
ILMN_2090607 interferon regulatory factor 2 IRF2 
ILMN_2092118 formyl peptide receptor 1 FPR1 
ILMN_2094061 inositol(myo)-1(or 4)-monophosphatase 2 IMPA2 
ILMN_2095840 K(lysine) acetyltransferase 6A KAT6A 
ILMN_2098126 chemokine (C-C motif) ligand 5 CCL5 
ILMN_2100209 Unnamed Transcript 
ILMN_2100437 hemoglobin  beta HBB 
ILMN_2101832 lysosomal protein transmembrane 4 beta LAPTM4B 
ILMN_2101920 heterogeneous nuclear ribonucleoprotein H1 (H) HNRNPH1 
ILMN_2105441 immunoglobulin J polypeptide  linker protein for 
immunoglobulin alp 
IGJ 
ILMN_2106656 basic leucine zipper nuclear factor 1 BLZF1 
ILMN_2107004 G protein-coupled receptor 1 GPR1 
ILMN_2109197 erythrocyte membrane protein band 4.1-like 3 EPB41L3 
ILMN_2109416 napsin B aspartic peptidase  pseudogene NAPSB 
ILMN_2111739 mannosidase  alpha   class 2C  member 1 MAN2C1 
ILMN_2112049 DNL-type zinc finger DNLZ 
ILMN_2113126 ribonuclease  RNase A family  3 RNASE3 
ILMN_2113362 ADP-ribosylation factor-like 6 interacting protein 1 ARL6IP1 
ILMN_2113738 minichromosome maintenance domain containing 2 MCMDC2 
ILMN_2114422 nucleotide-binding oligomerization domain containing 1 NOD1 
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ILMN_2115218 ankyrin repeat domain 10 ANKRD10 
ILMN_2115591 kelch domain containing 10 KLHDC10 
ILMN_2115669 sema domain  immunoglobulin domain (Ig)   
transmembrane domain (TM) 
SEMA4C 
ILMN_2116556 LSM5 homolog  U6 small nuclear RNA associated (S. 
cerevisiae) 
LSM5 
ILMN_2117240 deoxycytidine kinase DCK 
ILMN_2117623 plexin C1 PLXNC1 
ILMN_2118864 RAB1A  member RAS oncogene family RAB1A 
ILMN_2119486 cyclin D binding myb-like transcription factor 1 DMTF1 
ILMN_2120022 ADP-ribosylation factor-like 5B ARL5B 
ILMN_2121816 G protein-coupled receptor 137B GPR137B 
ILMN_2122511 collagen and calcium binding EGF domains 1 CCBE1 
ILMN_2123312 endoplasmic reticulum aminopeptidase 2 ERAP2 
ILMN_2123402 canopy FGF signaling regulator 2 CNPY2 
ILMN_2123557 family with sequence similarity 73  member A FAM73A 
ILMN_2124064 v-rel avian reticuloendotheliosis viral oncogene homolog REL 
ILMN_2124155 ATPase  class VI   type 11B ATP11B 
ILMN_2126832 SEC24 family member A SEC24A 
ILMN_2127605 low density lipoprotein receptor-related protein 3 LRP3 
ILMN_2129015 AF4/FMR2 family  member 1 AFF1 
ILMN_2129927 exostosin glycosyltransferase 1 EXT1 
ILMN_2130078 CDKN2A interacting protein N-terminal like CDKN2AI
P 
ILMN_2132599 ankyrin repeat domain 22 ANKRD22 
ILMN_2133316 GTPase  IMAP family member 7 GIMAP7 
ILMN_2137464 dishevelled segment polarity protein 3 DVL3 
ILMN_2137536 zinc finger  ZZ-type containing 3 ZZZ3 
ILMN_2137789 Kruppel-like factor 4 (gut) KLF4 
ILMN_2138435 mitochondrial ribosomal protein S27 MRPS27 
ILMN_2138765 perilipin 2 PLIN2 
ILMN_2139351 zinc finger protein 232 ZNF232 
ILMN_2140207 Unnamed Transcript 
ILMN_2140990 calcium/calmodulin-dependent protein kinase I CAMK1 
ILMN_2141941 torsin A interacting protein 1 TOR1AIP1 
ILMN_2144426 Unnamed Transcript 
ILMN_2145997 Sp4 transcription factor SP4 
ILMN_2147435 mannosidase  alpha   class 2A  member 1 MAN2A1 
ILMN_2148668 regulator of chromosome condensation (RCC1) and BTB 
(POZ) domain co 
RCBTB2 
ILMN_2148785 guanylate binding protein 1  interferon-inducible GBP1 
ILMN_2150258 ZFP36 ring finger protein-like 2 ZFP36L2 
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ILMN_2150294 FK506 binding protein 14  22 kDa FKBP14 
ILMN_2150851 serpin peptidase inhibitor  clade B (ovalbumin)   member 2 SERPINB2 
ILMN_2150856 serpin peptidase inhibitor  clade B (ovalbumin)   member 2 SERPINB2 
ILMN_2151277 lysophosphatidylglycerol acyltransferase 1 LPGAT1 
ILMN_2151281 GABA(A) receptor-associated protein like 1 GABARA
PL 
ILMN_2151541 DnaJ (Hsp40) homolog  subfamily C   member 10 DNAJC10 
ILMN_2153332 ataxin 1 ATXN1 
ILMN_2154322 sema domain  immunoglobulin domain (Ig)   short basic 
domain  secre 
SEMA3E 
ILMN_2154654 protein tyrosine phosphatase type IVA  member 1 PTP4A1 
ILMN_2154836 BTG family  member 3 BTG3 
ILMN_2156172 hexokinase 2 HK2 
ILMN_2157957 general transcription factor IIH  polypeptide 1   62kDa GTF2H1 
ILMN_2158336 SH3-domain GRB2-like endophilin B2 SH3GLB2 
ILMN_2159453 syntaxin binding protein 2 STXBP2 
ILMN_2159694 major histocompatibility complex  class II   DR beta 4 HLA-
DRB4 
ILMN_2159694 major histocompatibility complex  class II   DR beta 4 HLA-
DRB4 
ILMN_2162972 lysozyme LYZ 
ILMN_2163819 kinesin family member 21B KIF21B 
ILMN_2165753 major histocompatibility complex  class I   A HLA-A 
ILMN_2168217 G protein-coupled receptor 183 GPR183 
ILMN_2169439 integrin  alpha V ITGAV 
ILMN_2169761 copine VIII CPNE8 
ILMN_2169983 ATPase family  AAA domain containing 1 ATAD1 
ILMN_2171289 SAM domain  SH3 domain and nuclear localization signals 
1 
SAMSN1 
ILMN_2172174 purine nucleoside phosphorylase PNP 
ILMN_2173004 RAB8B  member RAS oncogene family RAB8B 
ILMN_2173451 glucose-6-phosphate isomerase GPI 
ILMN_2173909 zinc finger protein 14 ZNF14 
ILMN_2174612 CCR4-NOT transcription complex  subunit 8 CNOT8 
ILMN_2176882 zinc finger protein 69 ZNF69 
ILMN_2179018 NADH dehydrogenase (ubiquinone) 1  alpha/beta 
subcomplex  1  8kDa 
NDUFAB1 
ILMN_2180606 N(alpha)-acetyltransferase 50  NatE catalytic subunit NAA50 
ILMN_2182348 structural maintenance of chromosomes 3 SMC3 
ILMN_2183510 mesencephalic astrocyte-derived neurotrophic factor MANF 
ILMN_2184262 2'-5'-oligoadenylate synthetase 3  100kDa OAS3 
ILMN_2184373 chemokine (C-X-C motif) ligand 8 CXCL8 
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ILMN_2185984 SAM and SH3 domain containing 1 SASH1 
ILMN_2186061 6-phosphofructo-2-kinase/fructose-2 6-biphosphatase 3 PFKFB3 
ILMN_2186108 DiGeorge syndrome critical region gene 6 DGCR6 
ILMN_2186216 Unnamed Transcript 
ILMN_2189842 small nucleolar RNA  H/ACA box 10 SNORA10 
ILMN_2194649 transcriptional adaptor 1 TADA1 
ILMN_2196078 SLAM family member 6 SLAMF6 
ILMN_2196347 cyclin-dependent kinase inhibitor 1B (p27  Kip1) CDKN1B 
ILMN_2196479 5'-3' exoribonuclease 2 XRN2 
ILMN_2196550 KIAA0226-like KIAA0226 
ILMN_2196588 Unnamed Transcript 
ILMN_2197101 DEAD (Asp-Glu-Ala-Asp) box polypeptide 19A DDX19A 
ILMN_2197846 hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA 
thiolase/enoyl-CoA hyd 
HADHB 
ILMN_2198499 solute carrier family 25  member 51 SLC25A51 
ILMN_2199439 carbonic anhydrase II CA2 
ILMN_2204297 adaptor-related protein complex 5  mu 1 subunit AP5M1 
ILMN_2204754 thioredoxin-related transmembrane protein 4 TMX4 
ILMN_2204876 feline leukemia virus subgroup C cellular receptor family  
member 2 
FLVCR2 
ILMN_2204909 X-ray repair complementing defective repair in Chinese 
hamster cell 
XRCC2 
ILMN_2205350 NADH dehydrogenase (ubiquinone) complex I  assembly 
factor 4 
NDUFAF4 
ILMN_2210298 coiled-coil domain containing 61 CCDC61 
ILMN_2210601 ribonuclease L (2' 5'-oligoisoadenylate synthetase-
dependent) 
RNASEL 
ILMN_2210934 nuclear receptor subfamily 3  group C   member 2 NR3C2 
ILMN_2211189 inhibitor of kappa light polypeptide gene enhancer in B-
cells  kina 
IKBKAP 
ILMN_2211672 translin-associated factor X TSNAX 
ILMN_2211780 solute carrier family 25 (mitochondrial carrier; adenine 
nucleotide 
SLC25A4 
ILMN_2212763 intercellular adhesion molecule 3 ICAM3 
ILMN_2214603 protein phosphatase 2  regulatory subunit B''   gamma PPP2R3C 
ILMN_2214678 MAX dimerization protein 1 MXD1 
ILMN_2215211 zinc finger protein 514 ZNF514 
ILMN_2216157 guanine nucleotide binding protein (G protein) alpha 12 GNA12 
ILMN_2218780 pyruvate dehyrogenase phosphatase catalytic subunit 1 PDP1 
ILMN_2218856 Unnamed Transcript 
ILMN_2221408 ADP-ribosylation factor guanine nucleotide-exchange 
factor 1 (brefe 
ARFGEF1 
ILMN_2222074 protein tyrosine phosphatase  non-receptor type 12 PTPN12 
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ILMN_2223130 SWI/SNF related  matrix associated   actin dependent 
regulator of c 
SMARCA
5 
ILMN_2223720 ATM interactor ATMIN 
ILMN_2226015 leucine-rich repeat kinase 2 LRRK2 
ILMN_2229940 protease-associated domain containing 1 PRADC1 




ILMN_2230592 mitochondrial ribosomal protein L3 MRPL3 
ILMN_2231242 high mobility group box 1 HMGB1 
ILMN_2231928 MX dynamin-like GTPase 2 MX2 
ILMN_2233783 CD38 molecule CD38 
ILMN_2235785 potassium voltage-gated channel  subfamily H (eag-
related)   member 
KCNH6 
ILMN_2236625 urotensin 2 UTS2 
ILMN_2236655 histocompatibility (minor) 13 HM13 
ILMN_2236800 SON DNA binding protein SON 
ILMN_2241953 paired immunoglobin-like type 2 receptor alpha PILRA 
ILMN_2245676 basic transcription factor 3 BTF3 
ILMN_2247664 SON DNA binding protein SON 
ILMN_2252309 dipeptidyl-peptidase 7 DPP7 
ILMN_2252705 vacuolar protein sorting 13 homolog B (yeast) VPS13B 
ILMN_2253286 protein kinase C  zeta PRKCZ 
ILMN_2253300 transmembrane 9 superfamily member 1 TM9SF1 




ILMN_2258234 kelch-like family member 5 KLHL5 
ILMN_2258774 mitochondrial ribosomal protein L43 MRPL43 
ILMN_2259292 Unnamed Transcript 
ILMN_2259495 BH3 interacting domain death agonist BID 
ILMN_2260082 NLR family  apoptosis inhibitory protein NAIP 
ILMN_2261076 neural precursor cell expressed  developmentally down-
regulated 9 
NEDD9 
ILMN_2261416 CD3d molecule  delta (CD3-TCR complex) CD3D 
ILMN_2263466 acyl-CoA dehydrogenase  very long chain ACADVL 
ILMN_2264625 Nipped-B homolog (Drosophila) NIPBL 
ILMN_2266595 leukocyte immunoglobulin-like receptor  subfamily A 
(with TM domain 
LILRA5 
ILMN_2267135 ST3 beta-galactoside alpha-2 3-sialyltransferase 1 ST3GAL1 
ILMN_2267914 CD68 molecule CD68 
ILMN_2268409 vacuolar protein sorting 13 homolog B (yeast) VPS13B 
ILMN_2271379 serologically defined colon cancer antigen 3 SDCCAG3 
ILMN_2272074 TROVE domain family  member 2 TROVE2 
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ILMN_2272967 trafficking protein particle complex 6B TRAPPC6
B 
ILMN_2273261 F-box protein 3 FBXO3 
ILMN_2276996 chemokine (C-C motif) receptor 2 CCR2 
ILMN_2277099 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase 
activation prot 
YWHAB 
ILMN_2278561 Unnamed Transcript 
ILMN_2278729 eukaryotic translation initiation factor 3  subunit B EIF3B 
ILMN_2278850 RAB24  member RAS oncogene family RAB24 
ILMN_2280911 vacuolar protein sorting 41 homolog (S. cerevisiae) VPS41 
ILMN_2281502 dehydrogenase/reductase (SDR family) member 9 DHRS9 
ILMN_2282641 thromboxane A synthase 1 (platelet) TBXAS1 
ILMN_2284794 proteasome (prosome  macropain) subunit   beta type 8 PSMB8 
ILMN_2286014 cation channel  sperm associated 2 CATSPER
2 
ILMN_2288483 centrosomal protein 19kDa CEP19 
ILMN_2289924 trafficking protein  kinesin binding 1 TRAK1 
ILMN_2290118 multiple EGF-like-domains 9 MEGF9 
ILMN_2292178 C-type lectin domain family 12  member A CLEC12A 
ILMN_2292187 chimerin 2 CHN2 
ILMN_2293511 Unnamed Transcript 
ILMN_2293758 A kinase (PRKA) anchor protein 11 AKAP11 
ILMN_2293872 protein kinase  AMP-activated   gamma 2 non-catalytic 
subunit 
PRKAG2 
ILMN_2294751 activating signal cointegrator 1 complex subunit 3 ASCC3 
ILMN_2295252 chromosome 9 open reading frame 72 C9orf72 
ILMN_2296057 caspase 2  apoptosis-related cysteine peptidase CASP2 
ILMN_2296677 chromosome 9 open reading frame 72 C9orf72 
ILMN_2301624 microtubule-actin crosslinking factor 1 MACF1 
ILMN_2304624 eukaryotic translation initiation factor 4H EIF4H 
ILMN_2306565 metaxin 2 MTX2 
ILMN_2307450 zinc finger protein 302 ZNF302 
ILMN_2309245 bridging integrator 1 BIN1 
ILMN_2310896 NLR family  pyrin domain containing 3 NLRP3 
ILMN_2310968 RUN and FYVE domain containing 1 RUFY1 
ILMN_2311796 testis derived transcript (3 LIM domains) TES 
ILMN_2312606 interferon regulatory factor 5 IRF5 
ILMN_2312709 leucine carboxyl methyltransferase 1 LCMT1 
ILMN_2312732 dipeptidyl-peptidase 8 DPP8 
ILMN_2313889 zinc finger protein 682 ZNF682 
ILMN_2313901 peptidylglycine alpha-amidating monooxygenase PAM 
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ILMN_2313926 CDC42 small effector 2 CDC42SE
2 
ILMN_2318011 proteasome (prosome  macropain) subunit   alpha type 3 PSMA3 
ILMN_2318638 TGFB-induced factor homeobox 1 TGIF1 
ILMN_2318643 TGFB-induced factor homeobox 1 TGIF1 
ILMN_2319000 megakaryocyte-associated tyrosine kinase MATK 
ILMN_2319077 Fas cell surface death receptor FAS 
ILMN_2320964 adenosine deaminase  RNA-specific ADAR 
ILMN_2322375 v-maf avian musculoaponeurotic fibrosarcoma oncogene 
homolog F 
MAFF 
ILMN_2322458 optic atrophy 1 (autosomal dominant) OPA1 
ILMN_2322806 calpastatin CAST 
ILMN_2323172 colony stimulating factor 3 receptor (granulocyte) CSF3R 
ILMN_2323302 SON DNA binding protein SON 
ILMN_2323366 succinate dehydrogenase complex  subunit C   integral 
membrane prot 
SDHC 
ILMN_2323526 WW domain containing adaptor with coiled-coil WAC 
ILMN_2325837 CD3d molecule  delta (CD3-TCR complex) CD3D 
ILMN_2329429 GTPase  IMAP family member 6 GIMAP6 
ILMN_2329773 RAB27A  member RAS oncogene family RAB27A 
ILMN_2329927 ATP-binding cassette  sub-family G (WHITE)   member 1 ABCG1 
ILMN_2330845 N-ethylmaleimide-sensitive factor NSF 
ILMN_2331082 membrane-spanning 4-domains  subfamily A   member 7 MS4A7 
ILMN_2331087 membrane-spanning 4-domains  subfamily A   member 7 MS4A7 
ILMN_2331544 myelin basic protein MBP 
ILMN_2332368 vacuolar protein sorting 13 homolog B (yeast) VPS13B 
ILMN_2333107 amino-terminal enhancer of split AES 
ILMN_2333440 transmembrane 9 superfamily member 1 TM9SF1 
ILMN_2334989 chaperonin containing TCP1  subunit 3 (gamma) CCT3 
ILMN_2335704 neutrophil cytosolic factor 4  40kDa NCF4 
ILMN_2336130 Unnamed Transcript 
ILMN_2336280 QKI  KH domain containing   RNA binding QKI 
ILMN_2336781 superoxide dismutase 2  mitochondrial SOD2 
ILMN_2337655 tryptophanyl-tRNA synthetase WARS 
ILMN_2337928 chemokine (C-X-C motif) receptor 5 CXCR5 
ILMN_2338323 cell division cycle 25B CDC25B 
ILMN_2339835 prostaglandin-endoperoxide synthase 1 (prostaglandin G/H 
synthase a 
PTGS1 
ILMN_2339955 nuclear receptor subfamily 4  group A   member 2 NR4A2 
ILMN_2340721 transmembrane protein 134 TMEM134 





ILMN_2342638 asialoglycoprotein receptor 2 ASGR2 
ILMN_2343010 bolA family member 3 BOLA3 
ILMN_2344455 GTPase activating protein (SH3 domain) binding protein 1 G3BP1 
ILMN_2345142 sulfatase 2 SULF2 
ILMN_2345353 leukocyte specific transcript 1 LST1 
ILMN_2346831 mannosyl (alpha-1 6-)-glycoprotein beta-1  2-N-
acetylglucosaminyltr 
MGAT2 
ILMN_2347592 neuromedin B NMB 
ILMN_2347798 interferon  alpha-inducible protein 6 IFI6 
ILMN_2347888 La ribonucleoprotein domain family  member 4 LARP4 
ILMN_2347917 embryonic ectoderm development EED 
ILMN_2347943 zinc finger protein 384 ZNF384 
ILMN_2348090 mitochondrial ribosomal protein L55 MRPL55 
ILMN_2348093 ATP synthase  H+ transporting   mitochondrial Fo complex  
subunit F 
ATP5J 
ILMN_2348243 STE20-related kinase adaptor alpha STRADA 
ILMN_2349600 bromodomain containing 8 BRD8 
ILMN_2349831 dicer 1  ribonuclease type III DICER1 
ILMN_2352009 acyl-CoA dehydrogenase  very long chain ACADVL 
ILMN_2352303 Ras association (RalGDS/AF-6) domain family member 2 RASSF2 
ILMN_2352326 CoA synthase COASY 
ILMN_2352580 methyl-CpG binding domain protein 1 MBD1 
ILMN_2353358 lectin  galactoside-binding   soluble 8 LGALS8 
ILMN_2353633 egf-like module containing  mucin-like   hormone receptor-
like 2 
EMR2 
ILMN_2354391 Unnamed Transcript 
ILMN_2354478 cytoplasmic FMR1 interacting protein 2 CYFIP2 
ILMN_2355225 Unnamed Transcript 
ILMN_2355462 cytoplasmic FMR1 interacting protein 1 CYFIP1 
ILMN_2355463 cytoplasmic FMR1 interacting protein 1 CYFIP1 
ILMN_2355953 leukocyte immunoglobulin-like receptor  subfamily B 
(with TM and IT 
LILRB4 
ILMN_2356654 lectin  galactoside-binding   soluble 8 LGALS8 
ILMN_2357193 DEAD (Asp-Glu-Ala-Asp) box polypeptide 59 DDX59 
ILMN_2357419 leukocyte immunoglobulin-like receptor  subfamily A 
(with TM domain 
LILRA5 
ILMN_2357809 GTPase activating protein (SH3 domain) binding protein 1 G3BP1 
ILMN_2358069 MAD1 mitotic arrest deficient-like 1 (yeast) MAD1L1 
ILMN_2358652 nuclear RNA export factor 1 NXF1 
ILMN_2359601 calcium/calmodulin-dependent protein kinase II gamma CAMK2G 
ILMN_2361104 zinc finger  matrin-type 3 ZMAT3 
ILMN_2361807 osteosarcoma amplified 9  endoplasmic reticulum lectin OS9 
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ILMN_2362232 zinc finger protein 331 ZNF331 
ILMN_2362293 F-box protein 38 FBXO38 
ILMN_2362368 U2 small nuclear RNA auxiliary factor 1 U2AF1 
ILMN_2362581 fibronectin type III domain containing 3A FNDC3A 
ILMN_2362858 paired immunoglobin-like type 2 receptor alpha PILRA 
ILMN_2362902 Ras association (RalGDS/AF-6) domain family member 5 RASSF5 
ILMN_2363426 MYC associated factor X MAX 
ILMN_2364022 solute carrier family 16 (monocarboxylate transporter)  
member 3 
SLC16A3 
ILMN_2364272 muscleblind-like splicing regulator 2 MBNL2 
ILMN_2364674 tRNA phosphotransferase 1 TRPT1 
ILMN_2364971 protein phosphatase 2  regulatory subunit B'   gamma PPP2R5C 
ILMN_2365091 Fc fragment of IgA  receptor for FCAR 
ILMN_2365479 sorting nexin 1 SNX1 
ILMN_2365484 sorting nexin 1 SNX1 
ILMN_2365528 HAUS augmin-like complex  subunit 8 HAUS8 
ILMN_2366212 CD79b molecule  immunoglobulin-associated beta CD79B 
ILMN_2366634 pyruvate kinase  muscle PKM 
ILMN_2367113 caspase 6  apoptosis-related cysteine peptidase CASP6 
ILMN_2367215 prolylcarboxypeptidase (angiotensinase C) PRCP 
ILMN_2367418 osteoclast associated  immunoglobulin-like receptor OSCAR 
ILMN_2367681 sperm associated antigen 1 SPAG1 
ILMN_2367782 StAR-related lipid transfer (START) domain containing 7 STARD7 
ILMN_2368530 interleukin 32 IL32 
ILMN_2368597 SMG7 nonsense mediated mRNA decay factor SMG7 
ILMN_2369785 small nuclear ribonucleoprotein D2 polypeptide 16.5kDa SNRPD2 
ILMN_2370336 membrane-spanning 4-domains  subfamily A   member 4A MS4A4A 
ILMN_2370573 XIAP associated factor 1 XAF1 
ILMN_2370772 eukaryotic translation initiation factor 4 gamma 1 EIF4G1 
ILMN_2370882 acyl-CoA synthetase long-chain family member 5 ACSL5 
ILMN_2370976 myoferlin MYOF 
ILMN_2371280 colony stimulating factor 3 receptor (granulocyte) CSF3R 
ILMN_2371590 DEAD (Asp-Glu-Ala-Asp) box helicase 17 DDX17 
ILMN_2371825 amylo-alpha-1  6-glucosidase   4-alpha-glucanotransferase AGL 
ILMN_2372136 prolyl 4-hydroxylase  transmembrane (endoplasmic 
reticulum) 
P4HTM 
ILMN_2372413 BH3 interacting domain death agonist BID 
ILMN_2372974 signal-regulatory protein alpha SIRPA 
ILMN_2373266 splicing regulatory glutamine/lysine-rich protein 1 SREK1 
ILMN_2373335 ligase III  DNA   ATP-dependent LIG3 
ILMN_2373831 butyrophilin  subfamily 3   member A3 BTN3A3 
ILMN_2374036 cathepsin L CTSL 
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ILMN_2374362 abhydrolase domain containing 17B ABHD17B 
ILMN_2374383 tetraspanin 17 TSPAN17 
ILMN_2374778 deoxyuridine triphosphatase DUT 
ILMN_2375002 mitogen-activated protein kinase kinase kinase kinase 4 MAP4K4 
ILMN_2375003 mitogen-activated protein kinase kinase kinase kinase 4 MAP4K4 
ILMN_2375879 vascular endothelial growth factor A VEGFA 
ILMN_2376204 lymphotoxin beta (TNF superfamily  member 3) LTB 
ILMN_2376205 lymphotoxin beta (TNF superfamily  member 3) LTB 
ILMN_2376431 chemokine (C-C motif) receptor 2 CCR2 
ILMN_2377019 coronin  actin binding protein   1B CORO1B 
ILMN_2377980 protein phosphatase 1  catalytic subunit   alpha isozyme PPP1CA 
ILMN_2378316 nucleoporin like 1 NUPL1 
ILMN_2379469 eukaryotic translation initiation factor 3  subunit B EIF3B 
ILMN_2379599 CD163 molecule CD163 
ILMN_2379718 RAB24  member RAS oncogene family RAB24 
ILMN_2379967 Fc fragment of IgA  receptor for FCAR 
ILMN_2380418 bicaudal D homolog 2 (Drosophila) BICD2 
ILMN_2380605 myotubularin related protein 3 MTMR3 
ILMN_2380850 serologically defined colon cancer antigen 3 SDCCAG3 
ILMN_2380999 RecQ helicase-like RECQL 
ILMN_2382403 Fc fragment of IgG  low affinity IIb   receptor (CD32) FCGR2B 
ILMN_2382500 membrane-spanning 4-domains  subfamily A   member 14 MS4A14 
ILMN_2383419 glucocorticoid modulatory element binding protein 1 GMEB1 
ILMN_2383516 WD repeat domain 7 WDR7 
ILMN_2384181 dehydrogenase/reductase (SDR family) member 9 DHRS9 
ILMN_2384216 5'-3' exoribonuclease 1 XRN1 
ILMN_2385647 aminolevulinate  delta-   synthase 1 ALAS1 
ILMN_2386100 BUB3 mitotic checkpoint protein BUB3 
ILMN_2386982 protein kinase C  zeta PRKCZ 
ILMN_2387078 myelin protein zero-like 2 MPZL2 
ILMN_2387452 methyl-CpG binding domain protein 2 MBD2 
ILMN_2387791 mucosa associated lymphoid tissue lymphoma 
translocation gene 1 
MALT1 
ILMN_2388090 mitogen-activated protein kinase 14 MAPK14 
ILMN_2388507 v-akt murine thymoma viral oncogene homolog 1 AKT1 
ILMN_2388547 epithelial stromal interaction 1 (breast) EPSTI1 
ILMN_2388585 golgi-associated PDZ and coiled-coil motif containing GOPC 
ILMN_2388955 family with sequence similarity 212  member B FAM212B 
ILMN_2389347 nuclear receptor subfamily 3  group C   member 1 
(glucocorticoid re 
NR3C1 
ILMN_2389582 heterogeneous nuclear ribonucleoprotein L HNRNPL 
ILMN_2389844 Sp3 transcription factor SP3 
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ILMN_2389935 forty-two-three domain containing 1 FYTTD1 
ILMN_2390114 adaptor-related protein complex 3  delta 1 subunit AP3D1 
ILMN_2390299 proteasome (prosome  macropain) subunit   beta type 8 PSMB8 
ILMN_2390310 MIR22 host gene (non-protein coding) MIR22HG 
ILMN_2390853 cathepsin H CTSH 
ILMN_2390859 nuclear factor of kappa light polypeptide gene enhancer in 
B-cells 
NFKB2 
ILMN_2391512 N-acylethanolamine acid amidase NAAA 
ILMN_2391861 Unnamed Transcript 
ILMN_2391912 SEC14-like 1 (S. cerevisiae) SEC14L1 
ILMN_2392274 CD82 molecule CD82 
ILMN_2392569 formyl peptide receptor 2 FPR2 
ILMN_2393046 NHL repeat containing 3 NHLRC3 
ILMN_2393169 THO complex 5 THOC5 
ILMN_2393712 cortactin CTTN 
ILMN_2393763 actin related protein 2/3 complex  subunit 4   20kDa ARPC4 
ILMN_2395474 REV1  polymerase (DNA directed) REV1 
ILMN_2395827 RAS guanyl releasing protein 4 RASGRP4 
ILMN_2396020 dual specificity phosphatase 6 DUSP6 
ILMN_2396410 citrate synthase CS 
ILMN_2397028 serpin peptidase inhibitor  clade B (ovalbumin)   member 8 SERPINB8 
ILMN_2397521 lysine (K)-specific demethylase 6B KDM6B 
ILMN_2398865 vacuolar protein sorting 13 homolog C (S. cerevisiae) VPS13C 
ILMN_2399140 RAB5C  member RAS oncogene family RAB5C 
ILMN_2399174 trafficking protein  kinesin binding 1 TRAK1 
ILMN_2399363 C-type lectin domain family 4  member A CLEC4A 
ILMN_2401714 membrane-spanning 4-domains  subfamily A   member 1 MS4A1 
ILMN_2401933 ATPase  Ca++ transporting   plasma membrane 1 ATP2B1 
ILMN_2402131 TAF15 RNA polymerase II  TATA box binding protein 
(TBP)-associated 
TAF15 
ILMN_2402463 serine hydroxymethyltransferase 1 (soluble) SHMT1 
ILMN_2402806 transient receptor potential cation channel  subfamily C   
member 4 
TRPC4AP 
ILMN_2403228 C-type lectin domain family 12  member A CLEC12A 
ILMN_2403237 chimerin 2 CHN2 
ILMN_2403946 fasciculation and elongation protein zeta 2 (zygin II) FEZ2 
ILMN_2403994 RALY heterogeneous nuclear ribonucleoprotein RALY 
ILMN_2404063 amyloid beta (A4) precursor protein APP 
ILMN_2404065 amyloid beta (A4) precursor protein APP 
ILMN_2404135 RIO kinase 3 RIOK3 
ILMN_2404407 4-aminobutyrate aminotransferase ABAT 
ILMN_2405129 Rho guanine nucleotide exchange factor (GEF) 1 ARHGEF1 
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ILMN_2405297 notch 2 NOTCH2 
ILMN_2406335 ankyrin repeat domain 17 ANKRD17 
ILMN_2406501 superoxide dismutase 2  mitochondrial SOD2 
ILMN_2407389 glycoprotein (transmembrane) nmb GPNMB 
ILMN_2407464 Fas-activated serine/threonine kinase FASTK 
ILMN_2408543 plasminogen activator  urokinase receptor PLAUR 
ILMN_2408851 Rho GTPase activating protein 30 ARHGAP3
0 
ILMN_2410540 caspase 2  apoptosis-related cysteine peptidase CASP2 
ILMN_2410783 glucosidase  alpha; acid GAA 
ILMN_2410826 2'-5'-oligoadenylate synthetase 1  40/46kDa OAS1 
ILMN_2410909 v-akt murine thymoma viral oncogene homolog 1 AKT1 
ILMN_2411139 fibroblast growth factor (acidic) intracellular binding 
protein 
FIBP 
ILMN_2412380 TSC22 domain family  member 1 TSC22D1 
ILMN_2412807 dynactin 1 DCTN1 
ILMN_2413527 vinculin VCL 
ILMN_2414325 tumor necrosis factor  alpha-induced protein 8 TNFAIP8 
ILMN_2414762 toll-like receptor 10 TLR10 
ILMN_2415303 C-type lectin domain family 10  member A CLEC10A 
ILMN_2415898 DnaJ (Hsp40) homolog  subfamily B   member 14 DNAJB14 
ILMN_3176989 HAUS augmin-like complex  subunit 8 HAUS8 
ILMN_3184724 cadherin-like and PC-esterase domain containing 1 CPED1 
ILMN_3193306 transmembrane protein 251 TMEM251 
ILMN_3222974 protein kinase C  beta PRKCB 
ILMN_3224926 RNA binding motif protein 47 RBM47 




ILMN_3229812 phosphatidylinositol 4-kinase  catalytic   alpha PI4KA 
ILMN_3232156 cadherin-like and PC-esterase domain containing 1 CPED1 
ILMN_3232529 phosphatidylinositol 4-kinase  catalytic   alpha pseudogene 
1 
PI4KAP1 
ILMN_3234997 MAP7 domain containing 1 MAP7D1 
ILMN_3235096 small nucleolar RNA  H/ACA box 28 SNORA28 
ILMN_3235185 small nuclear ribonucleoprotein 200kDa (U5) SNRNP20
0 
ILMN_3235514 G protein-coupled receptor 183 GPR183 
ILMN_3235922 chromosome 11 open reading frame 21 C11orf21 
ILMN_3236156 oligosaccharyltransferase complex subunit (non-catalytic) OSTC 
ILMN_3236211 DiGeorge syndrome critical region gene 11 (non-protein 
coding) 
DGCR11 
ILMN_3237177 family with sequence similarity 175  member A FAM175A 
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ILMN_3237641 adaptor-related protein complex 5  mu 1 subunit AP5M1 
ILMN_3237956 zinc finger CCCH-type containing 12C ZC3H12C 
ILMN_3238435 small nucleolar RNA  H/ACA box 12 SNORA12 
ILMN_3238560 interferon  alpha-inducible protein 27-like 2 IFI27L2 
ILMN_3238680 chromosome 7 open reading frame 55 C7orf55 
ILMN_3238955 small nucleolar RNA  C/D box 10 SNORD10 
ILMN_3239965 indoleamine 2 3-dioxygenase 1 IDO1 
ILMN_3240144 Unnamed Transcript 
ILMN_3241626 pyroglutamylated RFamide peptide receptor QRFPR 
ILMN_3242377 NACC family member 2  BEN and BTB (POZ) domain 
containing 
NACC2 
ILMN_3244319 coiled-coil domain containing 125 CCDC125 
ILMN_3245116 golgi integral membrane protein 4 GOLIM4 
ILMN_3245616 CWC22 spliceosome-associated protein CWC22 
ILMN_3246409 heterogeneous nuclear ribonucleoprotein H1 (H) HNRNPH1 
ILMN_3247018 small nucleolar RNA  H/ACA box 67 SNORA67 
ILMN_3247882 ERI1 exoribonuclease family member 3 ERI3 
ILMN_3247998 signal transducing adaptor family member 1 STAP1 
ILMN_3248890 small nucleolar RNA  H/ACA box 24 SNORA24 
ILMN_3250209 C-terminal binding protein 2 CTBP2 
ILMN_3250243 methyltransferase like 21A METTL21
A 
ILMN_3250899 Unnamed Transcript 
ILMN_3251085 retinoblastoma binding protein 4 RBBP4 
ILMN_3251137 methyltransferase like 21A METTL21
A 
ILMN_3251293 thioredoxin-related transmembrane protein 1 TMX1 
ILMN_3251506 zinc finger protein 69 ZNF69 
ILMN_3251572 family with sequence similarity 134  member A FAM134A 
ILMN_3251629 Unnamed Transcript 
ILMN_3251699 amyloid beta (A4) precursor protein-binding  family B   
member 2 
APBB2 
ILMN_3253579 HAUS augmin-like complex  subunit 8 HAUS8 
ILMN_3258795 family with sequence similarity 13  member B FAM13B 
ILMN_3269775 transmembrane protein 251 TMEM251 
ILMN_3272500 interferon  alpha-inducible protein 27-like 1 IFI27L1 
ILMN_3299520 protein kinase C  beta PRKCB 
ILMN_3299804 zinc finger protein 638 ZNF638 
ILMN_3300313 prolyl 4-hydroxylase  transmembrane (endoplasmic 
reticulum) 
P4HTM 






ILMN_3302919 Myoferlin MYOF 
ILMN_3306730 RNA binding motif protein 47 RBM47 
ILMN_3307648 citrate synthase CS 
ILMN_3308138 RNA  U4 small nuclear 2 RNU4-2 
ILMN_3308265 microRNA 302c MIR302C 






Overlapping Genes Implicated Between Conserved Transcriptional Response to 
Adversity Studies 
Antoni- Affect   






ALAS2, AVPI1, C15orf48, C3AR1, CCL20, CCL3, 
CCL3L1, CCL4L2, CCL7, CXCR7, EMP1, GJB2, 
GPR132, GPR84, HLA-A29.1, IFIT3, IFNG, IL1A, 
IL1B, IL6, LMNA, LOC651524, LYPD3, MIR155HG, 
MMP9, MXD1, OLR1, PLAUR, PTGR2, PTGS2, 
SC5DL, SERPINB2, SPSB1, THBS1, TNFRSF21, 
ZNF331 
 w/ Cole 
(Loneliness)  
FOSB, HIST1H2BG, IL1B, PTGS2  
 w/Cole 
(Rearing) 
GZMB , SERPINB2, TKTL1 




FOSB, IFIT3, IL1A, IL1B, IL6, OASL, PTGS2, TNF 
 w/ Miller 
(Caregiving 
stress) 
ACSL1, ADORA2A, AHSA1, CRISPLD2, CXCL10, 
DYNLL1, EREG, FOLR3, FOSB, HSPA1B, HSPA5, 
HSPH1, KCNJ2, PHACTR1, SERPINB2, THBS1, 
TKTL1, TNF, ZNF331 
 w/ O’Connor 
(Complicated 
Grief) 
CLIC3, CXCL10, HBD, HLA-A29.1, HLA-DRB1, HLA 
DRB5, IFIT3, IL18RAP, KIR3DS1, LOC731682, 
MYOM2, OASL, SCGB3A1 




C19orf59, CXCL10, FFAR2, GK, HBG1, HBG2, HLA-
A29.1, HLA-DRB1, HLA-DRB5, IFIT3, IL1RN, 




ACSL1, AQP9, ARL5B, AVPI1, C15orf48, C3AR1, 
CCL20, CCL3, CCL3L1, CLIC3, CRISPLD2, CXCL10, 
EMP1, EREG, ETS2, FASLG, FOSB, GJB2, GPR84, 
HBA2, HBD, HBG1, HBG2, HBM, HIST1H2BG, HLA-
DRB1, HLA-DRB5, IL1A, IL1B, IL1RN, KCNJ2, 
LRRC50, MAP3K8, MMP9, MS4A7, MXD1, NFE2L2, 
OLR1, PLA2G7, PLAUR, PTGS2, RIN2, SERPINB2, 
SOD2, THBS1, TKTL1, TNF, ZC3H12A 
 w/ Wingo 
(Anxiety 
disorder) 











 w/ Cole 
(Loneliness)  
G0S2, IFI44, IL1B, PTGS2, RGS1, STAT1, TNFSF10 
 w/Cole 
(Rearing) 
IFIT1, IFIT2, SERPINB2 




IFI44, IFI44L, IFIT1, IFIT2, IFIT3, IL1A, IL1B, IL6, 
MX2, OAS2, OAS3, PTGS2  
 w/ Miller 
(Caregiving 
stress) 
GNA15, HERC5, IFIT1, ISG15, MX2, PHLDA1, 
SERPINB2, STAT1, THBD, THBS1, TNFSF10, 
TRIM22, ZNF331 
 w/ O’Connor 
(Complicated 
Grief) 
IFI44, IFI44L, IFIT1, IFIT3 









AVPI1 , C15orf48, C3AR1, C5AR1, CCL20, CCL3, 
CCL3L1, CCL3L3, CCL4L1, CD300LB, CXCL2, 
CYP1B1, EMP1, G0S2, GJB2 
 w/ Wingo 
(Anxiety 
disorder) 






IGKC, IL8, MS4A1, PF4 




FOSB, IFI27, IFI44, IGJ, IGLL1, IL1B, IL8, OAS1, 
PTGS2 
 w/ Miller 
(Caregiving 
stress) 
ARTS-1, ATXN1, BHLHB2, BIRC1, CCR2, CDKN1C, 
FOSB, HLA-DQA1, HLA-DQB1, HLA-DRB4, IGF2R, 
IL8, LR8 
 w/ O’Connor 
(Complicated 
Grief) 
DEFA1, IFI44, MS4A1 




C21orf7, CA2, CD79B, DEFA1, HIST1H3H, IFI27, 







CD79B, DEFA1, DUSP2, EGR1, FOSB, G0S2, 
HCA112, HIST1H2BG, HIST1H3H, HLA-DQB1, IFI27, 
IL1B, IL8 
 w/ Wingo 
(Anxiety 
disorder) 








FOSL2 , GBP1, IFIT1, IFIT2, IFITM3, IL8, IRF7  
 w/ Miller 
(Caregiving 
stress) 
ARL4C, CCL5, FOSL2, GBP1, IFIT1, IL8, LILRA2, 
SERPINB2, TKTL1  
 w/ O’Connor 
(Complicated 
Grief) 
GBP1, IFIT1, MS4A1 








EGR2, IFIT1, IL8, SERPINB2, TKTL1,  TLR4  








 w/ Miller 
(Caregiving 
stress) 
FOSB, FOSL2 , GBP1, IFI16, IFI35, IFIH1, IFIT1, IL8, 
MX2, TNF  
 w/ O’Connor 
(Complicated 
Grief) 
GBP1, IFI44, IFIT1, IFIT3, MX1, OAS3, OASL  








FOSB, IFI27, IFIT1, IFITM1, IL1A, IL1B, IL8, PTGS2, 
TNF  









 w/ O’Connor 
(Complicated 
Grief) 
CXCL10, GBP1, IFIT1, RETN  




CD9, CXCL10, FZD2, IFIT1, IMPA2, LILRA2, LMO2, 




ABCA1, ACSL1, ANPEP, ATF3, BCL3, CD163, 
CDKN1A, CPVL, CRISPLD2, CXCL10, CYFIP1, 
EMR2, EREG, FER1L3, FLJ22662, FOSB, GNA15, 
GRN, HBEGF, HK3, HLA-DQB1, IFIT1, IL8, IRS2, 
ISG15, KCNJ2, KIAA0513, MAD1L1, MNDA, NKG7, 
NOTCH2, PHLDA1, PLXNC1, PRKAR1A, RAB31, 
RTN1, SERPINB2, SLC31A2,SNF1LK, THBS1, 
TIPARP, TKTL1, TNF, TNS3, VNN1  
 w/ Wingo 
(Anxiety 
disorder) 
ARFGEF1, ATP2B1, CCDC56, CD1D, CLTC, CNDP2, 
COMT, CORO1A, CSF1R, GNS, HAT1, IFIH1, LSM1, 
NEDD9, PAFAH1B1, PEX11B, PKM2, PPP2CB, 
PPP3CA, PSMA3, PSMB8, QARS, RABGAP1L, 










CAMP , CD19, CEACAM8, CXCL10, DEFA1, 
DEFA1B, DEFA3, DEFA4, E2F5, ELANE, ERAP2, 
FCRL2, GSTM1, GSTM2, HLA-A29.1, HLA-DRB1, 
HLA-DRB5, IFI44L, IFIT1, IFIT3, LCN2, LGALS2, 
LOC653600, LTF, MIAT, MS4A1, MYOM2, OSBPL10, 
PGLYRP1, RNASE3, RPS23, S100P, SNHG8, TCL1A, 




ACTA2, CAMP, CD19, CEACAM6, CEACAM8, 
CLIC3, CXCL10, DEFA1, DEFA3, DEFA4, GSTT1, 
HBD, HLA-DRB1, HLA-DRB5, HOXB2, IFIT1, 
KIR2DL1, KLRF1, LCN2, PTGDS  
 w/ Wingo 
(Anxiety 
disorder) 











ACRBP, ALPL, ASGR2, CAMP, CD19, CD24, CD33, 
CD36, CD79A, CD79B, CEACAM8, CLEC10A, 
CXCL10, DEFA1, DEFA3, DEFA4, F13A1, FCER2, 
FCGR1A, FCGR1B, FPR1, GBGT1, GNG11, GPR162, 
HBG1, HBG2, HIST1H3H, HLA-DOB, HLA-DRB1, 
HLA-DRB5, IFI27, IFIT1, IL1RN, KIAA1598, LCN2, 
LOC90925, MNDA, MS4A6A, NAPSB, PDK4, 
PRSS23, SLC31A2, VPREB3, ZNF467 
 w/ Wingo 
(Anxiety 
disorder) 






 w/ Wingo 
(Anxiety 
disorder) 
ACRBP, C5AR1, CPNE8, CSF3R, F13A1, GIMAP7, 
KLRF1, LOC283345, LOC649946, MAFB, MYC, 
PILRA, PIM3, PLAUR, PLEKHF1, PTMA, SLC1A7, 







Correlation Among Continuous Social Environmental Factors 













  0.211 0.052 -0.165 
Chronic Burden   - 0.270 -0.249 
Perceived Stress    - -0.347 





Transcripts (Genes) with p<0.05 in Aim 1 Linear Regression Analyses by Social Environmental Factor 
 
Adult SES 
Illumina Transcript ID # 
& Gene Symbol 
Chronic 
Burden 
Illumina Transcript ID # 
& Gene Symbol 
Childhood SES 
Illumina Transcript ID # 




Illumina Transcript ID # 
& Gene Symbol 
Loneliness 
Illumina Transcript ID #  
& Gene Symbol 
Perceived 
Stress 
Illumina Transcript ID 
# 
& Gene Symbol 
Social Support 
Illumina Transcript ID # 



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































SP3     





N/A     







    





REV1     







    







    







    







    







    
181 
 







    









    







    









    





N/A     









    







N/A     







    
      ILMN_3
251506 
ZNF69       
      ILMN_3
307648 
CS       




      








Transcripts (Genes) Selected via Elastic Net in Aim 1 Analyses by Social Environmental Factor 
Adult 
SES 
Illumina Transcript ID # 
& Gene Symbol 
Chronic 
Burden 
Illumina Transcript ID # 
& Gene Symbol 
Childhood 
SES 
Illumina Transcript ID # 
& Gene Symbol 
Major or Lifetime 
Discrimination 
Illumina Transcript ID # 
& Gene Symbol 
Loneliness 
Illumina Transcript ID # 
& Gene Symbol 
Social 
Support 
Illumina Transcript ID # 
































































































































































































HOOK2   
ILMN_17
03180 

































































































GNA12   
ILMN_17
79410 





























      ILMN_17
08779 
GNLY   
ILMN_17
96075 









EID2B       ILMN_17
12944 





      ILMN_17
14896 
SART3   
ILMN_18
01156 









      ILMN_17
23035 














      ILMN_17
31123 





      ILMN_17
31233 
GZMH   
ILMN_21
29927 
EXT1       ILMN_17
46317 
NUPL1   
ILMN_21
73004 














UTS2       ILMN_17
56723 














      ILMN_17
72540 





      ILMN_17
77190 





      ILMN_17
85005 





      ILMN_17
85439 
CD79B   
185 
 
        ILMN_17
89244 
SOX8   
        ILMN_17
91483 
PDE4D   
        ILMN_17
96075 
VPS41   
        ILMN_17
96642 
NCF2   
        ILMN_18
01616 
EMP1   
        ILMN_18
06023 
JUN   
        ILMN_18
11258 
RELB   





        ILMN_21
00437 
HBB   





        ILMN_21
74612 
CNOT8   





        ILMN_21
86108 
DGCR6   
        ILMN_22
26015 
LRRK2   












        ILMN_23
36130 
N/A   










        ILMN_23
52580 
MBD1   





        ILMN_23
67418 
OSCAR   
        ILMN_23
76431 
CCR2   










        ILMN_24
02463 
SHMT1   
        ILMN_24
03237 
CHN2   





        ILMN_32
51629 






























































Gene List for Each Investigated Gene Ontology Biological Processes 
Biological Process Genes in Biological Process 
Chronic Inflammation IDO1, AHCY, VNN1, THBS1, CAMP, IL1RN, CEBPB, TNFAIP3, ADORA2B, TNF, CHAMP1, 
CX3CR1, CCL5, UNC13D, IL1RN, IL1B, LTA, CX3CR1, CCL5, IDO1  
Immune Response   ZFPM1, CTNNB1, PNKD, IL4R, CCM2, SECTM1, ERCC1, IPO7, PIK3AP1, ST6GAL1, 
CLEC10A, APP, IGSF6, SIKE1, IL18BP, PTPRC, PDPK1, BCL2L1, CD1C, HMGB2, ADCY9, 
CLEC7A, RASA3, TRIM32, UNC93B1, ABR, TNFSF14, TNFAIP1, TRIM27, RGS1, DHX9, IDO1, 
DUSP5, TRIM6, CRIP1, ACTR3, RNF168, SPPL3, SPG21, SRPK2, RPS6KA5, VAV3, CFH, 
AHCY, RSAD2, MAP2K2, OAS1, KLRG1, RGCC, MRE11A, DEAF1, POLR2K, RARA, CD79A, 
TNFRSF8, SEC61A1, ISG20, FCGR2B, SPN, CLCF1, SPTBN1, IRAK3, MEF2A, MX1, FCER2, 
PPP2R3C, GPSM3, PLEKHA1, STOML2, LFNG, ELMO1, IFIT3, RPSA, SERINC3, C6orf89, 
NUB1, GPER1, CLEC4C, TUBB, CD180, RAB27A, GAB2, WASL, HLA-H, TRIM56, PSMB6, 
SP2, CRK, RBX1, CXCL8, FCGR2A, INS, ZC3HAV1, MAPK3, LPPR2, LTBR, CDC37, WIPF1, 
BATF, C1QBP, SRPK2, FOS, BCR, CNPY3, TNK2, TCF12, SH2B2, ICOS, NCR3LG1, POLR2L, 
EXOSC6, SERPING1, IRF5, PPP3CA, AGO1, CCL3, TRIM35, F12, DUSP22, PROS1, 
TNFRSF10C, TAB2, SPPL2B, OAS1, MBP, ABR, CRCP, CMKLR1, F2RL1, IFITM2, CD97, 
PAG1, CASP8, ATG12, POLR3F, OAS2, NFKBIB, KLHL7, VNN1, OASL, ZAP70, MUL1, 
CDC42, GAPT, OAS1, ICOSLG, APOBEC3C, ARRB2, LYST, NCAM1, PAK2, ADCY3, TYK2, 
RNF8, CYFIP2, PVR, DUSP6, CCL21, ANGPT1, UBE2D2, LTF, NR1H2, TRIM21, DHX58, CCR1, 
LEF1, PELI1, TRPM4, ADARB1, COL4A3BP, APOBEC3A, PAXIP1, STX4, TXN, CTSG, LIG4, 
MAP2K3, SPNS1, MYO1F, ICAM4, AIM2, SIGLEC7, RAB27A, PTPN1, BIRC3, FOXO3, OASL, 
POLR3A, PRKAR2A, RNF19B, PSMA4, FOXP1, CXCL2, PSMB10, UNG, FTH1, JAK2, BAX, 
IP6K2, HFE, CAMK2D, FKBP1A, TNFSF12, FKBP1A, WASF2, IL2RB, SAMSN1, TRAT1, 
TNFRSF1A, ITGAM, BAD, KLRF1, CBLB, NFATC3, CCL23, THBS1, DEFB1, CSF1R, MT2A, 
SIGLEC7, CRK, HLX, IL1RAP, IFI6, SNAP23, SEMA4D, ETS1, PSMC4, PIK3C3, PEBP1, 
IL27RA, TREM1, LST1, CAMP, PPP1R9B, CD27, COLEC12, UBA3, POLR2H, IL1RN, C5AR1, 
CD81, STAT1, NFKBIB, TREML1, CCR6, STAT2, DHX9, FCRLA, STAT1, JAG1, MAPKAP1, 
LAT, PSMA1, LCN2, CCM2, MYO1G, IRAK4, PHB, TBX21, CEBPB, SUSD2, CD300A, FES, 
TRIM68, LILRA6, CD34, CTSL, PTPRA, SRPK2, SEMA3C, HNRNPC, PTPN22, AGO2, LILRB2, 
CDC42, PHB2, SNX6, CTSC, CTSB, IL6R, FGF23, IFIT5, NLRP3, ANG, PRKCZ, NCF1, 
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TNFRSF14, PLA2G6, MAP2K6, PANX1, PLD2, TRIM38, LGMN, NCOR2, NLRX1, ITK, 
TNFRSF10B, IK, PPP2R5D, UBE2D2, TNFRSF21, BAIAP2, RAB27A, IL12RB1, VPREB3, 
ATP6V0A2, HLA-DOB, CLEC7A, RNF135, GBP1, SH2D1B, EHHADH, TRAF3IP2, IFIT3, 
CD300C, SNCA, DLG1, FKBP1A, RPS6KA2, CD244, TNFAIP3, SEMA4A, PSMD1, UBE2L6, 
NEDD4, PSTPIP1, ARHGEF2, AIF1, TNIP1, FCGR3A, RASA2, ADORA2B, PSMA6, PSMD13, 
MARK3, CLEC10A, ACTG1, RELA, PIK3CA, IL7, BAIAP2, FTH1, TLR4, AGO4, EIF2AK2, 
FCGR2A, ELANE, MB21D1, MAPK1, PKN2, NFATC1, NFIL3, ARPC4, IFIT1, MICB, DAPK1, 
ADAM8, IRF1, ABL1, ADM, TAB1, OAS2, MRE11A, MAPK7, RAC2, KCNN4, CD79B, BCL3, 
APOBEC3F, RC3H2, C2, SLAMF7, IFI16, PRAM1, COCH, CLEC2D, PNKD, MYB, ANKRD17, 
NLRP3, CARD9, NFKBIB, VAMP2, PRKCB, ABL1, CORO1A, SERINC3, TSC2, PTK2, PSEN2, 
TNRC6A, RASGRP4, ITGB1, NFKB1, AQP9, CCR7, HLA-DRB1, RPS6KA1, LGALS9, PIK3R4, 
PTPN22, PAQR3, BCL10, PRKCB, NLRC5, ADAMDEC1, FBXO9, CLSTN1, HLA-DRB3, 
PROCR, VAV1, PRKCE, CASP9, ATG5, PVRL2, TRIM11, TSPAN32, LST1, CD1D, MSRB1, 
WDR83, TLR10, CCL2, GMNN, IL25, MAPK14, STX11, SHC1, SAMHD1, EXOSC9, MED1, 
CARD11, DEFB123, VPS72, CDKN1B, TLR5, BST2, SIRT2, CD1A, MAP4K2, NLRX1, OTUB1, 
IFI44L, LGALS1, MAP3K14, ORAI1, IL15, SELL, LY96, CD59, PCBP2, ZC3HAV1, TICAM1, 
RASA1, UBE2D2, MOV10, RFX1, CD1B, CPAMD8, LILRA5, PIK3R2, PSME1, TNRC6B, 
AKT1S1, IKBKB, CD4, SYNCRIP, CASP1, CFI, KRAS, TNF, PSMD4, CXCL16, FCGR3B, 
NOTCH1, ZC3HAV1, CHAMP1, RNF216, SRC, TRIM27, KBTBD7, LGALS3, DUSP22, AZU1, 
MALT1, TLR1, PARP9, GZMH, PTPRJ, KLB, HIST2H2BE, PTK2B, CRHR1, MAPKAPK3, 
PSMD9, LILRB5, SEMA4D, PSMD8, C1RL, PRKCQ, SPG21, TFEB, IGF2BP1, SPPL2A, ICAM4, 
GPR65, LILRA1, NBN, CD79A, THEMIS2, ITPR2, POU2F2, CD74, TRIM28, NCKIPSD, OAS2, 
PAG1, MDM2, PLCL2, NRG1, BCL6, DDX41, PSMD14, MSH2, KYNU, MAPK14, C1QA, 
FOXP1, PIGU, CDC42, MYD88, PRKAR1A, BAD, PTPN6, TRIM26, LIF, SNX4, FOXO1, 
RNF135, MNDA, ATG9A, SIRT1, NMI, TNRC6A, CD14, PLCG1, ELMO1, PRF1, MAP3K8, 
SLC11A1, OSCAR, SERPINB9, BCL2L1, TAPBP, GRB2, MEF2C, CR1, XAF1, CLEC6A, XRCC6, 
TOX4, ERAP2, VASP, TNFAIP8L2, INPP5D, PSMB5, EP300, CLEC1B, PLSCR1, CXCL9, IFI35, 
OAS3, IRF9, CX3CR1, POLR2F, IRAK2, NRROS, SARM1, CTNNB1, KYNU, CD6, POLR1C, 
TRIM8, C5, PTAFR, ITGA4, ZP3, RNF125, PSMB8, LTB4R, MILR1, CD33, ATF2, RELT, 
PSMB3, GRB2, SNAP23, S100A12, HLA-DPB1, TLR6, ITGAL, CUL1, GPX1, TAP1, CD300E, 
RBCK1, SKAP1, TNFSF9, ADAM15, STK11, C12orf4, IFNAR1, STAT5A, PRKD2, CSK, IRF4, 
IKBKE, EIF2AK4, NFATC3, LAMTOR2, IL5RA, ST6GAL1, ADAM15, LY75, CTNNB1, 
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NCF4,TRAFD1, TSC1,TNFSF13B, PRKRA, CNIH1, FADD, SUPT6H, RNF31, CTSK, RIPK2, 
DUSP10, TAP2, P2RX7, DPP8, ARPC1A, PSMA5, NAIP, PIK3R1, TSPAN32, ANG, KLHL7, 
MRE11A, AGO3, RPS6KB2, CD74, HLA-DMB, TNFSF8, UBB, NOD2, PTPRA, HLA-F, EGR1, 
CAMK2B, STAT6, PIK3CB, RIPK3, TNFRSF1B, IFNGR2, ANKHD1, IFNAR2, HLA-E, S100A13, 
TOLLIP, IRF2, ADAM17, ZBP1, REL, SNCA, PIK3CD, BPI, PSMB8, SMAD6, SOS1, CR1, 
POLR1C, PPBP, IL10RB, POLR1D, POLR3B, BIRC2, FOXP1, CD8A, SFTPD, LAIR1, KLHL6, 
RASGRP1, MTOR, UBE2L6, CCR2, BST1, PIK3CG, RPS6KA3, PNMA1, SLCO1B1, PRKACB, 
CLEC4E, PRKCA, IL1R2, HLA-DPA1, TLR2, FRS3, ZNF395, CCL8, NFKBIA, CCL3L1, CCL5, 
CIITA, UNC13D, HRAS, GBP2, CFB, PNKD, CCR2, IL1RN, KCNH8, IL1B, CYLD, NRAS, PIN1, 
ADAR, CFD, STAT1, C1orf177, CCR2, ITGB7, TAP2, PRKCSH, ELMO2, PTPN11, HLA-B, 
BTLA, CD44, ENC1, TRIM22, CD40, GZMA, TP53, GSK3B, GAS6, PELI2, CLEC5A, OSM, 
CD83, TUBB4B, PPP2R5D, SOCS3, MAP2K7, LYN, FYN, IFIH1, PGLYRP4, GAB1, FCRLB, 
LAMP1, DUSP7, CD19, CD300LB, TAPBP, PDE4B, PIK3R6, EPRS, CD164, TRAF6, TNFSF13, 
TGFBR3, ELMO1, CCM2, VIMP, CDKN1A, CLEC2B, GNPDA1, S1PR4, GAS6, CD36, FASN, 
LILRB3, NCF4, SWAP70, SLC26A6, CD58, SOCS5, CD79B, C1QC, POLR3H, GPRC5B, CASP9, 
CD37, LILRA3, CNIH1, PSME2, ICAM2, ANKRD17, CDKN1A, GPX1, C3AR1, CASP8, TRIB3, 
C19orf10, CXCL1, UBE2D1, MAPK14, SIT1, GCH1, MLST8, GNL1, ITPR1, FER, MAP2K3, 
IFNAR2, PDE4D, CXCL10, NFAM1, RASGRP4, AIF1, STX7, CD7, DAPK3, CTSC, TAX1BP1, 
JAK1, UBA7, VAV2, RASAL3, FGR, DDX60, RNASE1, SIGLEC9, GPER1, LTA, PTGER4, CD36, 
HIST1H2BK, C1QB, PSMD3, FYB, NCF2, PSEN1, PPP3R1, DDX58, FGF18, ERCC1, TRIM5, 
LIMK1, TSC1, PRKDC, DUSP3, CASP10, IL6ST, FFAR2, KLRD1, IRF7, LLGL1, PSMB9, 
CSF2RB, GPR183, PLA2G6, FZD5, NFKB2, KLRD1, DOCK2, PPARG, HMOX1, CD55, PSMD11, 
PRKCD, BCL2, IFITM1, TNFSF10, POLR3K, APBB1IP, ATF1, APOBEC3G, BTN3A1, CRK, 
LAT2, MATK, ADA, CAPZA1, VIMP, LGALS3, FCGR2B, SPRED1, PTPRC, SMAGP, MEFV, 
SIN3A, PSME1, JUN, PRKCB, MIF, IFI30, PADI4, LY86, SNX6, FAS, HLA-DQA1, SBNO2, 
CLEC4D, PSMC3, PSEN1, XBP1, CREBBP, CAMK2G, AGO3, ARPC2, PDPK1, RELB, PML, 
NRG1, VASP, ICAM1, SHC1, GCH1, TNFRSF10B, CTSL, DUSP22, HIST1H2BK, TNFRSF9, 
IL16, CNR1,TRIM25, NR1H3, PSMB7, TICAM1, ITPR3, SERINC3, PLCG2, GAB2, IL12RB1, 
TUBB2A, F2RL1, PPP3CA, KBTBD7, PARP9, ISG15, SUGT1, PAG1, KLRF1, PSMA2, IFI27, 
SYK, FTH1, PTK6, KLRB1, IRS2, PHLPP2, ARPC1B, HLX, CX3CR1, TNFSF4, IRF2, SPTAN1, 
PSMC6, CCL5, DHX36, MAP2K4, MAP2K4, ADAMDEC1, TNFSF15, CD300LF, RNASE3, 
NOD1, GBP5, RIPK1, ADAM17, ETS1, ERAP2, FCER1G, REL, SKAP2, MAVS, FCGR3B0, 
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CD58, GBP1, ADCY4, SOCS3, GBF1, STXBP2, HLA-DRB4, HLA-A, XRCC6, MR1, GPR183, 
TNIP2, LAMP3, SAMSN1, CXCL5, PNP, IKBKB, GPI, PRELID1, LIME1, ANXA1, OAS3, 
CXCL8, VAMP8, CLEC4G, SLAMF6, CDKN1B, POLR3A, VIPR1, TREML4, C10orf54, RNASEL, 
IKBKAP, ICAM3, LEF1, PPP2R3C, HMGB2, RABGEF1, RABGEF1, HMGB1, MX2, GPR65, 
MYO10, ECSIT, CD38, UBE2D3, TSC1, BCL2, LAT2, FYN, FOXP1, LGMN, PRKCZ, PRKDC, 
TRIM34, AGER, NAIP, CD3D, CACTIN, LILRA5, MAPKAP1, IL15, CCR2, YWHAB, ERCC1, 
FYB, PSMB8, SP100, PSMC4, VAV3, TIRAP, COL4A3BP, TANK, SLC26A6, CREBBP, ANG, 
ANG, PTPN2, PTPN2, APOBEC3F, CD46, NLRP3, IRF5, EXOSC9, DPP8, NLRP1, ELMO2, 
PSMA3, MATK, FAS, CAMK2D, ADAR, BAX, TRIM4, CD3D, LAT2, IP6K2, ECM1, RAB27A, 
CNIH1, PTK2B, TNFRSF10B, PRKD2, MBP, RNASE1, PRKDC, CREB1, CREB1, IL18BP, NCF4, 
CD1E, GCH1, PVRL2, CXCR5, LILRB5, MAPK7, NCOR2, PTPRC, PDE4B, PSMD13, IL7R, 
PSMD4, PTGES2, PTGES2, LST1, IFI6, CACTIN, SOCS5, WIPF1, KL, LGALS8, CD8A, CYFIP2, 
OTUB1, CYFIP1, CYFIP1, LILRB4, LGALS8, IL1RAP, LILRA5, CAMK2G, PPP2R5D, 
MAPKAP1, MAPK8, FCAR, CD79B, OSCAR, CD40, FGR, IL32, UBA52, IL15, XAF1, TANK, 
LIG4, BTN3A3, CTSL, PRKACB, TAX1BP1, CD37, LTB, LTB, CCR2, ERCC1, CASP8, MAP3K7, 
CD74, SUMO1, FCAR, SMAGP, FYN, CRCP, FCGR2B, CREB1, TRAF3, ITGB1, GPER1, 
NFATC1, ST6GAL1, ADAM15, PRKCZ, CCR6, DEAF1, MALT1, PDPK1, MAPK14, AKT1, 
ACTR2, TSPAN32, PSMB8, SP100, CTSH, NFKB2, SLC26A6, TRAF6, ICAM4, ARPC4, 
PLEKHA1, FBXW11, PRKACA, PSMC4, ASS1, ARRB2, RASGRP4, DUSP6, HCST, KDM6B, 
PYCARD, PML, SIRT2, TNFSF13, CLEC4A, AP1G1, AP1G1, PTPN2, MAPK9, PRKCSH, 
MS4A1, DUSP10, DUSP10, MAPK3, APP, APP, PSEN2, LAT, NOTCH2, BIRC3, RBCK1, 
ANKRD17, SPTBN4, S100A13, RNF135, IL24, OAS1, AKT1, ATG9A, PTPRA, APOBEC3F, 
LGALS9, CD97, TLR10, CLSTN1, CLEC10A, CD96, IP6K2, RPS6, PRKCB, LAMTOR3, CNRIP1, 
MUL1, GPR183, RASAL3, POLR2E, IDO1, USP18, GAPT, SIGLEC14, NDUFA2, PIK3R6, 
RAPGEF2, FCGR1C, MED1, PCBP2, PCBP2, FTH1, IP6K2, PRKCB, LAMTOR3, APOBEC3D, 
PGLYRP2, ADRBK1, BTF3P11  
Inflammatory Response TPST1 , IL4R, CCM2, PIK3AP1, HMGB2, CLEC7A, ABR, STAB1, IDO1, RPS6KA5, MGLL, CFH, 
AHCY, KLRG1, DEAF1, TNFRSF8, ADRA2A, SPN, STAT3, RPSA, PTGS1, GPER1, CD180, 
CXCL8, INS, HYAL3, LTBR, C1QBP, C5AR2, FOS, BCR, SERPING1, POLG2, CCL3, F12, 
MTA1, PROS1, ABR, F2RL1, CD97, HRH1, TFRC, VNN1, SLIT2, NR1D2, CCL21, PTGS2, 
CHST1, CCR1, GART, CXCR2, MAP2K3, ALOX5, SPNS1, HIF1A, AIM2, BIRC3, FOXP1, 
CXCL2, IER3, JAK2, HFE, TNFRSF1A, ITGAM, NFATC3, CCL23, THBS1, DEFB1, CSF1R, 
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IL1RAP, RXRA, DHX8, SNAP23, ETS1, CTNNBIP1, ZNF580, CAMP, PPP1R9B, CD27, IL1RN, 
C5AR1, LTA4H, CXXC1, LAT, CCM2, PHB, CEBPB, HNRNPC, ADRB2, PHB2, SNX6, GHRL, 
IL6R, KLK1, ORM1, NLRP3, PRKCZ, NCF1, TNFRSF14, NFX1, NR1D2, NLRX1, TNFRSF21, 
CLEC7A, PLA2G7, EHHADH, ZYX, TNFAIP3, PSTPIP1, FEM1C, S1PR3, AIF1, TNIP1, 
ADORA2B, PSMA6, SEH1L, RELA, TLR4, EIF2AK2, ELANE, ADAM8, SEH1L, MAPK7, 
AOAH, C2, IFI16, NLRP3, VAMP2, NFKB1, ZNF580, CCR7, HLA-DRB1, CEBPA, LGALS9, 
NLRP12, CLSTN1, LIPA, NFRKB, NFKBIZ, TLR10, FEM1A, CCL2, IL25, MAPK14, ZFP36, 
CASP5, CD163, TLR5, OLR1, NLRX1, LXN, SETD6, IL15, LY96, CD59, TICAM1, IKBKB, 
CASP1, CFI, TNF, IL17RA, NOTCH1, CHAMP1, AZU1, TLR1, CD163, PRKCQ, THEMIS2, LIAS, 
SIGIRR, BRD4, BCL6, MAPK14, FOXP1, MYD88, MGLL, SNX4, NMI, NLRP12, CD14, FPR2, 
SLC11A1, CR1, NFX1, PLSCR1, CXCL9, CX3CR1, FOLR2, IRAK2, NRROS, CD6, C5, PTAFR, 
ZP3, ADORA1, LTB4R, RELT, SNAP23, S100A12, TLR6, MAPK13, ITGAL, GPX1, CAMK1D, 
MCPH1, HNRNPA0, STAT5A, NFATC3, RPS6KA4, APOL3, LY75, CALCRL, P2RX1, NLRP12, 
RIPK2, DUSP10, P2RX7, NAIP, ACVR1, ATRN, NOD2, HIF1A, NFKBID, ABCF1, XCR1, 
TNFRSF1B, TOLLIP, REL, B4GALT1, PIK3CD, CR1, PPBP, IL10RB, PRDX2, POLB, BIRC2, 
FOXP1, RASGRP1, ELF3, PLAA, CCR2, NFKBIZ, PIK3CG, PNMA1, BRD4, CD47, PRKCA, 
ATRN, TLR2, CCL8, CCL3L1, CCL5, CIITA, UNC13D, CFB, CCR2, IL1RN, PROK2, LTB4R2, 
IL1B, CCR2, CASP4, MMP24, CD44, CD40, KLF4, OSM, SOCS3, LYN,  HDAC9, ASH1L, CCM2, 
VIMP, FASN, TNFAIP6, GPRC5B, NOV, GPX1, C3AR1, C19orf10, CXCL1, MAPK14, IL17C, 
MAS1, METRNL, MAP2K3, NFE2L2, STK39, CXCL10, NFAM1, AIF1, GART, CHST2, RNASE1, 
GPER1, LTA, CAMK1D, PTGER4, IL6ST, ALOX5AP, FFAR2, IL17RC, NFKB2, PPARG, 
HMOX1, CD55, PRKCD, CXCR4, METRNL, HDAC9, ADA, VIMP, TUSC2, NFX1, MEFV, 
PGAP3, CELA1, MIF, NDST1, ADORA2A, LY86, SNX6, SIGIRR, FAS, KCNJ10, SBNO2, 
TSPAN2, PLA2G4C, RELB, CSRP1, ICAM1, HP, TNFRSF9, CNR1, NR1H3, PRDX5, TICAM1, 
SDC1, F2RL1,  NPY5R, SYK, ACP5, UCN, CX3CR1, TNFSF4, CCL5, NOD1, GBP5, ETS1, 
FCER1G, REL, KLF4, SOCS3, LYZ, TNIP2, CXCL5, IKBKB, ANXA1, CXCL8, TSPAN2, 
VAMP8, HMGB2, TBC1D23, RABGEF1, RABGEF1, HMGB1, FOXP1, PRKCZ, SERPINA1, 
AGER, METRNL, NAIP, IL15, CCR2, SP100, TIRAP, PTPN2, PTPN2, CD46, NLRP3, NLRP1, 
FAS, CXCR4, APOL2, APOL2, ECM1, RNASE1, MAPK7, PTGS1, MEN1, F11R, METRNL, KL, 
ATRN, IL1RAP, GBA, PRCP, CD40, IL15, ZYX, CCR2, CD163, HIF1A, SEH1L, PRDX2, GPER1, 
PRKCZ, DEAF1, MAPK14, AKT1, SP100, NFKB2, FPR2, ABCF1, LIAS, ASS1, KDM6B, 
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PYCARD, PTPN2, MS4A1, DUSP10, DUSP10, STAT3, LAT, BIRC3, F11R, IL24, HDAC9, AKT1, 
STAT3, LGALS9, CD97, TLR10, CLSTN1, IDO1, NDUFA2, EIF2AK1, PGLYRP2  
Regulation of 
Inflammatory Response 
CCM2 , PIK3AP1, ABR, IDO1, MGLL, CFH, DEAF1, SPN, RPSA, GPER1, INS, C1QBP, BCR, 
SERPING1, CCL3, F12, MTA1, PROS1, ABR, SLIT2, NR1D2, PTGS2, BIRC3, FOXP1, IER3, 
JAK2, TNFRSF1A, CCL23, ETS1, PPP1R9B, CCM2, PHB, HNRNPC, ADRB2, PHB2, SNX6, 
GHRL, NLRP3, NR1D2, NLRX1, PLA2G7, EHHADH, ZYX, TNFAIP3, FEM1C, TNIP1, 
ADORA2B, PSMA6, RELA, TLR4, ELANE, ADAM8, MAPK7, AOAH, C2, NLRP3, VAMP2, 
NFKB1, CCR7, HLA-DRB1, NLRP12, TLR10, FEM1A, MAPK14, ZFP36, CASP5, NLRX1, 
SETD6, IL15, CD59, CASP1, CFI, TNF, IL17RA, BRD4, BCL6, MAPK14, FOXP1, MYD88, 
MGLL, SNX4, NLRP12, CR1, TNFAIP8L2, CX3CR1, CD6, C5, ZP3, ADORA1, S100A12, 
MAPK13, GPX1, MCPH1, STAT5A, CALCRL, NLRP12, DUSP10, NOD2, TNFRSF1B, CR1, 
BIRC2, FOXP1, CCR2, PIK3CG, BRD4, CD47, PRKCA, TLR2, CCL3L1, CCL5, CFB, CCR2, 
IL1B, CCR2, CASP4, KLF4, OSM, SOCS3, LYN, ASH1L, CCM2, VIMP, TNFAIP6, GPRC5B, 
NOV, GPX1, MAPK14, MAS1, METRNL, STK39, CXCL10, GPER1, LTA, PTGER4, IL6ST, 
ALOX5AP, FFAR2, IL17RC, PPARG, CD55, PRKCD, METRNL, ADA, VIMP, MEFV, PGAP3, 
ADORA2A, SNX6, SBNO2, CNR1, NR1H3, NPY5R, ACP5, CX3CR1, TNFSF4, CCL5, GBP5, 
ETS1, FCER1G, KLF4, SOCS3, ANXA1, VAMP8, TBC1D23, RABGEF1, RABGEF1, FOXP1, 
AGER, METRNL, IL15, CCR2, PTPN2, PTPN2, CD46, NLRP3, NLRP1, MAPK7, METRNL, GBA, 








Overlapping Genes Between Investigated Gene Ontology Biological Processes 
Chronic Inflammation   
 Immune Response IDO1, AHCY, VNN1, THBS1, CAMP, 
IL1RN, CEBPB, TNFAIP3, ADORA2B, 
TNF, CHAMP1, CX3CR1, CCL5, 
UNC13D, IL1RN, IL1B, LTA, CX3CR1, 
CCL5, IDO1  
 Inflammatory Response IDO1, AHCY, VNN1, THBS1, CAMP, 
IL1RN, CEBPB, TNFAIP3, ADORA2B, 
TNF, CHAMP1, CX3CR1, CCL5, 
UNC13D, IL1RN, IL1B, LTA, CX3CR1, 
CCL5, IDO1  
 Regulation of the Inflammatory Response IDO1, TNFAIP3, ADORA2B, 
TNF, CX3CR1, CCL5, IL1B, 
LTA, CX3CR1, CCL5, IDO1  
Immune Response   
 Inflammatory Response IL4R, CCM2, PIK3AP1, HMGB2, 
CLEC7A, ABR, IDO1, RPS6KA5, CFH, 
AHCY, KLRG1, DEAF1, TNFRSF8, 
SPN, RPSA, GPER1, CD180, CXCL8, 
INS, LTBR, C1QBP, FOS, BCR, 
SERPING1, CCL3, F12, PROS1, ABR, 
F2RL1, CD97, VNN1, CCL21, CCR1, 
MAP2K3, SPNS1, AIM2, BIRC3, 
FOXP1, CXCL2, JAK2, HFE, 
TNFRSF1A, ITGAM, NFATC3, CCL23, 
THBS1, DEFB1, CSF1R, IL1RAP, 
SNAP23, ETS1, CAMP, PPP1R9B, 
CD27, IL1RN, C5AR1, LAT, CCM2, 
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PHB, CEBPB, HNRNPC, PHB2, SNX6, 
IL6R, NLRP3, PRKCZ, NCF1, 
TNFRSF14, NLRX1, TNFRSF21, 
CLEC7A, EHHADH, TNFAIP3, 
PSTPIP1, AIF1, TNIP1, ADORA2B, 
PSMA6, RELA, TLR4, EIF2AK2, 
ELANE, ADAM8, MAPK7, C2, IFI16, 
NLRP3, VAMP2, NFKB1, CCR7, HLA-
DRB1, LGALS9, CLSTN1, TLR10, 
CCL2, IL25, MAPK14, TLR5, NLRX1, 
IL15, LY96, CD59, TICAM1, IKBKB, 
CASP1, CFI, TNF, NOTCH1, CHAMP1, 
AZU1, TLR1, PRKCQ, THEMIS2, 
BCL6, MAPK14, FOXP1, MYD88, 
SNX4, NMI, CD14, SLC11A1, CR1, 
PLSCR1, CXCL9, CX3CR1, IRAK2, 
NRROS, CD6, C5, PTAFR, ZP3, 
LTB4R, RELT, SNAP23, S100A12, 
TLR6, ITGAL, GPX1, STAT5A, 
NFATC3, LY75, RIPK2, DUSP10, 
P2RX7, NAIP, NOD2, TNFRSF1B, 
TOLLIP, REL, PIK3CD, CR1, PPBP, 
IL10RB, BIRC2, FOXP1, RASGRP1, 
CCR2, PIK3CG, PNMA1, PRKCA, 
TLR2, CCL8, CCL3L1, CCL5, CIITA, 
UNC13D, CFB, CCR2, IL1RN, IL1B, 
CCR2, CD44, CD40, OSM, SOCS3, 
LYN, CCM2, VIMP, FASN, GPRC5B, 
GPX1, C3AR1, C19orf10, CXCL1, 
MAPK14, MAP2K3, CXCL10, NFAM1, 
AIF1, RNASE1, GPER1, LTA, PTGER4, 
IL6ST, FFAR2, NFKB2, PPARG, 
206 
 
HMOX1, CD55, PRKCD, ADA, VIMP, 
MEFV, MIF, LY86, SNX6, FAS, 
SBNO2, RELB, ICAM1, TNFRSF9, 
CNR1, NR1H3, TICAM1, F2RL1, SYK, 
CX3CR1, TNFSF4, CCL5, NOD1, 
GBP5, ETS1, FCER1G, REL, SOCS3, 
TNIP2, CXCL5, IKBKB, ANXA1, 
CXCL8, VAMP8, HMGB2, RABGEF1, 
RABGEF1, HMGB1, FOXP1, PRKCZ, 
AGER, NAIP, IL15, CCR2, SP100, 
TIRAP, PTPN2, PTPN2, CD46, NLRP3, 
NLRP1, FAS, ECM1, RNASE1, 
MAPK7, KL, IL1RAP, CD40, IL15, 
CCR2, GPER1, PRKCZ, DEAF1, 
MAPK14, AKT1, SP100, NFKB2, ASS1, 
KDM6B, PYCARD, PTPN2, MS4A1, 
DUSP10, DUSP10, LAT, BIRC3, IL24, 
AKT1, LGALS9, CD97, TLR10, 
CLSTN1, IDO1, NDUFA2, PGLYRP2
  
 Regulation of the Inflammatory Response CCM2, PIK3AP1, ABR, IDO1, CFH, 
DEAF1, SPN, RPSA, GPER1, INS, 
C1QBP, BCR, SERPING1, CCL3, F12, 
PROS1, ABR, BIRC3, FOXP1, JAK2, 
TNFRSF1A, CCL23, ETS1, PPP1R9B, 
CCM2, PHB, HNRNPC, PHB2, SNX6, 
NLRP3, NLRX1, EHHADH, TNFAIP3, 
TNIP1, ADORA2B, PSMA6, RELA, 
TLR4, ELANE, ADAM8, MAPK7, C2, 
NLRP3, VAMP2, NFKB1, CCR7, HLA-
DRB1, TLR10, MAPK14, NLRX1, IL15, 
CD59, CASP1, CFI, TNF, BCL6, 
207 
 
MAPK14, FOXP1, MYD88, SNX4, CR1, 
TNFAIP8L2, CX3CR1, CD6, C5, ZP3, 
S100A12, GPX1, STAT5A, DUSP10, 
NOD2, TNFRSF1B, CR1, BIRC2, 
FOXP1, CCR2, PIK3CG, PRKCA, 
TLR2, CCL3L1, CCL5, CFB, CCR2, 
IL1B, CCR2, OSM, SOCS3, LYN, 
CCM2, VIMP, GPRC5B, GPX1, 
MAPK14, CXCL10, GPER1, LTA, 
PTGER4, IL6ST, FFAR2, PPARG, 
CD55, PRKCD, ADA, VIMP, MEFV, 
SNX6, SBNO2, CNR1, NR1H3, 
CX3CR1, TNFSF4, CCL5, GBP5, ETS1, 
FCER1G, SOCS3, ANXA1, VAMP8, 
RABGEF1, RABGEF1, FOXP1, AGER, 
IL15, CCR2, PTPN2, PTPN2, CD46, 
NLRP3, NLRP1, MAPK7, IL15, CCR2, 
GPER1, DEAF1, MAPK14, PTPN2, 
DUSP10, DUSP10, BIRC3, TLR10, 
IDO1, PGLYRP2  
Inflammatory Response   
 Regulation of the Inflammatory Response CCM2, PIK3AP1, ABR, IDO1, MGLL, 
CFH, DEAF1, SPN, RPSA, GPER1, INS, 
C1QBP, BCR, SERPING1, CCL3, F12, 
MTA1, PROS1, ABR, SLIT2, NR1D2, 
PTGS2, BIRC3, FOXP1, IER3, JAK2, 
TNFRSF1A, CCL23, ETS1, PPP1R9B, 
CCM2, PHB, HNRNPC, ADRB2, PHB2, 
SNX6, GHRL, NLRP3, NR1D2, NLRX1, 
PLA2G7, EHHADH, ZYX, TNFAIP3, 
FEM1C, TNIP1, ADORA2B, PSMA6, 
RELA, TLR4, ELANE, ADAM8, 
208 
 
MAPK7, AOAH, C2, NLRP3, VAMP2, 
NFKB1, CCR7, HLA-DRB1, NLRP12, 
TLR10, FEM1A, MAPK14, ZFP36, 
CASP5, NLRX1, SETD6, IL15, CD59, 
CASP1, CFI, TNF, IL17RA, BRD4, 
BCL6, MAPK14, FOXP1, MYD88, 
MGLL, SNX4, NLRP12, CR1, CX3CR1, 
CD6, C5, ZP3, ADORA1, S100A12, 
MAPK13, GPX1, MCPH1, STAT5A, 
CALCRL, NLRP12, DUSP10, NOD2, 
TNFRSF1B, CR1, BIRC2, FOXP1, 
CCR2, PIK3CG, BRD4, CD47, PRKCA, 
TLR2, CCL3L1, CCL5, CFB, CCR2, 
IL1B, CCR2, CASP4, KLF4, OSM, 
SOCS3, LYN, ASH1L, CCM2, VIMP, 
TNFAIP6, GPRC5B, NOV, GPX1, 
MAPK14, MAS1, METRNL, STK39, 
CXCL10, GPER1, LTA, PTGER4, 
IL6ST, ALOX5AP, FFAR2, IL17RC, 
PPARG, CD55, PRKCD, METRNL, 
ADA, VIMP, MEFV, PGAP3, 
ADORA2A, SNX6, SBNO2, CNR1, 
NR1H3, NPY5R, ACP5, CX3CR1, 
TNFSF4, CCL5, GBP5, ETS1, FCER1G, 
KLF4, SOCS3, ANXA1, VAMP8, 
TBC1D23, RABGEF1, RABGEF1, 
FOXP1, AGER, METRNL, IL15, CCR2, 
PTPN2, PTPN2, CD46, NLRP3, NLRP1, 
MAPK7, METRNL, GBA, IL15, ZYX, 
CCR2, GPER1, DEAF1, MAPK14, 
PTPN2, DUSP10, DUSP10, BIRC3, 
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  ILMN_1779
558 GAS6 
      
  ILMN_1780
465 CLEC5A 
      
  ILMN_1780
546 OSM 
      
  ILMN_1781
001 SOCS3 
      
  ILMN_1781
155 LYN 





      
  ILMN_1782
292 LAMP1 
      
  ILMN_1783
695 EPRS 
      
  ILMN_1784
871 FASN 
      
  ILMN_1785
175 SWAP70 
      
  ILMN_1786
024 POLR3H 





      
  ILMN_1798
706 GPR183 
      
  ILMN_1799
062 NFKB2 
      
  ILMN_1799
725 DOCK2 
      
  ILMN_1800
540 CD55 
      
  ILMN_1801
105 PRKCD 
      
  ILMN_1804
277 SPRED1 
      
  ILMN_1804
279 PTPRC 
      
  ILMN_1805
996 SIN3A 
      
  ILMN_1806
023 JUN 





      
  ILMN_1808
979 CLEC4D 
      
  ILMN_1812
001 VASP 
      
  ILMN_2055
781 KLRF1 
      
  ILMN_2079
655 KLRB1 
      
  ILMN_2088
437 CX3CR1 
      
  ILMN_2184
373 CXCL8 
      
  ILMN_2211
189 IKBKAP 





      
  ILMN_2246
510 TSC1 
      
  ILMN_2307
744 CD46 
      
  ILMN_2313
079 NLRP1 
      
  ILMN_2331
544 MBP 
      
  ILMN_2340
217 PTPRC 
      
  ILMN_2340
259 PDE4B 
      
  ILMN_2350
970 SOCS5 





      
  ILMN_2379
967 FCAR 
      
  ILMN_2383
934 ITGB1 
      
  ILMN_2384
188 NFATC1 
      
  ILMN_2390
859 NFKB2 
      
  ILMN_2399
622 AP1G1 
      
  ILMN_2404
063 APP 





      
  ILMN_2411
794 PTPRA 
      
  ILMN_2412
214 LGALS9 
      
  ILMN_3238
803 RASAL3 
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  ILMN_17
31233 GZMH 







        
  ILMN_17
38675 PTPN6 





        
  ILMN_17
46704 TRIM8 
        
  ILMN_17
47251 LTB4R 
        
  ILMN_17
48797 GRB2 





        
  ILMN_17
49591 ITGAL 





        
  ILMN_17
54121 CSK 
        
  ILMN_17
54507 IRF4 










        
  ILMN_17
58939 RIPK2 

























        
  ILMN_17
66165 SNCA 





        
  ILMN_17
68194 BIRC2 
        
  ILMN_17
68598 LAIR1 










        
  ILMN_17
77519 ITGB7 





        
  ILMN_17
79324 GZMA 
        
  ILMN_17
79558 GAS6 





        
  ILMN_17
80546 OSM 
        
  ILMN_17
81001 SOCS3 





        
  ILMN_17
81207 FYN 





        
  ILMN_17
83695 EPRS 
        
  ILMN_17
84871 FASN 






























        
  ILMN_18
00540 CD55 










        
  ILMN_18
04279 PTPRC 
        
  ILMN_18
05996 SIN3A 





        
  ILMN_18
07277 IFI30 





        
  ILMN_18
12001 VASP 
        
  ILMN_20
55781 KLRF1 

























        
  ILMN_22
46510 TSC1 
        
  ILMN_23
07744 CD46 
        
  ILMN_23
13079 NLRP1 
        
  ILMN_23
31544 MBP 
        
  ILMN_23
40217 PTPRC 
        
  ILMN_23
40259 PDE4B 





        
  ILMN_23
65091 FCAR 
        
  ILMN_23
79967 FCAR 
        
  ILMN_23
83934 ITGB1 










        
  ILMN_23
99622 AP1G1 
        
  ILMN_24
04063 APP 









































































































Genes with Racial/Ethnic Differences by Biological Process 
Race/ethnic comparison Biological Process Genes 
Black/White   
 Chronic Inflammation AHCY , VNN1, THBS1, IL1RN, CEBPB, 
ADORA2B, TNF, CX3CR1, CCL5, IL1RN , 
IL1B, LTA, CX3CR1, CCL5  
 Immune Response PNKD, IL4R, PIK3AP1, HMGB2, ADCY9, 
RASA3, TNFSF14, DUSP5, CRIP1, AHCY, 
OAS1, RGCC, RARA, CD79A, SPN, 
CLCF1, IRAK3, FCER2, PPP2R3C, 
PLEKHA1, STOML2, LFNG, CLEC4C, 
CD180, FCGR2A, MAPK3, C1QBP, 
EXOSC6, IRF5, CCL3, DUSP22, OAS1, 
F2RL1, IFITM2, CD97, 
PAG1, CASP8, VNN1, OAS1, NCAM1, 
ADCY3, CYFIP2, DUSP6, NR1H2, 
TRIM21, DHX58, TRPM4, ADARB1, 
COL4A3BP, TXN, CTSG, SPNS1, 
SIGLEC7, PTPN1, POLR3A, FOXP1, 
PSMB10, FTH1, HFE, TNFSF12, FKBP1A, 
ITGAM, THBS1, DEFB1, CSF1R , MT2A, 
SIGLEC7, ETS1, PEBP1, TREM1, CD81, 
STAT1, CCR6, FCRLA, STAT1, CCM2, 
CEBPB, FES, 
TRIM68, CTSL, AGO2, CTSB, NLRP3, 
MAP2K6, TNFRSF10, TNFRSF21, 
VPREB3, RNF135, SH2D1B, EHHADH, 
CD300C, RPS6KA2, PSMD1, UBE2L6, 
238 
 
NEDD4, AIF1, RASA2, ADORA2B, 
PSMA6, MARK3, FTH1, TLR4, ELANE, 
NFATC1, ADM, RAC2, CD79B, MYB, 
NLRP3, PRKCB, PTK2, ITGB1, CCR7, 
PAQR3, TSPAN32, LST1, CD1D, MSRB1, 
CCL2, VPS72, TLR5, SIRT2, CD1A, 
MAP4K2, OTUB1, LGALS1, SELL, 
RASA1, CD1B, CPAMD8, CD4, KRAS, 
TNF, PSMD4, CXCL16, FCGR3B, SRC, 
TRIM27, LGALS3, DUSP22, PTPRJ, 
PSMD9, SEMA4D, LILRA1, NBN, CD79A, 
THEMIS2, POU2F2, PAG1, BCL6, 
DDX41,MYD88, FOXO1, RNF135, ELMO1, 
PRF1, MAP3K8, CLEC6A, TNFAIP8L, 
PSMB5, PLSCR1, OAS3, IRF9, CX3CR1, 
POLR2F, IRAK2, NRROS, CTNNB1, 
POLR1C, TRIM8, C5, RNF125, LTB4R, 
MILR1, CD33, ATF2, 
HLA-DPB1, GPX1, SKAP1, C12orf4, CSK, 
IRF4, IKBKE, LAMTOR2, ST6GAL1, 
LY75, CTNNB1, TNFSF13B, DPP8, 
PSMA5, PIK3R1, TSPAN32, CD74, HLA-
DMB, TNFSF8, STAT6, RIPK3, IFNGR2, 
S100A13, ADAM17, BPI, SOS1, POLR1D, 
POLR3B, SFTPD, RASGRP1, CCR2, 
PIK3CG, RPS6KA3, PNMA1, HLA-DPA1, 
CCL3L1, HRAS, PNKD, CCR2, IL1RN, 
IL1B, CFD, CCR2, ITGB7, ELMO2, CD40, 
PELI2, CLEC5A, CD83, LYN, FYN, 
DUSP7, CD19, CCM2, CDKN1A, CD36, 
NCF4, SWAP70, CD79B, LILRA3, 
CDKN1A, CASP8, TRIB3, MLST8, GNL1, 
239 
 
AIF1, CD7, VAV2, RNASE1, SIGLEC9, 
GPER1, LTA, PTGER4, CD36, HIST1H2B, 
PPP3R1, ERCC1, IL6ST, FFAR2, KLRD1, 
GPR183, KLRD1, HMOX1, BTN3A1, 
LAT2, ADA, SPRED1, PTPRC, SMAGP, 
SIN3A, PSME1, JUN, LY86, CLEC4D, 
XBP1, RELB, TNFRSF10, CTSL, DUSP22, 
HIST1H2B, TNFRSF9, IL16, TRIM25, 
NR1H3, PSMB7, F2RL1, PAG1, IFI27, 
SYK, FTH1, PHLPP2, SPTAN1, TNFSF15, 
CD300LF, RNASE3, NOD1, GBP5, 
ADAM17, ETS1, ERAP2, SKAP2, STXBP2, 
HLA-DRB4, GPR183, CXCL5, PRELID1, 
ANXA1, VAMP8, CLEC4G, SLAMF6, 
TREML4, RNASEL, ICAM3, HMGB2, 
MYO10, ECSIT, LAT2,FOXP1, LGMN, 
TRIM34, CD3D, CCR2, YWHAB, ERCC1, 
COL4A3BP, APOBEC3F, NLRP3, IRF5, 
ELMO2, PSMA3, TRIM4, CD3D, LAT2, 
RAB27A, TNFRSF10, RNASE1, CREB1, 
IL18BP, NCF4, CXCR5, LILRB5, PDE4B, 
IL7R, PSMD4, PTGES2, PTGES2, SOCS5, 
KL, LGALS8, CYFIP2, OTUB1, LGALS8, 
CD79B, CD40, IL32, UBA52, XAF1, 
BTN3A3, CTSL, PRKACB, CD37, LTB, 
LTB, CCR2 ERCC1,CASP8, SMAGP, 
CRCP, ITGB1, GPER1, NFATC1, PRKCZ, 
TSPAN32, PLEKHA1, ASS1, PYCARD, 
CLEC4A, DUSP10, MAPK3, S100A13, 
RNF135, CD97, CD96, CNRIP1, SIGLEC14, 




 Inflammatory Response IL4R, PIK3AP1, HMGB2, AHCY, SPN, 
CD180 , HYAL3, C1QBP, POLG2, CCL3, 
F2RL1, CD97, VNN1,CCR1, GART, 
CXCR2, SPNS1, FOXP1, HFE, ITGAM, 
THBS1, DEFB1, CSF1R, ETS1, LTA4H, 
CCM2, CEBPB, ADRB2, GHRL, ORM1, 
NLRP3, NR1D2, TNFRSF21, PLA2G7, 
EHHADH, AIF1, ADORA2B, PSMA6, 
TLR4, ELANE, NLRP3, NFKB1, CCR7, 
NFKBIZ, CCL2, ZFP36, CASP5, TLR5, 
LXN, TNF, THEMIS2, BCL6, FOXP1, 
MYD88, PLSCR1, CX3CR1, IRAK2, 
NRROS, C5, ADORA1, LTB4R, SNAP23, 
S100A12, GPX1, CAMK1D, MCPH1, 
APOL3, LY75, CALCRL, P2RX1, ACVR1, 
B4GALT1, PRDX2, POLB, RASGRP1, 
ELF3, CCR2, NFKBIZ, PIK3CG, PNMA1, 
CD47, CCL3L1, CCR2, IL1RN, PROK2, 
IL1B, CCR2, CD40, KLF4, LYN, CCM2, 
TNFAIP6, NOV, METRNL, STK39, AIF1, 
GART, RNASE1, GPER1, LTA, CAMK1D, 
PTGER4, IL6ST, FFAR2, HMOX1, 
METRNL, ADA, NDST1, LY86, SIGIRR, 
TSPAN2, PLA2G4C, RELB, HP, TNFRSF9, 
NR1H3, F2RL1, SYK, CX3CR1, NOD1, 
GBP5, ETS1, KLF4, LYZ, CXCL5, ANXA1, 
VAMP8, HMGB2, FOXP1, METRNL, 
CCR2, NLRP3, APOL2, RNASE1, 
METRNL, KL, ATRN, CD40, tCCR2, 
HIF1A, SEH1L, PRDX2, GPER1, PRKCZ, 




 Regulation of the Inflammatory Response PIK3AP1, SPN, C1QBP, CCL3, FOXP1, 
ETS1, CCM2, ADRB2, GHRL, NLRP3, 
NR1D2, PLA2G7, EHHADH, ADORA2B, 
PSMA6, TLR4, ELANE, NLRP3, NFKB1, 
CCR7, ZFP36, CASP5, TNF, BCL6, 
MAPK14, FOXP1, MYD88, TNFAIP8L, 
CX3CR1, CD6, C5, ADORA1, S100A12, 
GPX1, MCPH1, CALCRL, CCR2, PIK3CG, 
CD47, CCL3L1, CCL5, CCR2, IL1B, CCR2, 
KLF4, LYN, CCM2, TNFAIP6, NOV, 
METRNL, STK39, GPER1, LTA, PTGER4, 
IL6ST, FFAR2, METRNL, ADA, NR1H3, 
CX3CR1, CCL5, GBP5, ETS1, KLF4, 
ANXA1, VAMP8, FOXP1, METRNL, 
CCR2, NLRP3, METRNL, CCR2, GPER1, 
DUSP10 
Black/Hispanic Chronic Inflammation AHCY, VNN1, TNFAIP3, TNF, CX3CR1, 
CCL5, IL1B, LTA, CCL5 
 Immune Response PNKD, IL4R, RGS1, DUSP5, CRIP1, 
RPS6KA5, OAS1, RGCC, SPN, CLCF1, 
SPTBN1, IRAK3, FCER2, PLEKHA1, 
LFNG, CD180, CXCL8, MAPK3, BATF, 
EXOSC6, DUSP22, OAS1, F2RL1, VNN1, 
GAPT, OAS1, ADCY3, CYFIP2, LEF1, 
TRPM4, ADARB1, CTSG, SPNS1, ICAM4, 
IP6K2, HFE, TRAT1, DEFB1, SIGLEC7, 
ETS1, CD27, CCM2, FES, TRIM68, NLRP3, 
MAP2K6, ITK, TNFRSF10, RNF135, 
SH2D1B, CD300C, RPS6KA2, TNFAIP3, 
PSMD1, CLEC10A, PKN2, NFATC1, 
NFIL3, IRF1, ABL1, RAC2, CD79B, 
NLRP3, CORO1A, ITGB1, CCR7, 
242 
 
TSPAN32, CD1D, CCL2, EXOSC9, 
CDKN1B, TLR5, BST2, SIRT2, MAP4K2, 
OTUB1, CPAMD8, LILRA5, TNF, CXCL16, 
FCGR3B, SRC, LGALS3, HIST2H2B, 
MAPKAPK3, PSMD9, NBN, THEMIS2, 
TRIM28, PAG1, BCL6, RNF135, OSCAR, 
CLEC6A, PSMB5, CD6, C5, CD33, HLA-
DPB1, RBCK1, SKAP1, CSK, IRF4, IKBKE, 
EIF2AK4, LY75, PRKRA, P2RX7, NAIP, 
EGR1, IFNGR2, IFNAR2, SOS1, POLR1D, 
CD8A, SFTPD, RASGRP1, CCR2, BST1,  
PNMA1, HLA-DPA1, CCL5, HRAS, PNKD, 
CCR2, IL1B, PIN1, CFD, CCR2, ELMO2, 
CD44, GZMA, OSM, TUBB4B, SOCS3, 
LYN, PDE4B, CCM2, S1PR4, CD36, 
CD79B, LILRA3, CDKN1A, TRIB3, GNL1, 
CD7, RNASE1, SIGLEC9, GPER1, LTA, 
CD36, HIST1H2B, PPP3R1, FFAR2, 
PPARG, HMOX1, IFITM1, LAT2, ADA, 
SMAGP, JUN, MIF, PADI4, CTSL, 
DUSP22, HIST1H2B, TNFRSF9, NR1H3, 
F2RL1, PAG1, KLRB1, ARPC1B, CCL5, 
RNASE3, ETS1, STXBP2, HLA-DRB4, 
GPR183, CXCL5, PRELID1, LIME1, 
CXCL8, CLEC4G, CDKN1B, TREML4, 
LEF1, FYN, NAIP, CD3D, CCR2, YWHAB, 
PSMC4, APOBEC3F, NLRP3, TRIM4, 
CD3D, LAT2, RNASE1, CREB1, PDE4B, 
IL7R, CD8A, CYFIP2, OTUB1, LILRA5, 
CD79B, IL32, BTN3A3, CTSL, LTB, LTB, 
CCR2, SMAGP, CRCP, ITGB1, GPER1, 
CCR6, TSPAN32, ICAM4, TNFSF13, 
243 
 
CLEC4A, AP1G1, AP1G1, BIRC3, RNF135, 
CD96, IP6K2, GAPT, MED1, IP6K2, 
PGLYRP2  
 Inflammatory Response IL4R, RPS6KA5, SPN, CD180, CXCL8, 
HYAL3, F2RL1, VNN1, PTGS2, SPNS1, 
HIF1A, HFE, DEFB1, ETS1, CD27, LTA4H, 
CCM2, NLRP3, NR1D2, PLA2G7, 
EHHADH, TNFAIP3, ELANE, NLRP3, 
CCR7, CCL2, CASP5, TLR5, LXN,TNF, 
THEMIS2, BCL6, NLRP12, CD6, C5, 
ADORA1, MCPH1, APOL3, LY75, RIPK2, 
P2RX7, NAIP, HIF1A, PRDX2, POLB, 
RASGRP1, CCR2, PNMA1, CD47, CCL5, 
CCR2, PROK2, IL1B, CCR2, CD44, OSM, 
SOCS3, LYN, CCM2, MAP2K3, NFE2L2, 
RNASE1, GPER1, LTA, FFAR2, PPARG, 
HMOX1, CXCR4, ADA, MIF, TSPAN2, 
PLA2G4C, HP, TNFRSF9, NR1H3, PRDX5, 
F2RL1, CCL5, ETS1, CXCL5, CXCL8, 
TSPAN2, NAIP, CCR2 ,NLRP3, CXCR4, 
RNASE1, CCR2, HIF1A, SEH1L, PRDX2, 
GPER1, DUSP10, BIRC3, PGLYRP2 
 Regulation of the Inflammatory Response SPN, RPSA, F12, PTGS2, ETS1, CCM2, 
NLRP3, NR1D2, PLA2G7, EHHADH, 
TNFAIP3, ELANE, NLRP3, CCR7, CASP5, 
TNF, BCL6, MYD88, NLRP12, CD6, C5, 
ADORA1, MCPH1, CCR2, CD47, CCL5, 
CCR2, IL1B, CCR2, OSM, SOCS3, LYN, 
CCM2, GPX1, GPER1, LTA, FFAR2, 
PPARG, ADA, NR1H3, CCL5, ETS1, CCR2, 




Hispanic/White Chronic Inflammation AHCY, VNN1, THBS1, CAMP, CEBPB, 
TNFAIP3, ADORA2B, TNF  
 Immune Response CLEC10A, HMGB2, ADCY9, ABR, 
TNFSF14, RGS1, CRIP1, RPS6KA5, AHCY, 
RGCC, CD79A, STOML2, CD180, WASL, 
CRK, RBX1, CXCL8, C1QBP, FOS, IRF5, 
CCL3, CD97, PAG1, POLR3F, VNN1, 
NCAM1, PAK2, CCR1, LEF1, TRPM4, 
COL4A3BP, TXN, BIRC3, FOXO3, 
POLR3A, CXCL2, PSMB10, FTH1, JAK2, 
CAMK2D, TNFSF12, TRAT1, TNFRSF1A, 
CBLB, NFATC3, SIGLEC7, IFI6, PEBP1, 
TREM1, LST1, C5AR1, NFKBIB, FCRLA, 
PHB, CEBPB, AGO2, PHB2, TRIM38, 
LGMN, IK, TNFRSF21, RNF135, CD300C, 
RPS6KA2, CD244, PSMD1, AIF1, RASA2, 
ADORA2B, MARK, FTH1, PKN2, NFIL3, 
ARPC4, MAPK7, CD79B, BCL3, PNKD, 
MYB, TNRC6A, ITGB1, PAQR3, LST1, 
CD1D, MSRB1, EXOSC9, VPS72, 
CDKN1B, BST2, LGALS1, SELL, RASA1, 
KRAS, PSMD4, HIST2H2B, SEMA4D, 
PSMD8, LILRA1, CD79A, THEMIS2, 
POU2F2, PAG1, BCL6, DDX41, FOXP1, 
FOXO1, RNF135, MNDA, SIRT1, MAP3K8, 
TNFAIP8L ,EP300, POLR2F, IRAK2, 
NRROS, CTNNB1, POLR1C, RNF125, 
MILR1, PSMB3, HLA-DPB1, ADAM15, 
IRF4, EIF2AK4, LAMTOR2, ST6GAL1, 
CTNNB1, DPP8, ARPC1A, PSMA5, NAIP, 
PIK3R1, TSPAN32, HLA-DMB, UBB, 
PIK3CB, IFNGR2, S100A13, REL, BPI, 
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SOS1, BIRC2, BST1, PIK3CG, PNMA1, 
NFKBIA, CCL3L1, PNKD, PIN1, CCR2, 
ITGB7, CD44, CD40, PELI2, OSM, CD83, 
SOCS3, CD19, TRAF6, CDKN1A, SWAP70, 
SOCS5, CD79B, POLR3H, GPX1, C19orf10, 
MLST8, FER, IFNAR2, AIF1, RNASE1, 
PTGER4, CD36, NCF2, PPP3R1, FFAR2, 
GPR183, POLR3K, LAT2, VIMP, PTPRC, 
SMAGP ,SIN3A, PSME1, LY86, CLEC4D, 
PSMC3, XBP1, AGO3, TNFRSF10, CTSL, 
TNFRSF9, IL16, NR1H3, PSMB7, IL12RB1, 
ISG15, PAG1, PSMA2, PHLPP2, TNFSF15, 
CD300LF, NOD1, ADAM17, ERAP2, REL, 
SOCS3, MR1, GPR183, GPI, PRELID1, 
CXCL8, CLEC4G, SLAMF6, CDKN1B, 
POLR3A, ICAM3, LEF1, ECSIT, FYN, 
LGMN, TRIM34, NAIP, CD3D, ERCC1, 
COL4A3BP, EXOSC9, DPP8, PSMA3, 
CAMK2D, CD3D, LAT2, RAB27A, 
TNFRSF10, RNASE1, CREB1, CREB1, 
IL18BP, NCF4, MAPK7, PDE4B, PSMD13, 
PSMD4, PTGES2, LST1, WIPF1, KL, 
LGALS8, CYFIP1, CYFIP1, LGALS8, 
CD79B, CD40, UBA52, XAF1, BTN3A3, 
CTSL, PRKACB, ERCC1, CASP8, SMAGP, 
CRCP, ITGB1, PRKCZ, CCR6, ARPC4, 
PLEKHA1, FBXW11, DUSP6, PYCARD, 
MAPK3, BIRC3, RBCK1, RNF135, CD97, 
CLEC10A, IP6K2, RPS6, GPR183, 
NDUFA2, FTH1  
 Inflammatory Response HMGB2, ABR, RPS6KA5, AHCY, CD180, 
CXCL8, HYAL3, C1QBP, FOS, CCL3, 
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CD97, VNN1, PTGS2, CCR1, CXCR2, 
BIRC3, FOXP1, CXCL2, JAK2, TNFRSF1A, 
NFATC3, THBS1, C5AR1, PHB, CEBPB, 
PHB2, GHRL, ORM1, TNFRSF21, PLA2G7, 
AIF1, ADORA2B, MAPK7, NFKB1, 
CEBPA, NFKBIZ, ZFP36, OLR1, THEMIS2, 
LIAS, BCL6, FOXP1, NLRP12, CD14, 
IRAK2, NRROS, CAMK1D, MCPH1, 
APOL3, P2RX1, NAIP, ACVR1, REL, 
PIK3CD, PRDX2, POLB, BIRC2, PIK3CG, 
PNMA1, ATRN, CCL3L1, CCR2, CD44, 
CD40, KLF4, OSM, SOCS3, FASN, 
TNFAIP6, NOV, GPX1, C19orf10, 
METRNL, NFE2L2, STK39, AIF1, GART,  
RNASE1, CAMK1D, PTGER4, FFAR2, 
CXCR4, VIMP, TUSC2, NDST1, LY86, 
SIGIRR, PLA2G4C, TNFRSF9, NR1H3, 
PRDX5, NOD1, REL, KLF4, SOCS3, LYZ, 
CXCL8, NAIP, CXCR4, RNASE1, MAPK7, 
METRNL, KL, ATRN, CD40, PRDX2, 
PRKCZ, PYCARD, BIRC3, F11R, CD97, 
NDUFA2  
 Regulation of the Inflammatory Response ABR, C1QBP, CCL3, PTGS2, BIRC3, 
FOXP1, JAK2, TNFRSF1A, PHB, PHB2, 
GHRL, PLA2G7, TNFAIP3, ADORA2B, 
MAPK7, NFKB1, ZFP36, BCL6, FOXP1, 
NLRP12, TNFAIP8L, ADORA1, MCPH1, 
CALCRL, BIRC2, PIK3CG, CCL3L1, 
CCR2, KLF4, OSM, SOCS3, TNFAIP6, 
NOV, GPX1, METRNL, STK39, PTGER4, 
FFAR2, VIMP, NR1H3, KLF4, SOCS3, 





Overlapping Genes Significantly Associated with at Least Two Race/Ethnic Comparisons by Biological Process  
Biological Process Racial/Ethnic Comparisons Genes 
Chronic Inflammation   
 Black/White – Hispanic White AHCY, VNN1, THBS1, CEBPB, 
ADORA2B, TNF 
 Black/White - Black/Hispanic AHCY, VNN1, TNF, CX3CR1, CCL5, 
IL1B, LTA, CCL5 
 Black/Hispanic - Hispanic/White AHCY , VNN1, TNFAIP3, TNF 
 All AHCY, VNN1, TNF 
Immune Response   
 Black/White – Hispanic White HMGB2, ADCY9, TNFSF14, CRIP1, 
AHCY, RGCC, CD79A, STOML2, 
CD180, C1QBP, IRF5, CCL3, CD97, 
PAG1, VNN1, NCAM1, TRPM4, 
COL4A3B, TXN, POLR3A, PSMB10, 
FTH1, TNFSF12, SIGLEC7, PEBP1, 
TREM1, FCRLA, CEBPB, AGO2, 
TNFRSF2, RNF135, CD300C, 
RPS6KA2, PSMD1, AIF1, RASA2, 
ADORA2B, MARK3, FTH1, CD79B, 
MYB, ITGB1, PAQR3, LST1, CD1D, 
MSRB1, VPS72, LGALS1, SELL, 
RASA1, KRAS, PSMD4, SEMA4D, 
LILRA1, CD79A, THEMIS2, POU2F2, 
PAG1, BCL6, DDX41, FOXO1, 
RNF135, MAP3K8, TNFAIP8, POLR2F, 
IRAK2, NRROS, CTNNB1, POLR1C, 
RNF125, MILR1, HLA-DPB, IRF4, 
LAMTOR2, ST6GAL1, CTNNB1, 
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DPP8, PSMA5, PIK3R1, TSPAN32, 
HLA-DMB, IFNGR2, S100A13, BPI, 
SOS1, PIK3CG, PNMA1, CCL3L1, 
PNKD, CCR2, ITGB7, CD40, PELI2, 
CD83, CD19, CDKN1A, SWAP70, 
CD79B, MLST8, AIF1, RNASE1, 
PTGER4, CD36, PPP3R1, FFAR2, 
GPR183, LAT2, PTPRC, SMAGP, 
SIN3A, PSME1, LY86, CLEC4D, XBP1, 
TNFRSF1, CTSL, TNFRSF9, IL16, 
NR1H3, PSMB7, PAG1, PHLPP2, 
TNFSF15, CD300LF, NOD1, ADAM17, 
ERAP2, GPR183, PRELID1, CLEC4G, 
SLAMF6, ICAM3, ECSIT, LGMN, 
TRIM34, CD3D, ERCC1, COL4A3B, 
PSMA3, CD3D, LAT2, RAB27A, 
TNFRSF1, RNASE1, CREB1, IL18BP, 
NCF4, PDE4B, PSMD4, PTGES2, KL, 
LGALS8, LGALS8, CD79B, CD40, 
UBA52, XAF1, BTN3A3, CTSL, 
PRKACB, ERCC1, CASP8, SMAGP, 
CRCP, ITGB1, PRKCZ, PLEKHA1, 
PYCARD, MAPK3, RNF135, CD97, 
NDUFA2, FTH1  
 Black/White - Black/Hispanic PNKD, IL4R, DUSP5, CRIP1, OAS1, 
RGCC, SPN, CLCF1, IRAK3, FCER2, 
PLEKHA1, LFNG, CD180, MAPK3, 
EXOSC6, DUSP22, OAS1, F2RL1, 
VNN1, OAS1, ADCY3, CYFIP2, 
TRPM4, ADARB1, CTSG, SPNS1, 
HFE, DEFB1, SIGLEC7, ETS1, CCM2, 
FES, TRIM68, NLRP3, MAP2K6, 
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TNFRSF1, RNF135, SH2D1B, CD300C, 
RPS6KA2, PSMD1, NFATC1, RAC2, 
CD79B, NLRP3, ITGB1, CCR7, 
TSPAN32, CD1D, CCL2, TLR5, SIRT2, 
MAP4K2, OTUB1, CPAMD8, TNF, 
CXCL16, FCGR3B, SRC, LGALS3, 
PSMD9, NBN, THEMIS2, PAG1, BCL6, 
RNF135, CLEC6A, PSMB5, C5, CD33, 
HLA-DPB, SKAP1, CSK, IRF4, IKBKE, 
LY75, IFNGR2, SOS1, POLR1D, 
SFTPD, RASGRP1, CCR2, PNMA1, 
HLA-DPA, HRAS, PNKD, CCR2, IL1B, 
CFD, CCR2, ELMO2, LYN, CCM2, 
CD36, CD79B, LILRA3, CDKN1A, 
TRIB3, GNL1, CD7, RNASE1, 
SIGLEC9, GPER1, LTA, CD36, 
HIST1H2, PPP3R1, FFAR2, HMOX1, 
LAT2, ADA, SMAGP, JUN, CTSL, 
DUSP22, HIST1H2, TNFRSF9, NR1H3, 
F2RL1, PAG1, RNASE3, ETS1, 
STXBP2, HLA-DRB, GPR183, CXCL5, 
PRELID1, CLEC4G, TREML4, CD3D, 
CCR2, YWHAB, APOBEC3, NLRP3, 
TRIM4, CD3D, LAT2, RNASE1, 
PDE4B, IL7R, CYFIP2, OTUB1, 
CD79B, IL32, BTN3A3, CTSL, LTB, 
LTB, CCR2, SMAGP, CRCP, ITGB1, 
GPER1, TSPAN32, CLEC4A, RNF135, 
CD96, IP6K2  
 Black/Hispanic - Hispanic/White RGS1, CRIP1, RPS6KA5, RGCC, 
CD180, CXCL8, VNN1, LEF1, TRPM4, 
TRAT1, SIGLEC7, RNF135, CD300C, 
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RPS6KA2, PSMD1, PKN2, NFIL3, 
CD79B, ITGB1, CD1D, EXOSC9, 
CDKN1B, BST2, HIST2H2, THEMIS2, 
PAG1, BCL6, RNF135, HLA-DPB, 
IRF4, EIF2AK4, NAIP, IFNGR2, SOS1, 
BST1, PNMA1, PNKD, PIN1, CCR2, 
CD44, OSM, SOCS3, CD79B, RNASE1, 
CD36, PPP3R1, FFAR2, LAT2, 
SMAGP, CTSL, TNFRSF9, NR1H3, 
PAG1, GPR183, PRELID1, CXCL8, 
CLEC4G, CDKN1B, LEF1, FYN, NAIP, 
CD3D, CD3D, LAT2, RNASE1, 
CREB1, PDE4B, CD79B, BTN3A3, 
CTSL, SMAGP, CRCP, ITGB1, CCR6, 
BIRC3, RNF135, IP6K2 
 All CRIP1, RGCC, CD180, VNN1, TRPM4, 
SIGLEC7, RNF135, CD300C, 
RPS6KA2, PSMD1, CD79B, ITGB1, 
CD1D, THEMIS2, PAG1, BCL6, 
RNF135, HLA DPB, IRF4, IFNGR2, 
SOS1, PNMA1, PNKD, CCR2, CD79B, 
RNASE1, CD36, PPP3R1, FFAR2, 
LAT2, SMAGP, CTSL, TNFRSF9, 
NR1H3, PAG1, GPR183, PRELID1, 
CLEC4G, CD3D CD3D, LAT2, 
RNASE1, PDE4B, CD79B, BTN3A3, 
CTSL, SMAGP, CRCP, ITGB1, RNF135 
Inflammatory Response   
 Black/White – Hispanic White HMGB2, AHCY, CD180, HYAL3, 
C1QBP, CCL3, CD97, VNN1, CCR1, 
CXCR2, FOXP1, THBS1, CEBPB, 
GHRL, ORM1, TNFRSF2, PLA2G7, 
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AIF1, ADORA2B, NFKB1, NFKBIZ, 
ZFP36, THEMIS2, BCL6, FOXP1, 
IRAK2, NRROS, CAMK1D, MCPH1, 
APOL3, P2RX1, ACVR1, PRDX2, 
POLB, PIK3CG, PNMA1, CCL3L1, 
CCR2, CD40, KLF4, TNFAIP6, NOV, 
METRNL, STK39, AIF1, GART, 
RNASE1, CAMK1D, PTGER4, FFAR2, 
NDST1, LY86, SIGIRR, PLA2G4C, 
TNFRSF9, NR1H3, NOD1, KLF4, LYZ, 
RNASE1, METRNL, KL, ATRN, CD40, 
PRDX2, PRKCZ, PYCARD, F11R, 
CD97, NDUFA2  
 Black/White - Black/Hispanic IL4R, SPN, CD180, HYAL3, F2RL1, 
VNN1, SPNS1, HFE, DEFB1, ETS1, 
LTA4H, CCM2, NLRP3, NR1D2, 
PLA2G7, EHHADH, ELANE, NLRP3, 
CCR7, CCL2, CASP5, TLR5, LXN, 
TNF, THEMIS2, BCL6, C5, ADORA1, 
MCPH1, APOL3, LY75, PRDX2, POLB, 
RASGRP1, CCR2, PNMA1, CD47, 
CCR2, PROK2, IL1B, CCR2, LYN, 
CCM2, RNASE1, GPER1, LTA, FFAR2, 
HMOX1, ADA, TSPAN2, PLA2G4C, 
HP, TNFRSF9, NR1H3, F2RL1, ETS1, 
CXCL5, CCR2, NLRP3, RNASE1, 
CCR2, HIF1A, SEH1L, PRDX2, 
GPER1, DUSP10  
 Black/Hispanic - Hispanic/White RPS6KA5, CD180, CXCL8, HYAL3, 
VNN1, PTGS2, PLA2G7, THEMIS2, 
BCL6, NLRP12, MCPH1, APOL3, 
NAIP, PRDX2, POLB, PNMA1, CCR2, 
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CD44, OSM, SOCS3, NFE2L2, 
RNASE1, FFAR2, CXCR4, PLA2G4C, 
TNFRSF9, NR1H3, PRDX5, CXCL8, 
NAIP, CXCR4, RNASE1, PRDX2, 
BIRC3  
 All CD180 , HYAL3, VNN1, PLA2G7, 
THEMIS2, BCL6, MCPH1, APOL3, 
PRDX2, POLB, PNMA1, CCR2, 
RNASE1, FFAR2, PLA2G4C, 
TNFRSF9, NR1H3, RNASE1, PRDX2
  
Regulation of the Inflammatory Response   
 Black/White – Hispanic White C1QBP, CCL3, FOXP1, GHRL, 
PLA2G7, ADORA2B , NFKB1, ZFP36, 
BCL6, FOXP1, TNFAIP8, ADORA1, 
MCPH1, CALCRL, PIK3CG, CCL3L1, 
CCR2, KLF4, TNFAIP6, NOV, 
METRNL, STK39, PTGER4, FFAR2, 
NR1H3, KLF4, METRNL  
 Black/White - Black/Hispanic SPN, ETS1, CCM2, NLRP3, NR1D2, 
PLA2G7, EHHADH, ELANE, NLRP3, 
CCR7, CASP5, TNF, BCL6, MYD88, 
CD6, C5, ADORA1, MCPH1, CCR2, 
CD47, CCL5, CCR2, IL1B, CCR2, LYN, 
CCM2, GPER1, LTA, FFAR2, ADA, 
NR1H3, CCL5, ETS1, CCR2, NLRP3, 
CCR2, GPER1, DUSP10  
 Black/Hispanic - Hispanic/White PTGS2 , PLA2G7, TNFAIP3, BCL6, 
NLRP12, ADORA1, MCPH1, CCR2, 




 All PLA2G7, BCL6, ADORA1, MCPH1, 



































Overlap between Gene Transcripts Assessed in Aim  2 and 3 with Gene Transcripts 
Assessed in Aim 1 
Aim 2 & 3 biological 
processes 
# of transcripts in  each 
biological process 
# of transcripts also assessed 
in Aim 1* 
Chronic Inflammation 20 17 
Immune Response 1251 422 
Inflammatory Response 438 148 
Regulation of Inflammatory 
Response 
192 60 
* 1854 gene transcripts were assessed in Aim 1 
 
 
 
 
